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Post-extubation dysphagia is well documented in the Intensive Care Unit (ICU) 
population, particularly following prolonged intubation (≥48 hours). Identifying patients with 
dysphagia is important as these individuals are more likely to develop pneumonia, and ICU 
patients who develop pneumonia are more likely to have poor outcomes. Despite the 
frequency and clinical significance of post-extubation dysphagia, there are currently no 
recognised, standard protocols outlining how and when to assess swallowing in patients after 
extubation. Assessing swallowing in this population is complicated by the high prevalence of 
silent aspiration, which cannot be identified on clinical assessment.  
Silent aspiration has been associated with attenuation of the cough reflex in the stroke 
population and cough reflex testing (CRT) has shown promise as a screening tool to identify 
patients who are at risk of silent aspiration. There is evidence in the literature that the cough 
reflex is impaired following short periods of orotracheal intubation for minor surgery, but the 
cough reflex has never been studied specifically in the post-extubation ICU population. Thus, 
it may be hypothesised that CRT is a suitable tool for assessing the cough reflex following 
extubation and may also be able to identify which patients are at the greatest risk of silent 
aspiration. 
This research programme investigated the impact of orotracheal intubation on the 
cough reflex. The goals of Study I were to identify and quantify impairment of the cough 
reflex following extubation and to track recovery of the cough reflex. Eighty-six participants 
who were admitted for elective coronary artery bypass grafting (CABG) underwent CRT 
prior to intubation using 0.4, 0.8 and 1.2 mol/L nebulised citric acid to establish baseline 
thresholds for reflexive cough. CRT was repeated within two hours of extubation to identify 
change from baseline cough. If a participant’s cough sensitivity was at their pre-intubation 
baseline, their participation in the study was complete. Participants who had an absent cough 
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or required a stronger concentration of citric acid to stimulate cough were retested every 
morning and evening thereafter until they coughed at their baseline level, withdrew from the 
study or were discharged from hospital. Participants varied in time to recovery of cough 
reflex. Sixty percent of participants had an absent cough reflex at the first follow-up after 
extubation (M=70 minutes). By the fifth follow-up, which occurred at approximately 48 
hours post-extubation, 86% of participants had recovered their baseline cough sensitivity. 
Age, gender and length of intubation had no significant impact on the time to recovery of 
cough reflex (p>0.3). There was a highly significant correlation between opioid dose and 
CRT result with participants with higher doses (mg/kg/hr) returning more quickly to baseline 
CRT. However, this was more likely due to the pattern of opioid administration, with patients 
passing the first CRT after extubation consistently having had higher recent opioid doses than 
patients passing on the fourth or fifth follow-up, rather than a causative relationship between 
high doses of opioids and increased cough sensitivity.  
The primary aim of Study II was to determine the sensitivity and specificity of CRT 
for identifying silent aspiration. One hundred and six ICU patients underwent CRT using 0.4, 
0.6 and 0.8 mol/L nebulised citric acid and videoendoscopic evaluation of swallowing (VES) 
within 24 hours of extubation. Cough reflex threshold was established for each participant 
and cough responses were classified as strong or weak. VES was recorded for later evaluation 
by a speech-language therapist (SLT) who was blinded to the results of CRT.  
Thirty-nine (37%) participants had an absent cough to CRT. Thirteen (12%) 
participants aspirated on VES, 9 (69%) without a cough response. Sensitivity of CRT to 
identify silent aspiration was excellent at detecting both aspiration and silent aspiration at 0.4 
and 0.6 mol/L nebulised citric acid, with weak cough responses grouped with absent 
responses. However, specificity of CRT to detect aspiration or silent aspiration was poor at 
all concentration and regardless of the grouping of weak cough responses with strong or 
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weak responses. There was a significant correlation between intubation duration and presence 
of aspiration on VES (p=0.01). There was no significant correlation between silent aspiration 
on VES and length of intubation or either overt or silent aspiration and age, gender, reason 
for ICU admission, indication for intubation, APACHE III score, morphine equivalent dose 
or time of testing post-extubation.  
In summary, this research programme is the first to identify that cough reflex to citric 
acid is impaired following extubation and that this impairment often persists for up to 48 
hours. It confirms that ICU patients are at risk of aspiration and silent aspiration following 
extubation, and provides new evidence that CRT has poor specificity when screening for 
silent aspiration risk in this population. This poor specificity suggests that the causes of post-
extubation aspiration and post-extubation cough impairment differ. These results contribute 
to better understanding of post-extubation dysphagia. More research is needed to determine if 
CRT would be beneficial within particular patient groups after extubation and to determine 
the cause of post-extubation cough impairment. 
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1 Introduction, Literature Review and Statement of the Problem 
1.1 Introduction 
Post-extubation dysphagia is common and patients who have been intubated are more 
likely to aspirate when eating and drinking (Ajemian, Nirmul, Anderson, Zirlen, & Kwasnik, 
2001; El Solh, Okada, Bhat, & Pietrantoni, 2003; Leder, Cohn, & Moller, 1998; Scheel, 
Pisegna, McNally, Noordzij, & Langmore, 2016). Individuals who aspirate are more likely to 
have poor outcomes, including the development of pneumonia, longer stays in hospital and 
greater chance of death (Macht et al., 2011). Although this phenomenon is well recognised, 
there are currently no accepted protocols on how and when to assess swallowing in this 
population. Following extubation, some patients aspirate without producing a cough response 
(Ajemian et al., 2001; El Solh et al., 2003; Leder et al., 1998) and traditional clinical 
swallowing assessment is not able to reliably detect silent aspiration. Research into the use of 
cough reflex testing (CRT) to screen for risk of silent aspiration has shown promise in the 
stroke population and may be a useful tool for the post-extubation population. However, little 
is known about the effect of intubation on the cough reflex. This research programme will 
investigate the impact of orotracheal intubation on the cough reflex and the value of CRT in 
this population. 
Following this brief introduction, Part A of this thesis explores the literature on 
normal and disordered swallowing in the intensive care unit (ICU) setting, specifically after 
extubation. In addition, the importance and mechanisms of airway protection and effect of 
intubation on the airway are outlined. Finally, existing research on CRT is explored in detail, 
including the various methodologies used by different research groups. This information lays 
the foundation for the methodology selected in the research programme.  
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In Part B, two original research projects are presented. The aims of the first project, 
Study I, were to identify and quantify impairment of cough reflex to citric acid following 
extubation and to track recovery of the cough reflex. The primary aim of the second study 
was to determine the sensitivity and specificity of CRT for detecting silent aspiration by 
analysing the correlation between response to CRT and response to aspiration on 
videoendoscopy (VES). The hypotheses of these two studies, research methodologies, 
analyses and results are presented. 
In Part C, the results of the research programme are discussed in the context of related 
literature. These are the first studies to examine CRT in the post-extubation population and 
the significance of the new information is explored. The reasons for differences between 
validity results in this research programme and previous studies are debated. There are 
several limitations to the research studies presented in this thesis and these are also outlined. 
Finally, Part D explores directions for future research. Both swallowing and cough 
reflex are impaired after extubation. Although CRT has poor specificity as a screening tool 
for silent aspiration in the ICU population, better understanding of how orotracheal intubation 
affects the cough reflex and swallowing and further attempts to develop valid assessment 
tools for this population will ensure that risk is minimised in this vulnerable group. 
1.2 Normal Swallowing and Airway Protection 
1.2.1 Normal Swallowing 
Swallowing is one of the most complex reflexes initiated within the central nervous 
system (Doty, 1951). It involves the sensory and motor pathways in the cerebrum, cerebellum 
and brainstem, and numerous muscles innervated by five cranial nerves. To fully understand 
the disorders of swallowing and their impact, it is essential to first understand both normal 
swallowing physiology and the mechanisms for protecting the airway from contamination by 
food, drink and saliva. With each swallow, material is carried from the oral cavity through 
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the pharynx, past a closed and protected airway, through the oesophagus and then to the 
stomach in a smooth, continuous and complex series of muscle movements. Various 
researchers have delineated aspects of swallowing in different ways (Dodds, 1989; 
Logemann, 1998; Matsuo, 2008), but it is important to acknowledge that these divisions are 
artificial and events in one phase of swallowing may impact other phases (Daniels & 
Huckabee, 2014). Daniels and Huckabee (2014) promote a model holistic of swallowing 
which includes the pre-oral phase, in addition to the oral, pharyngeal and oesophageal phases.  
1.2.1.1 Pre-oral Phase 
Before food or drink enters the mouth, the body prepares for ingestion in response to 
stimulation received through the senses. The olfactory nerve (CNI) and occipital nerve (CN 
II) receive olfactory and visual information and relay this input to the cortex. Salivation is 
triggered (CN VII, IX) to lubricate the oral cavity and prepare for digestion. Visual and 
olfactory information from the bolus is processed by the cortex and used to modify the 
resulting swallowing output (Ebihara et al., 2006; Ushioda et al., 2012).  
1.2.1.2 Oral Phase 
The start of the oral phase is delineated by bolus entering into the oral cavity. The 
mouth opens (CN V, AC) and the tongue drops to accept the bolus (CNXII). The bolus is 
contained anteriorly by the lips (CNVII) and posteriorly by the base of tongue (CN IX & X). 
Mastication and lingual manipulation (CNV, VII, XII, AC) modify the bolus to a consistency 
appropriate for swallowing. The base of the tongue drops (CN XII) to allow the bolus access 
to the pharynx and the tongue presses against the palate (CN XII), anteriorly to posteriorly, to 
propel the bolus towards the pharynx (Daniels & Huckabee, 2014).  
During the pre-oral and oral phases, sensory information is gathered from mechanical 
and chemical receptors in the teeth (CN V), palate (CN V), mucosa of the mouth and gums 
(CN V), tongue (V, VII & IX), soft palate (CN IX) and faucial arches (CN X) and is 
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transmitted via cranial nerves to brainstem (Daniels & Huckabee, 2014; Dodds, 1989). The 
posterior oral cavity, including the region of the faucial arches and junction of the naso- and 
oropharynx, is densely innervated with sensory neurons (VII, IX, X). These neurons synapse 
in the nucleus tractus solitarius (NTS), the primary sensory nucleus for swallowing, located 
in the dorsal region of the medulla (Miller, 2008; Nishino, 2013). Sensory information from 
the oral cavity is also relayed to the cortex and is crucial for tailoring the swallowing 
response to each individual bolus (Miller, 2008; Nishino, 2013; Teismann et al., 2007). 
1.2.1.3 Pharyngeal Phase 
The swallowing motor plan created in the NTS is transmitted to the nucleus ambiguus 
(NA), which in turn sends excitatory signals to activate the muscles of the pharynx, larynx 
and oesophagus (Amri & Car, 1988). The combined contributions of the NTS and NA, and 
the associated interneurons, constitute a central pattern generator for swallowing (Kessler & 
Jean, 1985) and are responsible for the pharyngeal response to sensory input in the oral 
cavity.  
Once the brainstem networks initiate the pharyngeal phase, precise timing of events is 
critical to ensure efficient transfer of the bolus from the upper pharynx to the oesophagus. It 
is essential that structures of the pharynx are able to move quickly and without obstruction. 
As the bolus leaves the oral cavity, the soft palate elevates (CN IX, X) to create a closed 
pressure system in the pharynx (Matsuo, 2008). The base of tongue retracts and the 
pharyngeal constrictors contract (CN IX & X) to create the beginning of a pressure wave, 
which moves inferiorly, pushing the bolus towards the oesophagus (Dodds, 1989). More 
critically, this contraction also shortens and reduces the volume of the pharynx (Matsuo, 
2008). The submental muscles pull the hyoid bone anteriorly (CN V, ansa cervicalis), while 
the posterior belly of the digastric, the stylohyoid and the middle pharyngeal constrictor 
simultaneously pull it superiorly and posteriorly (CN VII, IX, X) (Ludlow et al., 2007; 
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Matsuo, 2008). Anterior movement of the hyoid is essential for effective swallowing as it 
deflects the epiglottis (Steele et al., 2011) and exerts traction on the upper oesophageal 
sphincter (UES) (Dodds, 1989; Matsuo, 2008). The UES relaxes (CNX) as it is being pulled 
open and allows passage of the bolus into the oesophagus (Dodds, 1989; Matsuo, 2008). 
Several levels of airway protection occur during the pharyngeal phase of swallowing 
to prevent the bolus from contaminating the airway. The arytenoids approximate (CN X) to 
bring together the true and false vocal cords (Van Daele, McCulloch, Palmer, & Langmore, 
2005), and tilt forward to contact the epiglottis (Matsuo, 2008). The movement of the hyoid, 
and consequently the thyroid cartilage, positions the larynx underneath the base of the tongue 
(Matsuo, 2008). The epiglottis, in its deflected position, protects the glottis (Matsuo, 2008). 
Supraglottic shortening (ansa cervicalis) compresses the quadrangular membrane, blocking 
the entrance to the laryngeal vestibule (Daniels & Huckabee, 2014). The many levels of 
airway protection provide redundancy in the case of injury.  
Sensory input during the pharyngeal phase is provided by CN IX & X from the 
oropharynx and hypopharynx and the superior laryngeal nerve (SLN) of the vagus from the 
larynx and proximal trachea (Armstrong & Netterville, 1995) and recurrent laryngeal nerve 
(RLN) from the distal trachea. Afferent neurons throughout the pharynx synapse on 
interneurons within the NTS and directly to the NA in the case of the SLN (Sugiyama et al., 
2011), providing sensory information to the brainstem swallowing centres (Miller, 2008). 
This input allows rapid modulation of the sequence and timing of motor activities during 
swallowing and generation of prompt airway clearance as needed (Steele & Miller, 2010). 
1.2.1.4 Oesophageal Phase 
This final phase in the transfer of the bolus from mouth to stomach begins as the 
bolus passes the UES and enters the oesophagus (Daniels & Huckabee, 2014). As the hyoid 
descends, the UES passively closes and actively returns to its baseline contracted state. The 
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muscles of the oesophagus create a peristaltic wave, pushing the bolus to the stomach 
(Dodds, 1989; Miller, 2008). The innervation of the oesophagus is complex; the smooth 
muscle of the oesophagus is innervated differently from the striated muscle and both work 
together in a coordinated fashion to propel the bolus (Miller, 2008). Afferent neurons from 
the length of the oesophagus synapse in the NTS (Miller, 2008). Sensory input from and 
motor output to a particular segment of the oesophagus is assigned to a specific region of the 
NTS (Miller, 2008). This creates a continuous loop of sensory feedback and motor response, 
allowing the brainstem swallowing centres to tailor the strength of oesophageal contractions 
to each bolus (Dong, 2001).  
Integration of sensorimotor information from numerous central and peripheral neural 
structures and precise coordination of the movement of several proximal and distal 
anatomical structures is essential for normal swallowing to occur. Disruption of any part of 
this process can result in significant swallowing impairment, introducing inefficiency to the 
swallowing act and compromising swallowing safety.  
1.2.2 Airway Protection 
The anatomy and physiology of human swallowing is unique from other mammals. 
As humans have evolved over millions of years, from walking on all fours to standing 
upright, the larynx has moved further from the oral cavity to its current location near the 
oesophageal inlet (Brooks, 2011). This has created an increased risk that food, fluid and 
secretions can be aspirated (Brooks, 2011). The multiple levels of laryngeal closure - closure 
of the true vocal folds, closure of the ventricular folds, approximation of the arytenoids over 
the vocal folds, compression of the quadrangular of the membrane and epiglottic deflection - 
ensure that bolus material does not enter the airway (Daniels & Huckabee, 2014; Matsuo, 
2008). However, when laryngeal closure is incomplete due to neurological or structural 
impairment, a portion of the bolus can enter the laryngeal vestibule and contact the mucosa of 
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the larynx, trachea or bronchi. The human cough reflex has evolved as the airway’s primary 
defence against the intrusion of foreign material, including airway particles, gastric contents, 
saliva and ingested food and fluid (Mazzone, Mori, & Canning, 2005). 
Cough is defined in the European Respiratory Society (ERS) Guidelines on the 
Assessment of Cough as “a three-phase expulsive motor act characterized by an inspiratory 
effort (inspiratory phase), followed by a forced expiratory effort against a closed glottis 
(compressive phase) and then by opening of the glottis and rapid expiratory airflow 
(expulsive phase)” (Morice et al., 2007, p. 1256). Each component is essential for an 
effective cough. Sufficient intake of air during the inspiratory phase and adequate build-up of 
pressure during the compressive phase result in a powerful expulsive phase, which clears 
material from the airway, thus preventing aspiration and its potential harmful consequences. 
The human cough reflex is complex, involving multiple cough receptors responding to 
different stimuli and, in turn, triggering different types of involuntary cough. This 
redundancy is seen with other reflexes and has developed over millions of years to protect the 
airway from aspiration of food, fluid and stomach contents as well as inhalation of irritant 
chemicals and gasses (Brooks, 2011; Canning & Mori, 2011). Understanding the anatomy 
and physiology of cough receptors and neural networks is key to understanding the 
relationship between cough and aspiration. 
1.2.3 Airway receptors  
The airways are densely lined with a range of receptors designed to detect foreign 
material. These receptors are identified by the stimuli they respond to and are grouped into 
mechanoreceptors and chemoreceptors. Each type of receptor triggers a unique motor 
response; stimulation of more than one receptor type can result in cough. The types of 
receptors are shown in Figure 1 with characteristics of each receptor outlined.  
1.2.3.1 Mechanoreceptors 
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Lung inflation, bronchospasm and light touch, such as that created by a piece of 
aspirated food or liquid, all trigger low threshold mechanoreceptors (Canning, 2006; 
Mazzone, 2005). In addition, some chemicals can indirectly trigger mechanoreceptors, 
including citric acid. This is thought to be because their contact with the mucosa triggers 
bronchospasm and mucous secretions, which in turn activate the rapidly adapting receptors 
(RAR) (Canning, 2006; Mazzone, 2005). The best-known types of mechanoreceptors, RARs 
and slowly adapting receptors (SARs), share many characteristics, such as their origination 
and termination points, action potential range and response to mechanical stimuli. However, 
there are differences that make these two receptor types distinct (Mazzone, 2005).  
 RARs are present primarily in the intrapulmonary airways, although they do exist 
throughout the airways (Canning, 2006). RARs are so called because they quickly adapt to 
sustained stimulus, as in the case of a breath-hold (Canning, 2006). RARs are active 
throughout the inflation and deflation of the lungs and become increasingly active when rate 
and volume of breathing increases (Canning, 2006). When stimulated, rapid breathing ensues, 
the smooth muscles of the airway contract and mucous production increases (Canning, 2006; 
Mazzone, 2005). Many stimuli that activate RARs do not activate cough and stimuli that 
induce cough through stimulation of RARs do so only under specific conditions. This 
suggests that stimulating cough is not the primary role of the RARs (Canning, 2006). 
SARs are most active at peak lung inflation and are likely involved in ceasing 
inspiration and initiating expiration. They also have a role in airway tone (Mazzone, 2005). 
SARs appear to play a role in cough, possibly modulating the expiratory effort in cough, 
although cough stimulation does not appear to be their primary function (Canning, 2006). 
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Figure 1. Properties of Airway Receptors. 
From “Anatomy and neurophysiology of the cough reflex: ACCP evidence-based clinical practice guidelines,” by B. J. Canning, 2006, Chest, 
129, p. 33S to 47S. Copyright 2006 by American College of Chest Physicians. Reprinted with permission.  
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1.2.3.2 Chemoreceptors 
In contrast to RARs and SARs, chemoreceptors are not active during normal 
breathing. Chemoreceptors become active when the airways are irritated or inflamed, and can 
be stimulated by exposure to a variety of chemicals, including capsaicin, bradykinin, citric 
acid and sulphur dioxide (Canning, 2006; Mazzone, 2005). Chemoreceptors are located 
throughout the airways. Some of these receptors can also be triggered with a very strong 
mechanical stimulation, such as the prodding of the laryngeal mucosa (Canning, 2006; 
Mazzone, 2005).  
C-fibers are the most common type of chemoreceptor and the most prevalent receptor 
innervating the airways and lungs. They are unmyelinated, in contrast to RARs and SARs, 
and conduct signals at a lower velocity. Stimulation of C-fibers provokes apnoea, 
bradycardia, hypotension and, in guinea pigs and rats, bronchospasm, mucous secretion and 
neurogenic inflammation (Canning, 2006; Lee & Undem, 2008). C-fiber activation may 
provoke cough, as the chemical stimulants that activate C-fibers can trigger coughing in 
conscious humans and animals (Canning, 2006; Lee & Undem, 2008). In particular, 
stimulation with bradykinin and capsaicin result in paroxysmal coughing (Canning & Mori, 
2011). C-fiber activation in anaesthetised animals does not trigger cough (Canning & Mori, 
2011). In addition, coughing in humans in response to capsaicin is always preceded by a 
reported irritation in the throat, termed an “urge to cough” (Davenport, Sapienza, & Bolser, 
2002; Mazzone, McGovern, Koo, & Farrell, 2009; Mazzone, McLennan, McGovern, Egan, 
& Farrell, 2007). For these reasons, C-fiber-triggered cough is thought to involve sensory 
processing and be, at least in part, a behavioural response to airway irritation, not a pure 
reflex (Lee & Undem, 2008; Mazzone et al., 2009). C-fibers are not likely to be the primary 
cough receptor, but do clearly play an important role in cough (Canning, 2006).  
1.2.3.3 True Cough Receptors 
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A group of receptors, present in the larynx, trachea and, to a lesser extent, main stem 
bronchi, which respond to both mechanical and chemical stimuli, have been termed the “true” 
cough receptors (Canning, 2006; Mazzone, 2005). Canning first identified what he termed the 
“true” cough receptor in guinea pigs, but he suggests they also exist in humans (Canning, 
2006). These receptors are myelinated and are known to be incredibly sensitive to punctuate 
stimuli as well as acid, water and 4-aminopyridine, but do not respond to capsaicin, 
hypertonic saline solution or bradykinin (Canning, 2006; Canning & Mori, 2011). True cough 
receptors are similar to RARs in myelination and that they adapt to stimuli (Canning, 2006; 
Lee & Undem, 2008), but are distinguished from other mechanoreceptors by their sensitivity 
to unique stimuli and slower action potential than RARs and SARs (Canning, 2006; Lee & 
Undem, 2008). Stimulation of the true cough receptor triggers a few powerful coughs, which 
would be effective for clearing aspirated material (Canning & Mori, 2011). In addition, their 
sensitivity to acid, including citric acid, and subtle mechanical stimuli may point to their role 
in protecting the airway from aspiration of foreign matter, including food, fluid and stomach 
contents (Brooks, 2011; Morice et al., 2007).  
1.2.4 Afferent Pathways of Cough 
Whether cough is triggered by a chemical or mechanical stimulus, transduction of the 
signal to the brain begins with an interaction between the stimulus and the molecules of the 
nerve terminals. When the threshold is reached an action potential is triggered and travels via 
the vagus nerve to the brainstem (Kollarik & Undem, 2006). The signal travels primarily 
ipsilaterally, but both branches of the vagus nerve transduce signals from the receptors to the 
brainstem, such that damage to one of the vagus nerves will not impact cough (Canning, 
2006). Both the RLN and SLN branches of the vagus nerve contain afferent nerves from the 
airway receptors (Canning et al., 2004). The RLN plays a greater role in cough. When the 
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RLNs of anaesthetised guinea pigs were severed bilaterally, stimulation to the larynx and 
trachea did not trigger cough, but severance of the SLNs had no effect (Canning et al., 2004). 
The afferent fibres of the vagal nerves continue via the nodose and jugular ganglia to 
the brainstem where they terminate primarily at the NTS, a complex integration centre of 
afferent input located in the medulla, within the brainstem (Narula, McGovern, Yang, Farrell, 
& Mazzone, 2014). In response to mechanical stimulation or acid inhalation, presumably 
stimulating the true cough receptor, a purely reflexive cough can be triggered via neural 
projections from the NTS to the ventral respiratory group (Narula et al., 2014; Shannon et al., 
2004). This brainstem reflex is not cortically controlled and cannot be consciously modified. 
Triggering of the reflex results in an extremely rapid cough motor output, likely intended to 
protect the airways from aspiration (Ando, Farrell, & Mazzone, 2014; Canning & Mori, 
2011).  
In the case of cortically modulated cough, the pathway to the brainstem is shared. The 
action potential travels via the vagus nerve to the NTS and connects with second order 
neurons, which transmit the signal to supramedullary areas (Mazzone et al., 2009). 
Functional magnetic resonance imaging during inhaled capsaicin challenges has revealed 
numerous areas of the brain activated with urge-to-cough including the sensorimotor cortex, 
anterior mid-cingulate cortex, anterior insula, prefrontal cortex supplementary motor area, 
cerebellum, thalamus and lentiform nuclei (Farrell, Cole, Chiapoco, Egan, & Mazzone, 2012; 
Mazzone et al., 2009; Mazzone et al., 2007). Some areas of the brain appear to be involved in 
localising the irritating sensation (Farrell et al., 2012). Other areas, which show dose-
dependent responses, process the sensory information while yet others may be involved in 
supressing cough (Farrell et al., 2012). The purpose of the urge to cough is presumably to 
engage the cortex in evaluating the cough and modifying the cough response. Precisely how 
this occurs is not fully understood (Davenport, Vovk, Duke, Bolser, & Robertson, 2009). 
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However, it is important to acknowledge the ability of humans to exercise wide-ranging 
control over cough output, including the production of a purely volitional cough, supressing 
the urge to cough and coughing in response to placebo stimuli (Ando et al., 2014). These 
factors can all make assessment of cough very challenging.  
1.2.5 Other airway reflexes  
The cough reflex exists alongside other airway protection reflexes, which assist in 
keeping the airways clear of harmful material. The expiratory reflex and glottic closure reflex 
can be triggered by stimulation to the vocal cords or mucosa of the trachea (Widdicombe, 
Eccles, & Fontana, 2006). The expiratory reflex, which is defined as immediate closure and 
reopening of the glottis that coincides with exhalation, without preceding inhalation, may 
occur prior to a reflexive cough (Fontana & Lavorini, 2006; Widdicombe, Addington, 
Fontana, & Stephens, 2011). The purpose of the expiratory reflex is presumably to assist with 
clearance of material from the airway prior to cough and plays an important role in clearing 
aspirate from the airway (Fontana & Lavorini, 2006; Widdicombe et al., 2011). An individual 
response to aspiration may consist of several expiratory reflexes, coughs and glottal closures 
in rapid succession, referred to as a cough epoch (Widdicombe et al., 2006). Although 
assessment of airway protection in patients who are at risk of aspiration has focused on the 
cough reflex, these other reflexes likely also play an important role in preventing aspiration 
or clearing material from the airway after it has been aspirated.  
1.2.6 Motor Component of Coughing 
The efferent pathways of the brainstem are not unique to cough. The pathways and 
brainstem structures that produce coughing are the same that produce tidal breathing as well 
as other reflexes, including swallowing, expiration reflex, gagging, laryngospasm, 
bronchoconstriction, apnoea and retching (Brooks, 2011; Mazzone, Cole, Ando, Egan, & 
Farrell, 2011; Shannon et al., 2004). In the case of purely reflexive cough, the action potential 
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is conveyed from the airway receptors to the NTS in the medulla as described above. From 
there, interneurons conduct the signal to the pontine and ventral respiratory groups and 
further through a complex brainstem network that is not fully understood (Shannon et al., 
2004). The usual breathing pattern is reconfigured to produce a cough pattern and the pre-
motor drive is conducted to the respiratory and motor neuron pools (Mazzone et al., 2011; 
Narula et al., 2014; Shannon et al., 2004). In the case of urge-related coughing, corticobulbar 
tracks from the motor control centre provide further input to the brainstem cough centres to 
supress or modify cough output (Mazzone et al., 2011). Interestingly, voluntary cough 
appears to bypass the medulla, utilising a corticospinal tract (Mazzone et al., 2011). The 
entire afferent and efferent pathway is pictured in Figure 2. 
1.2.7 Summary 
Swallowing has been described as a four-phase process, consisting of the pre-oral, 
oral, pharyngeal and oesophageal phases. It is a complex process that requires integration of 
sensory input and motor output as well as the precise and rapid movement of a number of 
structures. When this process is disrupted and laryngeal closure is incomplete, bolus may 
enter the airway. The cough reflex has evolved alongside other airway reflexes to protect the 
airway from contamination. 
Cough occurs in response to the stimulation of mechano- and chemoreceptors in the 
airways. The signal from the receptors is conveyed via the vagus nerve to the brainstem and, 
in the case of cortically modulated cough, to the cortex via second order neurons. Centres in 
the brainstem reconfigure the normal respiratory pattern in response to sensory input to 
produce the three phases of cough: inspiratory, compressive and expulsive. Knowledge of the 
various airway receptors, including mechano- and chemoreceptors, and their sensitivity to 
various tussigens is essential for understanding CRT methodology. 
 
 
Figure 2. Revised Model for the Neural Control of Cough. 
From “A framework for understanding shared substrates of airway protection,” by M. S. 
Troche, A. E. Brandimore, J. Godoy, & K/ W. Hegland, 2014, Journal of Applied Oral 
Science,22(4), p. 251-260. Open Access by SciELO 2014.  
1.3 Disordered Swallowing 
Dysphagia is the term used to describe a disruption in the normal process of 
swallowing. Dysphagia can occur during any of the phases of swallowing and can result from 
any condition that impacts the structure or function of swallowing. For the purposes of this 
discussion, the term dysphagia will be narrowly defined, referring exclusively to 
oropharyngeal dysphagia. In a 2012 household survey of Americans, 4% of the adult 
population reported experiencing dysphagia within the previous 12 months (Bhattacharyya, 
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2014). Bhattacharyya (2014) grouped the causes of dysphagia into several categories: stroke, 
neurologic disease, head and neck cancer, advanced age, injury to the head or neck, 
prescription medication or drugs, congestive heart failure, arthritis or chronic obstructive 
pulmonary disease. Over 11% of respondents attributed their dysphagia to a stroke and 
another 7.2% attributed it to another neurological cause, such as Alzheimer’s, Parkinson’s or 
Multiple Sclerosis, making neurological diagnoses by far the most common cause of 
dysphagia among the survey respondents. Indeed, stroke (Mann, Hankey, & Cameron, 2000) 
and Parkinson’s disease (Kalf, De Swart, Bloem, & Munneke, 2012) are well recognised as 
causing impaired function of swallowing. Neurological causes of dysphagia may be common, 
but with only 18% of respondents attributing their dysphagia to neurological impairment, it is 
apparent that the causes of dysphagia are varied. Head and neck cancer (4.9%), advanced age 
(2.6%) and head or neck injury (2.6%) were the third, fourth and fifth most commonly 
identified causes of dysphagia. Notably, 70% of respondents identified a cause that could not 
be easily categorised, again reflecting the vast and varied causes of dysphagia. 
Dysphagia can occur at any age, but is more common in elderly individuals than in 
younger, with Bhattacharyya (2014) reporting an increased odds ratio of 1.19 per decade of 
life. Dysphagia is particularly prevalent in adults over 85 years of age (Bhattacharyya, 2014) 
and in elderly residents of residential care (Easterling & Robbins, 2008; Park et al., 2013). It 
is also common in the hospital setting as both an acute and a chronic health issue. For 
example, an elderly patient with a longstanding dysphagia may be admitted for treatment of 
pneumonia, or may develop dysphagia suddenly as a result of an acute illness that requires 
hospitalisation (Pizzorni et al., 2014). Cichero, Heaton and Bassett (2009) screened patients 
admitted to medical wards over a seven week period and reported a dysphagia prevalence of 
25%. ICUs treat the most critically ill hospitalised patients and dysphagia is common in this 
patient cohort (Macht, Wimbish, Bodine, & Moss, 2013). ICU patients may have a range of 
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factors related to their primary illness, co-morbidities or as a side effect of treatment that 
could contribute to the occurrence of dysphagia. Very often dysphagia will result from a 
combination of several factors. Potential mechanisms for dysphagia in ICU patients have 
been categorised by Macht and colleagues (2013) and are listed in the Figure 3. 
 
 
Figure 3. Six Potential Mechanisms for the Development of ICU-Acquired Swallowing 
Disorders. 
From “ICU-acquired swallowing disorders,” by Macht, Wimbish, Bodine, & Moss, 2013, 
Critical Care Medicine, 41(10), p. 2396-2405. Copyright 2013 by Wolters Kluwer Health, 
Inc.. Reprinted with permission. 
 
1.3.1 Consequences of Dysphagia 
Individuals with dysphagia can experience a number of serious consequences. One 
potential consequence of dysphagia is aspiration. When swallowing is impaired, it is possible 
for the bolus, or a portion of the bolus, to contaminate the larynx. Aspiration occurs when 
ingested material penetrates the upper airway to the point of contacting the vocal folds. A 
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cough should be triggered at this point to clear the aspirated material from the larynx (Pitts et 
al., 2013). However, ‘silent’ aspiration occurs when material enters the airway and contacts 
or passes the below the vocal folds without stimulating an overt, behavioural response. 
Aspiration, both overt and silent, is a well-documented issue in the ICU population (Ajemian 
et al., 2001; El Solh et al., 2003; Leder et al., 1998; Macht et al., 2013; Scheel et al., 2016) 
and has serious consequences. 
1.3.1.1 Pneumonia 
Critically ill patients with dysphagia are more likely to have poor outcomes than their 
counterparts without dysphagia (Macht et al., 2011). Macht and colleagues (2011) reviewed 
the medical records of 630 ICU patients who were referred to SLT after extubation. The 
presence of dysphagia, as identified by clinical assessment, was significantly and 
independently associated with pneumonia, reintubation and death. This finding is likely due 
in part to the link between aspiration and pneumonia.  
When aspiration occurs as a result of dysphagia, oropharyngeal material colonised 
with pathogenic bacteria from the oral cavity may enter the lungs. This triggers an acute 
pulmonary inflammatory response, known as aspiration pneumonia (Marik, 2001). Aspiration 
is a key precursor to aspiration pneumonia, but aspiration itself does not always lead to 
pneumonia. In an important study by Langmore, Terpenning, Schork, Chen, Murray and 
colleagues (1998), the authors identified several key risk factors that contributed to the 
development of pneumonia in a cohort of male veterans with a range of medical conditions 
across the outpatient, inpatient acute and residential care settings. The authors reported that 
pneumonia is most likely to develop when there is bacterial colonisation, an aspiration event 
and reduced host resistance. The specific factors that correlated with development of 
pneumonia are outlined in the Figure 4. It is important to note that the study did not include 
ICU patients. Therefore, translation of these identified risks may not directly apply to patients 
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who are critically unwell, but it is worth considering the findings of this study in the ICU 
context as many patients present with a number of the factors identified by Langmore and 
colleagues (1998).  
 
Figure 4. Significant Predictors of Aspiration Pneumonia. 
From “Predictors of aspiration pneumonia: how important is dysphagia,” by S. E. Langmore, 
et al., 1998, Dysphagia, 13(2), p. 69-81. Copyright 1998 by Springer. Reprinted with 
permission. 
 
Pneumonia in the ICU population can be loosely grouped into two categories: 
community-acquired and hospital acquired, which is known as nosocomial pneumonia 
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(Herkel et al., 2016). Patients may be admitted to ICU with a community-acquired 
pneumonia, but when the pneumonia presents during ICU treatment it is considered 
nosocomial pneumonia. Critically ill patients are at high risk of nosocomial pneumonia due 
to several risk factors inherent to this population, including supine positioning and the 
prevalence of gastroparesis, nasogastric feeding and gastroesophageal reflux (Drakulovic et 
al., 1999; Kollef, 1993; Marik, 2001; Potts, Zaroukian, Guerrero, & Baker, 1993). When 
nosocomial pneumonia occurs within 48 hours of mechanical ventilation it is termed 
ventilator associated pneumonia (VAP) (Hunter, 2006). VAP is the most common 
nosocomial infection in ICU. A survey of relevant literature on VAP revealed that 10% to 
20% of patients who were ventilated for more than 48 hours developed VAP (Hunter, 2006). 
Development of VAP can have significant consequences on an individual's hospital course 
and outcome. In a study by Safdar, Dezfulian, Collard and Saint (2005), mean ICU length of 
stay for patients who developed pneumonia was 6.1 days longer than their counterparts 
without pneumonia. When calculated into United States dollars in 2005, this equated to over 
$10,000 per stay in additional cost. In addition, the odds ratio for death in ICU was 2.03 for 
patients with pneumonia when compared to patients without pneumonia.  
Aspiration is a major contributor to VAP as ventilated patients usually do not have the 
ability to protect their airway and the endotracheal tube can act as a conduit for pathogens to 
travel from the mouth to the lungs (Bouza et al., 2003; Bouza et al., 2008; Safdar et al., 
2005). Chevret, Hemmer, Carlet and Langer (1993) followed 996 patients from ICU 
admission to hospital discharge and reported that impaired airway reflexes at the time of ICU 
admission were the best predictor of nosocomial pneumonia. The authors defined decreased 
airway reflexes as “severe impairment of spontaneous breathing, glottic closure and cough 
reflexes with reduced defence reactions to endotracheal intubation or pharyngeal suctioning” 
(Chevret et al., 1993, p.257). Patients with decreased airway reflexes were 2.3 times more 
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likely to develop pneumonia during their admission. Twenty-two percent of patients who 
required greater than 48 hours of intubation developed pneumonia compared to 9% of all 
patients admitted to ICU. These results strongly suggest that strategies that could reduce the 
occurrence of aspiration in this population would be beneficial for patient outcomes. 
1.3.1.2 Malnutrition  
When individuals have difficulty eating and drinking their caloric consumption is 
reduced. ICU patients who are started on an oral diet soon after extubation manage 
approximately half of their daily nutritional requirements in the week following extubation 
due to a range of factors, including restricted diets, lack of appetite, nausea and vomiting 
(Peterson et al., 2010). Because patients with moderate to severe dysphagia are significantly 
more likely to have a delay in resuming oral intake after extubation (Barker, Martino, 
Reichardt, Hickey, & Ralph-Edwards, 2009), this population is particularly at risk of 
malnutrition. The link between dysphagia and malnutrition is well established (Hudson, 
Daubert, & Mills, 2000). Malnutrition puts individuals at increased risk of mortality and 
morbidity. Morbidities include loss of muscle function, cardio-respiratory function and 
gastrointestinal function as well as reduced immunity, wound healing and psychosocial well-
being (Saunders & Smith, 2010). In already unwell ICU patients, malnutrition is significantly 
and adversely associated with mortality, length of stay and cost of treatment (Lew et al., 
2016). 
1.3.1.3 Cost of treatment 
The presence of dysphagia after orotracheal intubation is widely recognised to 
increase length of stay (Barker et al., 2009; Bordon et al., 2011; Brown et al., 2011; Ferraris, 
Ferraris, Moritz, & Welch, 2001; Hogue et al., 1995; Macht et al., 2011; Rousou et al., 2000). 
In a mixed ICU population without neurological deficits who had mechanical ventilation for 
any time period, median length of ICU stay was 3 days for patients without dysphagia 
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compared to 10 days for patients with dysphagia (Macht et al., 2011). This finding was 
supported by a study evaluating post-extubation dysphagia in a group of patients following 
cardiac surgery (Ferraris et al., 2001). Patients without oropharyngeal dysphagia required a 
significantly shorter length of post-operative stay (M = 5.7 days) than patients with 
oropharyngeal dysphagia (M = 16.1 days). This complication has not only medical but 
financial implications. The increased length of hospital stay in the study by Ferraris and 
colleagues (2001) translated to an average cost of treatment of US$36,087 for non-dysphagic 
patients versus US$69,320 for those with dysphagia. 
1.3.2 Causes of Dysphagia in ICU 
An audit of ICU admissions was completed in 2005 for 91 hospitals that contribute to 
the United Kingdom Trauma Audit and Research Network (Simpson, Clancy, Goldfrad, & 
Rowan, 2005). The main aim of the audit was to identify characteristics of patients admitted 
to ICU directly from the emergency department (ED); however, the researchers included data 
for all 46,587 admissions to ICUs that occurred between 1996-1999, categorised into ED 
admissions and non-ED admissions (Figure 5). Each individual ICU is likely to have its own 
unique case mix and the study by Simpson and colleagues (2005) provides a very broad 
picture of the wide variety of patients admitted to ICU, which will be more or less 
representative of an individual ICU. 
Macht and colleagues’ six mechanisms of dysphagia (2013) provide a useful 
framework for considering the effect of each diagnosis on swallowing. When the data from 
Simpson and colleagues (2005) and the six mechanisms of dysphagia (Macht et al., 2013) are 
considered together, it is possible to hypothesize the profile of dysphagia in an ICU. The list 
of diagnoses provided in Simpson and colleagues’ survey (2005) is extensive and considering 
the potential impact of each on swallowing is outside the scope of this thesis, but it is worth 
considering a few aetiologies that are commonly linked to swallowing disorders. 
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Figure 5. Reason for Admission to ICUs from EDs. 
From “Admissions to intensive care units from emergency departments: a descriptive study,” by H. K. Simpson, M. Clancy, C. Goldfrad & K. 
Rowan, 2005, Admissions to intensive care units from emergency departments: a descriptive study, Emergency Medicine Journal, 22(6), p. 423-
428. Copyright 2005 by BMJ Publishing Group, Ltd.. Reprinted with permission. 
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1.3.2.1 Neurological Causes of Dysphagia in ICU 
Macht and colleagues’ (2013) six mechanisms of dysphagia are highly relevant to 
ICU patients with neuromuscular disorders. This population may experience dysphagia that 
occurs through four of the six mechanisms: weakness (Robbins et al., 2007), reduced 
laryngeal sensation (Stephens, Addington, & Widdicombe, 2003), altered sensorium (Ji et al., 
2013), and dyssynchronous breathing and swallowing (Wang, Shieh, Chen, & Wu, 2015). 
Patients with severe neurological injury may also be bedbound for an extended period of 
time, placing them at risk of gastroesophageal reflux (Aderinto‐Adike & Quigley, 2014), 
which adds an additional potential mechanism of dysphagia. Patients with neuromuscular 
disorders may require admission to ICU. Indeed, in their audit of ICU admissions, Simpson 
and colleagues (2005) reported almost 3500 admissions (7.5%) for central nervous system 
disorders, neuromuscular disorders and conditions requiring neurosurgery. This category 
encompasses a wide range of diagnoses, including ischaemic and haemorrhagic strokes, head 
injury, seizures, progressive neurological disorders and brain tumours. 
Each of these aetiologies presents a unique profile of risk, with some patients at 
greater risk of dysphagia than others. Stroke patients are at particularly high risk of 
dysphagia, with the prevalence reported to be as high as 64% following stroke (Mann et al., 
2000). A similar prevalence has been reported following head injury. Mackay, Morgan and 
Bernstein (1999) performed videofluoroscopic swallowing studies (VFSS) on 54 
consecutively enrolled patients with severe head injury and reported an incidence of 
dysphagia of 61%. Although Simpson and colleagues (2005) do not specifically report the 
number of patients admitted with head injury, they did record 1,987 (4.3%) admissions for 
trauma to the head and neck. Other researchers have estimated that approximately 3,500 
patients are admitted to ICU with head injury each year in the United Kingdom (Helmy, 
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Vizcaychipi, & Gupta, 2007), indicating that dysphagia resulting from head injury is a 
significant issue in ICU.  
Patients admitted with any primary diagnosis that requires prolonged ICU admission 
may develop systemic weakness over the course of their treatment, which can be classified as 
critical illness polyneuropathy (CIP) (Apostolakis, Papakonstantinou, Baikoussis, & 
Papadopoulos, 2015). CIP has been defined as “a predominantly motor, axonal dysfunction 
of unknown aetiology, with acute onset after development of respiratory insufficiency in a 
setting of systemic inflammatory response with multiple organ dysfunction” (Leijten & De 
Weerd, 1994, p. 15). In a prospective study of 22 patients with CIP who underwent 
videoendoscopy (VES) during admission to a neurological rehabilitation ICU, disordered 
swallowing was identified in 20 (91%) participants (Ponfick, Linden, & Nowak, 2015). More 
specifically, 13 of 17 (78%) participants who were offered thin liquids aspirated on VES 
performed on the third day of admission to the unit.  
Collectively, the above figures above represent just a portion of patients with 
neurological impairment admitted in ICU, but do provide some insight into the significance 
of neurological dysphagia in the ICU patient cohort. The combination of swallowing 
impairment with concomitant risk factors present in the critically ill ICU population may 
make ICU patients with neurological injury particularly susceptible to aspiration and 
subsequent development of nosocomial pneumonia.  
1.3.2.2 Dysphagia following surgery 
Simpson and colleagues (2005) reported that nearly 40% of ICU admissions were 
related to surgical management. ICU patients may experience dysphagia as a consequence of 
surgical management for a number of reasons, one being perioperative stroke (Selim, 2007). 
Risk of perioperative stroke depends on the complexity and type of surgery. For example, 
duration of cardiopulmonary bypass and cross-clamp time are risk factors for perioperative 
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stroke in patients undergoing cardiac surgery (Selim, 2007). Stroke incidence has been 
reported to be 1.4% to 3.8% percent following coronary artery bypass grafting (CABG), 
8.7% following aortic repair and 9.7% following double or triple valve surgery (Selim, 2007). 
Other surgery carries a lower risk of stroke, with the reported incidence of perioperative 
stroke following general surgery of 0.08% to 0.70%.  
Another potential cause of swallowing disorder following surgery is intra-operative 
cranial nerve damage, such as injury to the recurrent laryngeal nerve during cardiac surgery 
(DiLisio, Mazzeffi, Bodian, & Fischer, 2013). In addition, ICU patients who have had 
surgery are likely to spend extended time in a supine position, increasing the risk of 
gastroesophageal reflux (Aderinto‐ Adike & Quigley, 2014), and will often have altered 
sensorium following surgery (Schenning & Deiner, 2015), two of the identified mechanisms 
for swallowing disorders in ICU (Macht et al., 2013). 
1.3.2.3 Dysphagia following cardiothoracic surgery  
In the survey of ICU admissions by Simpson and colleagues (2005), nearly one fifth 
(18.8%) of all patients were admitted for treatment following vascular surgery, with patients 
requiring valve replacements and bypass grafting in this group. This admission rate made 
vascular surgery the second most common reason for non-ED admissions. As with other ICU 
patients, the cardiothoracic population is at risk of developing post-operative dysphagia 
(Barker et al., 2009; Daly, Miles, Scott, & Gillham, 2016; Ferraris et al., 2001; Hogue et al., 
1995). In a study by Hogue and colleagues (1995) investigating swallowing following cardiac 
surgery, all patients who demonstrated overt signs of dysphagia, including coughing while 
drinking, underwent videofluoroscopic swallow studies (VFSS). Ninety percent of the 
participants demonstrated aspiration, 22% of these without stimulating a cough response. By 
examining only those with an overt swallowing problem, it is likely that their method of 
participant selection would have missed a number of patients who were silently aspirating, 
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which suggests that the true prevalence of silent aspiration is greater than the figure reported 
by the authors. 
In a recent study, Daly and colleagues (2016) audited the medical records of 190 
patients who were intubated for more than 48 hours following cardiothoracic surgery. Details 
about each patient’s diagnosis, surgery, recovery and swallowing ability were analysed. 
Forty-one (22%) of the patients were referred to Speech-language Therapy (SLT) during their 
recovery for assessment of suspected dysphagia and 33 (17%) were diagnosed as having 
some degree of dysphagia. Twenty-four of the patients with dysphagia underwent 
instrumental assessment of which 17 (70%) demonstrated silent aspiration. The authors 
concluded that implementation of a standardised protocol for referral to SLT would improve 
early identification of at-risk patients and potentially reduce the risk of aspiration and 
subsequent pneumonia. However, the authors failed to address patients who did not show 
overt signs of aspiration when eating and, as a result, were not identified by observational 
screening or clinical assessment. Although both studies offer valuable insight into the 
presence of post-extubation dysphagia in patients who have undergone cardiothoracic 
surgery, they do not sufficiently address the issue of silent aspiration in this population.  
1.3.2.4 Post-extubation Dysphagia 
Dysphagia may also occur as a complication of ventilation for respiratory failure. The 
occurrence of post-extubation dysphagia has long been reported in the literature as a 
complication of ICU treatment (Burgess, Cooper, Marino, Peuler, & Warriner, 1979). 
Reported prevalence of dysphagia after orotracheal extubation varies widely from 3% to as 
high as 58% (Ferraris et al., 2001; Hogue et al., 1995; Scheel et al., 2016), making it a 
significant contributor to dysphagia in the ICU population. The existing research into post-





When the swallowing process is disordered as a result of neurological impairment or 
injury, aspiration of food, fluid or saliva into the airways may occur. Aspiration may be overt 
or silent and, in the presence of additional risk factors, may lead to a number of serious 
consequences, including pneumonia. Dysphagia is associated with increased length of stay 
and cost of hospital treatment. Dysphagia occurs frequently in the ICU population due to 
neurological injury, ICU acquired weakness and surgery, cardiothoracic surgery, and 
orotracheal intubation. Post-extubation dysphagia is a frequent complication of orotracheal 
intubation and deserves further discussion.  
1.4  Post-extubation dysphagia 
A number of researchers have examined dysphagia in the post-extubation ICU 
population. Characteristics of 18 studies examining post-extubation dysphagia are outlined in 
Table 1. The variation in results can be partly attributed to the diverse patient populations 
studied and the diagnostic methods used. Many studies are retrospective in nature (Barker et 
al., 2009; Bordon et al., 2011; Daly et al., 2016; Macht et al., 2011; Malandraki, Markaki, 
Georgopoulos, Psychogios, & Nanasc, 2016; Padovani, Moraes, de Medeiros, de Almeida, & 
de Andrade, 2008; Rousou et al., 2000) or only include clinical assessment measures of 
dysphagia rather than instrumental assessment (Bordon et al., 2011; Brown et al., 2011; 
Kwok, Davis, Cagle, Sue, & Kaups, 2013; Macht et al., 2011; Padovani et al., 2008). 
Therefore, these studies are not considered to have robust methodology for detecting the true 
rate of dysphagia. 
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Table 1. Characteristics of Studies Examining Post-extubation Dysphagia. 















P All >48hrs* VES PAS  6 56% 56%(25%) 
63% on oral diet by 
discharge 
Barker, Martino, 













8% > 10 days to return to 
oral intake 
Barquist, Brown, 
Cohn, Lundy & 
Jackowski, 2001 
70 Trauma P All >48 hrs 




Control = PAS  6 or 
clinical aspiration 
(suctioning of feeds from 
below vocal cords) 








No clinical aspiration > 
96 hours post-extubation 
Bordon, Bokhari, 
Sperry, Testa, 
Feinstein, et al., 2011 











Stevenson, et al., 






16% nil by mouth 










P All Any 
Evidence of 
radiopaque dye on 
chest x-ray (24 
participants 
immediately post-
extubation1, 20 at 
4hrs2, 20 at 8hrs3) 
Evidence of radiopaque 
dye in trachea or below 































P All >24hrs 
Swallow latency, 
number and cough 






coughing with swallowing 
NRb NR 
Swallowing latency 
significantly reduced by 
Day 7 
El Solh, Okada, Bhat 




Pro All >48hrs* VES PAS  6 44% 44%(13%)c 
Dysphagia present in 30% 
at 5 days, 7% at 14 days 
and 7% at 6 weeks 
Ferraris, Ferraris, 









Abnormal screeningd 3% 2%(NR) 
4/16 patients with 
aspiration on VES 
required > 4 months, 
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30/31 returned to normal 
diet by 6 months 
Hafner, Neuhuber, 
Hirtenfelder, 








Any* VES PAS  6 56% 56%(17%)e NR 
Hogue, Lappas, 
Creswell, Ferguson, 








Abnormality in one 
element of swallowing on 
VFSSf 
3%** 4%(<1%) NR 
Kwok, Davis, Cagle, 
Sue & Kaups, 2013 








All resolved – no 
timeframe given 
Leder, Cohn & 
Moller, 1998 
20 Trauma P All >48hrs VES PAS  6 45% 45%(20%) 
















during admission for 54% 
Malandraki, Markaki, 
Georopoulos, 











55% with mod/sev 
dysphagia NBM at 
discharge 





#=number of participants, P=prospective, R=retrospective, VES=videoendoscopy of swallowing, VFSS=videofluoroscopy of swallowing, PAS=Penetration-
Aspiration Scale, NR=not reported 
*  Excluded participants with tracheostomies 
** Length of intubation a significant predictor 
a Only files of patients referred for clinical assessment were reviewed (41 or 190 patients). 
pneumonia & death 
Noordally, Sohawon, 





P All >48hrs 
Clinical assessment, 
VES & +/-VFSS 
Abnormal clinical 
assessment, VES or VFSS 
NR 27%j(NR) NR 
Padovani, Moraes, de 
Medeiros, de 
Almeida & de 
Andrade, 2008 
44 Brain injury R 
Suspected 
dysphagia 
>48hrs* Clinical assessment 
Dysphagia Severity Scale 
and Functional Oral 
Intake Scale 
57%k NR(NR) NR 
Rosou, Tighe, Garb, 
Krasner, Engelman, 




R All Any VFSS Abnormal VFSSl 3%** NR(NR) NR 
Scheel, Pisegna, 





P All >48hrs VES PAS  3 58% 22%(8%) NR 
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b  Did not have a cut-off for dysphagia, but swallow latency significantly increased in intubated participants. Nil difference in number of swallows or 
coughing. 
c 42 young (<65yrs) and 42 elderly (65yrs); 36% young and 56% elderly aspirated; 7% young and 20% elderly silently aspirated 
d A study nurse observed all participants and referred those with overt signs of dysphagia for clinical assessment, which included VFSS 
e Participants were referred for the study if they exhibited symptoms of dysphagia as displayed in Figure 3. Participant number includes all patients 
screened, but dysphagia prevalence is within only those participants referred for clinical exam.  
f Analysis performed separately for participants with and without tracheostomy. The elements of swallowing included time of oral transport, sensorimotor 
function, pharyngeal peristalsis, epiglottic closure and pulmonary aspiration 
g Authors did not specify how they identified silent aspiration 
h Only files of patients referred for clinical assessment were reviewed (446 of 2484 patients).There was a significant correlation between length of 
intubation and dysphagia when only participants without tracheotomy were included in analysis. Presence of tracheotomy was associated with 
dysphagia, but patients with tracheotomy were more likely to referred for clinical assessment. 
i 5% of participants had mild dysphagia, 23% had moderate or severe according to clinical assessment 
j 27% aspirated on thin liquid, 18% on thickened water 
k Dysphagia prevalence is percentage of participants referred for clinical exam, not percentage of total admissions. 43% normal or functional, 7% mild 
dysphagia, 9% mild-moderate dysphagia, 11% moderate dysphagia, 11% moderate to severe dysphagia, 18% severe dysphagia 
l Dysphagia considered to be present when subjective signs and symptoms were confirmed with VFSS
 
 
The two studies reporting the lowest incidence of dysphagia post-extubation, both 
3%, examined swallowing in patients after cardiac surgery (Ferraris et al., 2001; Hogue et al., 
1995). In both studies, participants were assessed for dysphagia only if they demonstrated 
overt signs of aspiration, causing suspicion of oropharyngeal dysphagia. These participants 
underwent a videofluoroscopic swallowing study (VFSS). Aspiration was classified as the 
presence of barium contrast below the vocal cords. Hogue and colleagues, like many other 
researchers investigating post-extubation dysphagia, used the Penetration–Aspiration Scale 
(PAS) (Rosenbek, Robbins, Roecker, Coyle, & Wood, 1996) to rate the presence, degree and 
response to penetration and aspiration. The authors considered dysphagia to be present if oral 
transport, sensorimotor function, pharyngeal peristalsis or epiglottic deflection were 
subjectively judged to be abnormal. Ferraris and colleagues (2001) considered dysphagia to 
be present in anyone who “experienced difficulty initiating a swallow or who had any 
symptomatic abnormality in swallowing physiology of the upper aerodigestive tract” (p. 
1793) as observed by a research nurse at the screening stage. In both of these studies, the 
selection method would be unlikely to identify patients with sensory deficits who displayed 
no overt signs of dysphagia or aspiration. Also of note, Hogue and colleagues assessed only 
puree consistency on VFSS, which is less likely than thin fluids to be aspirated in individuals 
with neurogenic dysphagia (Clave et al., 2007). Collectively, these factors contribute to a 
reported prevalence of dysphagia that is likely below the true prevalence in the ICU 
population. 
In four studies reporting much higher dysphagia incidence, ranging from 44% to 58% 
(Ajemian et al., 2001; El Solh et al., 2003; Leder et al., 1998; Scheel et al., 2016), every 
participant underwent videoendoscopy, regardless of the presence or absence of symptoms. 
Therefore, these studies may provide a more accurate estimate of the true prevalence of 
dysphagia in the ICU population. When comparing the studies, it is important to consider the 
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authors’ definitions of dysphagia. Ajemian and colleagues, El Solh and colleagues and Leder 
and colleagues each defined dysphagia as a PAS score of six or greater, indicating the 
presence of material below the vocal folds, and reported a presence of aspiration in 56%, 
44% and 45% respectively. Scheel and colleagues (2016) defined dysphagia as PAS ≥3, 
which likely explains their higher reported rate of dysphagia at 58%. Scheel and colleagues 
(2016) reported an aspiration rate (PAS ≥6) of 22%.  
There are two other key differences that potentially contribute to the disparity in 
findings between the studies reporting lower incidence (Ferraris et al., 2001; Hogue et al., 
1995) and the studies reporting a higher incidence of aspiration (Ajemian et al., 2001; El Solh 
et al., 2003; Leder et al., 1998; Scheel et al., 2016). First, the two studies with a lower 
reported incidence of dysphagia both used VFSS to diagnose aspiration while the studies with 
higher reported incidences all used videoendoscopic evaluation of swallowing (VES). There 
is evidence that clinicians rate penetration and aspiration viewed on VES as more severe 
compared to simultaneous VFSS (Kelly, Leslie, Beale, Payten, & Drinnan, 2006). As a result, 
participants in the VES groups may have been given higher PAS scores. Second, all 
participants in the studies with higher reported incidences were intubated for at least 48 
hours. This is an important differentiation, as longer duration of intubation has been 
associated with increased risk of dysphagia in a number of studies (Barker et al., 2009; 
Brown et al., 2011; Hogue et al., 1995; Macht et al., 2011; Rousou et al., 2000). 
It is worth noting that some studies enrolled participants with tracheotomies in situ 
(Bordon et al., 2011; Brown et al., 2011; Daly et al., 2016; Hogue et al., 1995; Leder et al., 
1998; Macht et al., 2011), others excluded participants with tracheotomies (Ajemian et al., 
2001; Barker et al., 2009; El Solh et al., 2003; Hafner et al., 2008; Noordally et al., 2011; 
Padovani et al., 2008; Scheel et al., 2009) and some did not specify whether their participants 
included patients with tracheotomies (Barquist et al., 2001; de Larminat et al., 1995; Ferraris 
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et al., 2001; Rousou et al., 2000). Ajemian and colleagues (2001) and El Solh and colleagues 
(2003) cited the reported link between tracheotomy and dysphagia as the reason for excluding 
these participants. Indeed, several of the studies that included participants with tracheotomies 
reported an association between the presence of a tracheotomy and dysphagia (Brown et al., 
2011; Daly et al., 2016; Hogue et al., 1995; Macht et al., 2011). However, three of these 
studies also reported that length of intubation was a significant predictor of dysphagia 
(Brown et al., 2011; Daly et al., 2016; Macht et al., 2011). Given that prolonged intubation is 
an indication for tracheotomy (Cosgrove & Carrie, 2015), it is possible that the increased risk 
of dysphagia in this cohort is due to prolonged intubation, rather than tracheotomy. Recent 
research does not support an independent link between tracheotomy and dysphagia (Donzelli, 
Brady, Wesling, & Theisen, 2005; Jin, Kyoung, Gi, Min, & Ju, 2012; Leder & Ross, 2010). 
To avoid this potential complication, it may be best to exclude participants with 
tracheostomies from future research studies focusing on dysphagia post-extubation or, at a 
minimum, to analyse this cohort separately. 
1.4.1 Silent aspiration post-extubation 
Silent aspiration occurs in the post-extubation population, but it is difficult to 
determine how common this is due to a wide range of methods reported in the literature. 
Studies examining post-extubation silent aspiration in a general ICU population report 
prevalence of 8% (Scheel et al., 2016), 17% (Hafner et al., 2008) and 25% (Ajemian et al., 
2001). Hafner and colleagues (2008) reported silent aspiration prevalence only as measured 
in participants who presented with overt signs of aspiration. Individuals who aspirate silently 
are less likely to be identified through observation of overt swallowing difficulties and were 
therefore less likely to be enrolled as participants. Because of this study design, their reported 
prevalence of 17% may not be representative of the true prevalence in the ICU population.  
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Scheel and colleagues (2016) and Ajemian and colleagues (2001) employed similar 
methods to each other with all participants undergoing VES within 48 hours of extubation. 
The reason for the large discrepancies between the results of the two studies is unclear, but 
may be related to the age of participants. El Solh and colleagues (2003) reported a higher 
frequency of silent aspiration in participants older than 65 years of age (20%) than in 
participants younger than 65 years of age (7%). Ajemian and colleagues (2001) report the 
mean age of their participants classified into “aspirators” and “non-aspirators”, 69 years and 
66 years respectively. Scheel and colleagues (2016) reported a slightly lower mean age of 
their total participant cohort at 58 years. Other explanations may include a difference in 
median lengths of intubation across participants, which was not consistently reported, or 
differences in the patient population.  
There is very limited data in the literature regarding post-extubation silent aspiration 
in patients who have been intubated for less than 48 hours. Few prospective studies have 
employed instrumental assessment and all but two that did included only participants who 
had been intubated for greater than 48 hours (Ajemian et al., 2001; Barquist et al., 2001; El 
Solh et al., 2003; Kwok et al., 2013; Leder et al., 1998; Scheel et al., 2016). The two studies 
that included a range of intubation times only included participants who had been referred for 
a swallowing assessment due to suspected dysphagia (Hafner et al., 2008; Hogue et al., 
1995), which, as mentioned previously, is likely to result in lower reported rates of silent 
aspiration.  
1.4.2 Impact of length of intubation on swallowing 
The length of orotracheal intubation is frequently reported in the literature as a 
significant predictor of dysphagia (Barker et al., 2009; Bordon et al., 2011; Brown et al., 
2011; Hogue et al., 1995; Kwok et al., 2013; Macht et al., 2011; Malandraki et al., 2016; 
Rousou et al., 2000). In a study by Bordon and colleagues (2011), the number of ventilator 
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days was the only significant, independent predictor of post-extubation dysphagia in 151 
trauma patients who required orotracheal intubation greater than 48 hours. The risk of post-
extubation dysphagia increased in these subjects by 14% for each day on the ventilator. This 
finding was supported by a retrospective review of ICU patients who had undergone a 
bedside swallowing evaluation (Macht et al., 2011). Intubation for greater than seven days 
was an independent predictor of severity of dysphagia, even when patients with acute 
neuromuscular disease or CVA were excluded. 
Wide-ranging methodologies between studies again make it difficult to compare 
results. Several studies investigating the impact of the length of intubation on post-extubation 
dysphagia only included participants if they had been intubated for 48 hours or more 
(Ajemian et al., 2001; Barker et al., 2009; Barquist et al., 2001; Bordon et al., 2011; Daly et 
al., 2016; El Solh et al., 2003; Leder et al., 1998; Noordally et al., 2011; Padovani et al., 
2008; Scheel et al., 2016). Several studies focused only on specific populations and the 
results cannot necessarily be extrapolated to the general ICU population (Brown et al., 2011; 
Burgess et al., 1979; Ferraris et al., 2001; Hogue et al., 1995; Rousou et al., 2000). Some 
studies did not employ instrumental assessment and may not be reliably identifying 
participants with dysphagia (Brown et al., 2011; Burgess et al., 1979; Ferraris et al., 2001; 
Macht et al., 2011; Malandraki et al., 2016). In their 2010 systematic review of literature on 
the incidence of dysphagia in this population, Skoretz and colleagues commented that the 
effect of duration of orotracheal intubation on dysphagia could not be determined because the 
studies they reviewed were heterogeneous and there was insufficient evidence to draw strong 
conclusions (Skoretz, Flowers, & Martino, 2010). There is a gap in the literature regarding 
the relationship between length of intubation and presence of dysphagia, particularly short-
term intubation.  
1.4.3 Resolution of post-extubation dysphagia 
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While post-extubation dysphagia is relatively common, it usually resolves. In the 
majority of cases reported in the literature, dysphagia resolved by discharge from hospital 
(Ajemian et al., 2001; Barker et al., 2009; Brown et al., 2011; de Larminat et al., 1995; El 
Solh et al., 2003; Ferraris et al., 2001; Leder et al., 1998; Macht et al., 2011; Rousou et al., 
2000). Most research groups who considered resolution of dysphagia measured it as return to 
oral diet (Ajemian et al., 2001; Barker et al., 2009; Brown et al., 2011; Ferraris et al., 2001; 
Kwok et al., 2013; Leder et al., 1998), which doesn’t capture subtle changes or definitively 
rule out on-going aspiration. El Solh and colleagues (2003) repeated VES on patients with 
dysphagia on days 5 and 14 and at 6 weeks. With an initial prevalence of aspiration (PAS ≥6) 
of 44%, this reduced to 30% and 7% at each respective follow-up. None of the studies have 
looked at changes in swallowing in the hours immediately following extubation, despite the 
clinical relevance of this question. Clinicians routinely decide when to initiate oral intake 
after extubation or if alternative nutrition is needed. Future studies should consider reviewing 
swallowing within the initial hours post extubation to determine how rapidly post-extubation 
can resolve.  
1.4.4 Causes of Post-extubation Dysphagia 
The exact aetiology of dysphagia after oral intubation is unknown, but proposed 
possibilities include laryngotracheal injury (Brown et al., 2011; Colice, 1992; de Larminat et 
al., 1995; El Solh et al., 2003; Tolep, Getch, & Criner, 1996), neurological adaptation 
(Tanaka, Isono, Ishikawa, & Nishino, 2005), weakness from muscle atrophy (Brown et al., 
2011; DeVita & Spierer-Rundback, 1990; Tolep et al., 1996), the use of neuromuscular 
blocking agents (Brown et al., 2011; de Larminat et al., 1995; Tolep et al., 1996), disruption 
in respiration (de Camargo, Ono, Park, Caruso & Carvalho, 2010) or underlying neurological 
illness (Tolep et al., 1996). After extubation, any individual patient is likely to have multiple 
aetiologies impacting swallowing. When considered in the context of Macht and colleagues’ 
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(2013) mechanisms for the development of swallowing disorders in ICU, these potential 
aetiologies may cause dysphagia through injury to the larynx, reduction in laryngeal 
sensation, neuromuscular weakness, or dyssynchronous breathing.  
Rapid and complete movement of the laryngeal structures is essential for safe and 
efficient swallowing and laryngeal trauma from intubation can contribute to dysphagia in the 
ICU population through two proposed mechanisms: injury to the laryngeal tissues causing 
oedema, ulceration and granulation of the tissue or damage to the recurrent laryngeal nerve 
(RLN) as a result cuff pressure (Colton House et al., 2011). Examples of laryngotracheal 
injury are well documented in the literature and include subglottic, arytenoid and vocal cord 
oedema, as well as granulation and ulceration of the vocal cords (Colton House, Noordzij, 
Murgia, & Langmore, 2011; Scheel et al., 2016; Tadie et al., 2010). Colton House and 
colleagues (2011) performed VES within 24 hours of extubation on 61 adult ICU patients 
who were intubated for more than 48 hours and reported that 100% of participants had some 
degree of laryngeal injury. Colice and colleagues (1989) reported that 52% of ICU patients 
had moderate to severe laryngeal damage following four days of intubation. Two of the 
subjects in the study by Colice and colleagues (1989) had such severe ulceration of their 
vocal cords that they couldn’t achieve laryngeal closure and aspiration of fluids was observed 
on laryngoscopy. Both subsequently developed recurrent aspiration pneumonia. Similarly, 
Scheel and colleagues (2016) reported a significant correlation between PAS scores and 
findings of vocal process granuloma and left or right vocal cord oedema.  
The correlation between duration of intubation and severity of laryngeal injury is 
disputed (Bishop, Hibbard, Fink, Vogel, & Weymuller, 1985; Colice, 1992; Colton House et 
al., 2011; Kastanos, Miro, Perez, Mir, & Agusti-Vidal, 1983; Peppard & Dickens, 1983; 
Postma et al., 2007; Stauffer, Olson, & Petty, 1981; Tadie et al., 2010; Tanaka et al., 2005; 
Vila et al., 1997; Whited, 1984). Bishop commented on the challenges associated with 
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determining the significance of prolonged intubation in his 1989 discussion paper on the 
causes of laryngotracheal injury following orotracheal intubation.  
“In human studies, the data are always confounded by the fact that the patients 
intubated the longest are almost always the sickest patients, with the largest numbers 
of infections, the most episodes of hypertension, etc.” (p. 185) 
In a commentary on the systematic review by Skoretz and colleagues (2010), Heffner 
(2010) proposes that laryngeal injury can occur with relatively short periods of intubation. 
This is supported by a study by Bishop and colleagues (1985) in which 14 dogs were 
intubated and underwent laryngeal and tracheal endoscopy at days one, seven, 14 and then 
every two weeks until death to observe for laryngeal damage. Dogs were killed at day one, 
two weeks, four weeks, six weeks and 12 weeks and their larynges were removed and 
examined. There was a significant increase in ulceration of the laryngeal mucosa between 
day one and day seven, but no significant increase beyond that point. Stauffer and colleagues 
(1981) observed airway lesions on post-mortem examination after as few as seven hours of 
intubation, supporting the argument that laryngeal injury can occur after short periods of 
orotracheal intubation. 
There is limited data on the resolution of intubation injury in the general ICU 
population (Colice, 1992; Kastanos et al., 1983; Peppard & Dickens, 1983; Stauffer et al., 
1981; Whited, 1984). The data that exists suggests that laryngeal injuries do improve, but not 
always rapidly. Colice and colleagues (1992) performed laryngoscopy within 24 hours of 
extubation and then performed follow-up laryngoscopies every two weeks until either 
assessment was normal or a moderate or severe adverse effect was recognized. They reported 
that median time to resolution of laryngeal injury was four weeks and 92% of the subjects 
had a normal exam by eight weeks. Kastanos and colleagues (1983) completed an initial 
laryngoscopy within two weeks of extubation then repeat laryngoscopies every two months. 
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By three months, 84% had a normal laryngoscopy. Combined, these studies suggest that the 
vast majority of laryngeal intubation injuries resolve within two to three months. Both of 
these studies report similar recovery times despite different enrolment criteria: Kastanos and 
colleagues (1983) enrolled patients with a minimum of 24 hours of intubation while Colice 
and colleagues (1992) employed a minimum of four days of intubation. Intubation injuries 
may be as likely to occur and as long lasting following short-term intubation compared to 
longer-term intubation. This may offer a possible explanation for the existence of dysphagia 
after short-term intubation. It is tempting to compare recovery times for post-extubation 
dysphagia and laryngeal injury from intubation, but lack of standardisation and reporting of 
timeframes for follow-up make this impossible. 
Although much of the data presented is from studies that are 20 to 30 years old, 
laryngeal injury continues to occur with modern equipment and techniques. One very recent 
study by Nordang, Lindholm, Larsson and Linder (2016) compared the traditional 
endotracheal tube to a new tube that the authors hypothesized would cause fewer laryngeal 
injuries. Median length of intubation was 21 hours in the experimental group and 22 hours in 
the control group. Laryngoscopy performed within 24 hours of extubation revealed laryngeal 
abnormalities is all participants. At the follow-up laryngoscopy, performed between three and 
six weeks post-extubation, 11 participants from each group had persistent laryngeal 
pathology that was classified as more than erythema. There was not a significant difference 
between the experimental and control groups. These recent data suggest that, despite 
evolving equipment and methods, laryngeal injury continues to occur as a result of intubation 
and can persist for weeks. 
In some cases, contact of the endotracheal tube cuff with the tracheal mucosa can 
cause erosion and damage to the recurrent laryngeal nerve (RLN), which enters the larynx 
between the thyroid and cricoid cartilages (Colton House et al., 2011). Damage is 
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exacerbated by high cuff pressures. Colton House and colleagues observed vocal cord 
immobility in 39% of ICU patients who were intubated for 48 hours or more and proposed 
injury to the RLN as the cause. These findings have been supported by other studies, which 
also attributed the impairment in mobility to high cuff pressures (Tadie et al., 2010). In a 
study by Hamdan, Sibai, Rameh and Kanazeh (2007), cuff parameters, specifically pressure 
and volume, were the most important variables associated with intubation related dysphagia. 
Collectively, these studies provide evidence that pressure from the endotracheal cuff has a 
detrimental effect on the RLN, which provides efferent innervation to the vocal cords, critical 
for airway protection. This can occur following even short periods of intubation and the 
resulting impairment of laryngeal closure places patients at high risk of aspiration. 
Although contact between the endotracheal tube components and the mucosa of the 
larynx and trachea can cause impairment of laryngeal function, a study by Tanaka and 
colleagues (2005) suggests that there are additional causes of laryngeal impairment. They 
compared two types of artificial airways: a low pressure cuffed endotracheal tube (ETT), 
which passes through the glottis and terminates in the trachea, and the laryngeal mask airway 
(LMA), which terminates just superior to the laryngeal vestibule. The authors hypothesized 
that use of a LMA would preserve laryngeal reflexes post-extubation. Twenty patients 
undergoing general anaesthesia and intubation for minor elective surgery were randomly 
assigned to receive either ETT or LMA. Laryngeal responses and the angle of the vocal cords 
were assessed under non-opioid anaesthesia before placement of the tube. After the surgery 
was completed, the effect of the muscle relaxant was fully reversed and the testing was 
repeated. Although glottal angle was only affected in the ETT group, cough reflex in 
response to water injected into the glottis was absent in all participants across both groups. 
This is the only study that has specifically examined the effect of intubation on the cough 
reflex and is important to highlight. The high prevalence of silent aspiration in the ICU 
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population may be related to this impairment of cough reflex. Tanaka and colleagues (2005) 
proposed that either the presence of the tube in the pharynx or larynx or noxious anaesthetics 
present in the airway could evoke accommodation or adaptation of the receptors and/or 
neural pathways, thus blunting the airway reflexes.  
There is less evidence regarding other proposed causes of dysphagia, including 
muscle atrophy, lingering neuromuscular blocking agents, underlying neurological illness, 
and the disruption of breathing and swallowing patterns, specific to the post-extubation 
population. Muscle atrophy can occur after relatively short periods of inactivity. Atrophy of 
the diaphragm can occur after just a few days of mechanical ventilation (Levine et al., 2008). 
This could cause aspiration, but would not explain the frequent occurrence of silent aspiration 
in this population (Barquist et al., 2001; Davis & Thompson Stanton, 2004; El Solh et al., 
2003; Hogue et al., 1995; Leder et al., 1998). The disruption of the typical expiration-
swallow-expiration cycle that de Camargo and colleagues (2010) observed in a single patient 
who had been intubated for four days, if indeed it did occur routinely after extubation, would 
also not explain silent aspiration. Regarding residual neuromuscular blocking agents (de 
Larminat et al., 1995; Tanaka et al., 2005) and underlying neurological illness (de Larminat 
et al., 1995; El Solh et al., 2003; Macht et al., 2011), studies that controlled for these factors 
continued to show that dysphagia was common, indicating that they were not the sole 
aetiology. Lingering residual neuromuscular blocking agents and analgesics would also not 
account for the documented cases of dysphagia that are slow to resolve, persisting long after 
these agents are out of the patient’s system. It is most likely that any individual patient who 
experiences dysphagia after extubation would be impacted by a combination of the factors 
above, affecting one individual to a greater or lesser extent than another. This conundrum 
makes it very difficult for studies to determine the cause of dysphagia; any attempts would 




Oropharyngeal dysphagia is a well-documented complication of orotracheal 
intubation in the ICU population. The reported prevalence varies widely between studies due 
to varied study methodology. In particular, the enrolment of only those patients who display 
overt signs of dysphagia automatically excludes many silent aspirators. Length of intubation 
has been reported to correlate with the presence of dysphagia, but very few studies have 
examined the impact of short (<24 hours) periods of intubation. The aetiology of post-
extubation dysphagia is not fully understood, but laryngotracheal injury resulting from 
orotracheal intubation is well documented and often cited as a cause of dysphagia. In reality, 
the ICU patient group is extremely complex and dysphagia in any individual is likely a result 
of a number of factors. 
1.5 Assessment of Swallowing in ICU 
Despite the high prevalence of dysphagia in ICU patients after extubation, swallowing 
screening and clinical assessment does not routinely occur in this population. In a survey of 
American SLTs who provide swallowing assessment to patients who have been mechanically 
ventilated, only 3% reported that they assess all recently extubated patients (Macht et al., 
2012). There is little guidance in the literature regarding the role of the SLT in assessing 
dysphagia after extubation. Baumgartner, Bewyer and Bruner (2008) provide an overview of 
the role of SLT in the ICU. The authors suggest that patients who have had prolonged 
endotracheal intubation should be referred to SLT for clinical assessment prior to initiating 
oral intake, citing the studies by Ajemian and colleagues (2001), Colice, Stukel and Dain 
(1989) and El Solh and colleagues (2003), who all reported impairment in participants after a 
minimum of 48 hours of intubation. In a paper discussing the evaluation of dysphagia after 
orotracheal intubation and tracheostomy, Goldsmith (2000) states that there is not a single 
recommended method for assessing or managing patient who have recently been extubated. 
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However, assessment should include a careful consideration of all contributing factors and, 
the author states, should be diagnostic rather than screening because of the inability of 
existing screening tools to detect silent aspiration. A screening tool that is able to detect silent 
aspirations, or the risk of silent aspiration, would be beneficial in this population. Goldsmith 
also advises that patients remain nil-by-mouth for 24 hours following orotracheal extubation 
to allow healing of laryngeal injury and return of laryngeal sensation (Goldsmith, 2000). 
However, with limited data on the recovery of swallowing in the first 24 to 48 hours 
following extubation, there is little support in the literature for this approach.  
Scheel and colleagues (2016) compared the results of swallowing assessments of 
participants who were assessed within 24 hours of extubation to results of patients who had 
been intubated for less than 24 hours and found no significant differences. The authors 
suggested that delaying oral intake for 24 hours may not change the outcome of the 
swallowing assessment and more rapid assessment may offer the benefits of engaging the 
swallowing mechanism sooner and avoiding placement of nasogastric tubes. Despite the clear 
need for swallowing assessment in at least some patients after extubation, none of the 
international professional organisations that oversee SLT services, including the New 
Zealand Speech-Language Hearing Association, American Speech, Language and Hearing 
Association, or Royal College of Speech-Language Therapists, have clear guidelines 
specifically for the screening, assessment or management of recently extubated patients. 
1.5.1 Screening for a swallowing disorder 
Screening for a disease is a way to identify individuals who likely have that disease 
within a given population. Screening for dysphagia is well established in the literature, 
particularly in individuals with neurogenic disorders. In a prospective audit of 2,352 stroke 
admissions, odds of developing pneumonia were three times greater for patients who did not 
undergo a formal dysphagia screening (Hinchey et al., 2005). A number of screening tools for 
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dysphagia exist, although, in many cases, the strength of evidence is variable (Daniels, 
Anderson, & Willson, 2012). A screening tool should ideally be easy to administer and 
inexpensive, have high sensitivity and specificity, and shouldn’t require specialist knowledge 
to complete (Kertscher, Speyer, Palmieri, & Plant, 2014). Given the reported incidence of 
dysphagia and aspiration after orotracheal intubation in the ICU population and the 
relationship between aspiration and poor patient outcomes, it would seem beneficial to screen 
all patients after extubation to identify those at risk for aspiration. A screening should ideally 
include a mechanism for identifying which patients are at increased risk of silent aspiration. 
1.5.2 Clinical swallowing assessment 
The clinical swallowing assessment is typically the first step towards identifying 
dysphagia and determining a management plan. A clinical assessment typically consists of a 
review of a patient’s medical history, observations of the patient’s communication and 
cognitive abilities, examination of the structure of the oral cavity, including the condition of 
the teeth and mucosa, tests of oromotor and sensory function, and trials of food and fluid 
(Carnaby-Mann & Lenius, 2008). Factors identified in any phase of the assessment may 
indicate an increased risk of dysphagia. The clinician synthesizes these observations and 
creates a hypothesis regarding the presence or absence, cause and nature of dysphagia and 
begins to formulate a management plan (Carnaby-Mann & Lenius, 2008).  
Although clinical assessment provides vital information, its limitations need to be 
carefully considered. In a study by McCullough and colleagues (2001), specificity of the 
clinical assessment was reported to be 82% while sensitivity was just 68%. These figures 
indicate that the clinical assessment may do a reasonable job of ruling out dysphagia, but 
underestimates its presence. The authors also reported that most components of the clinical 
assessment were not valid on their own. Clinical assessment is particularly poor at identifying 
individuals who aspirate silently as silent aspiration cannot be detected on clinical assessment 
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due to the absence of outward signs such as coughing (Ramsey, Smithard, & Kalra, 2003). 
Because silent aspiration is common in the ICU post-extubation population, standard clinical 
assessment as outlined above is not sufficient for this population and instrumental assessment 
should be considered. 
1.5.3 Instrumental assessment 
Use of instrumental assessment enables the clinician to further diagnose the presence 
of dysphagia, define pathophysiology and plan treatment, including use of compensatory 
strategies and rehabilitative techniques. Because the majority of the swallowing process 
cannot be externally observed, instrumentation that allows a clinician to visualise internal 
structure and function in a dynamic way offers clear advantages. There are two primary 
methods of instrumental assessment: videofluoroscopy and videoendoscopy. 
1.5.3.1 Videofluoroscopic Swallowing Study (VFSS) 
VFSS is generally considered the “gold standard” of swallowing assessments 
(O’Donoghue & Bagnall, 1999). VFSS allows visualisation of bolus flow, through sequential 
radiographic images, from the mouth, through the pharynx and into the oesophagus. It also 
allows the assessor to visualise the movement of deep structures, such as the hyoid, which are 
not visible with non-radiographic imaging. Aspiration can be identified and the timing, 
subjective judgement of amount and subsequent response can be documented. In addition, 
VFSS provides an opportunity to trial compensatory strategies, such as texture modification 
or positioning, and to judge the impact on swallowing. Information gained about the 
physiology of swallowing is then used to guide rehabilitation (Martin-Harris & Jones, 2008). 
There are limitations of VFSS, including the use of expensive equipment and 
exposure of individuals to radiation (Schröter-Morasch, Bartolome, Troppmann, & Ziegler, 
1999). In addition, some patients are not able to participate in VFSS due to transferring or 
positioning restrictions, as with the critically unwell or obese patient, or because the VFSS 
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cannot be performed in a timely manner (Langmore, Schatz, & Olsen, 1988). The ICU post-
extubation population often have very restricted mobility and instrumental assessment that 
could be used at bedside may be more suitable. For this reason, VES may be the preferred 
method of instrumental assessment for this population. 
1.5.3.2 Videoendoscopy of Swallowing (VES) 
Langmore, Schatz and Olsen first described the fiberoptic endoscopic evaluation of 
swallowing (FEES) protocol in 1988. Nasoendoscopy had long been employed as a means of 
evaluating the structure and function of the larynx, but Langmore and colleagues were first to 
document a protocol for performing dynamic swallowing assessment during nasendoscopy. 
The protocol they established has changed little over the more than 25 years since that 
publication. However, contemporary deviations to their original protocol are often referred to 
as VES. The endoscope is passed through the inferior nasal meatus until the velopharyngeal 
port is in view. The individual is asked to dry swallow to assess function of the 
velopharyngeal port. The scope is then progressed forward and down until the tip of the 
scope is positioned in the oropharynx. The presence, amount, consistency and location of 
secretions are noted and competence of the vocal cords assessed. The patient consumes 
boluses of food and liquid, usually liquid boluses of 5ml and 10ml and a puree bolus of 10ml 
as a minimum. Any type of food can be given during the study, depending on the status of the 
individual and goal of the assessment. All boluses are died blue or green so they can be easily 
visualised against the structures of the larynx and pharynx, which range in colour from white 
to pink to red. 
The pharynx and larynx can be observed before and after swallowing, but during 
swallowing there is “white out” of the image when the pharyngeal muscles contract and 
obscure the camera view (Langmore et al., 1988). Premature spillage and pre-swallow 
penetration and aspiration can be observed prior to initiation of swallowing. After 
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swallowing, the assessor can observe the presence of residue, laryngeal penetration and 
aspiration and attempts to clear these by dry swallowing, throat clearing or coughing. The tip 
of the scope can be used to gently probe the pharyngeal and laryngeal structures as a gross 
assessment of sensitivity. If an individual does not respond to this probing, the assessor may 
assume that the individual would not respond to aspirate.  
VES offers some key benefits over VFSS. VES is easily portable and can be 
performed at the patient’s bedside, making it possible to assess very unwell, bedbound or 
obese patients. VES also allows the assessor to view secretions and make judgements about a 
patient’s ability to manage secretions. The presence of pooled secretions has been shown to 
correlate with the presence of laryngeal penetration, aspiration and diet recommendations 
(Donzelli, Wesling, Brady, & Craney, 2003; Murray, Langmore, Ginsberg, & Dostie, 1996). 
VES allows for visualisation of the surface of the pharynx and larynx and identification of 
laryngeal pathology, which has also been linked to the presence of aspiration on 
videoendoscopy in recently extubated ICU patients (Scheel et al., 2016). When the results of 
simultaneous VFSS and VES are compared, with VFSS as the gold standard, the validity of 
VES to detect laryngeal penetration and aspiration is excellent (Aviv, 2000; Rao, Brady, 
Chaudhuri, & Wesling, 2003; Schatz, Langmore, & Olsen, 1991). There is some evidence 
that clinicians rate penetration and aspiration viewed on VES as more severe compared to 
VFSS. In a study by Kelly and colleagues (2006), participants underwent a simultaneous 
VES and VFSS. SLTs rating the studies consistently assigned a higher PAS score to the VES 
study, indicating that they detected laryngeal penetration and aspiration more often during 
VES than VFSS. This tendency needs to be kept in mind when interpreting VES. VFSS and 
VES have demonstrated similar inter-rater reliability for PAS ratings (Kelly et al., 2006).  
1.5.3.2.1 Patient Tolerance of VES  
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Contraindications for VES include acute facial fracture, recurrent or persistent 
epistaxis, obstruction of both nares, severe agitation and inability to participate in the 
procedure (Leder & Murray, 2008). However, VES is generally well tolerated by patients. In 
a cohort of 300 acute stroke patients who underwent VES within the first few days of stroke 
onset, 6% of participants had a self-limiting nosebleed (Warnecke, 2009). There were also 
statistically significant changes in systolic blood pressure, heart rate and oxygen saturations. 
However, the authors considered all effects to be mild and no participant suffered a serious 
adverse effect. In the same study, 30% of participants rated the procedure, when done without 
topical anaesthesia, as “not uncomfortable”, 53% found it “mildly uncomfortable”, 13% 
found it “moderately uncomfortable, and only 3% found it “severely uncomfortable” 
(Warnecke, 2009). This study was conducted in acute stroke patients and the tolerance may 
differ in ICU patients, but has not been tested. ICU patients may be more likely to be 
influenced by anaesthetics and sedation or may be better able to follow instructions and may 
tolerate the procedure better. Conversely, some ICU patients may be agitated and find VES 
less comfortable. Further research on patient tolerance of VES in the ICU population would 
be beneficial. 
When Langmore and colleagues first described FEES in 1988, the authors advised 
against the application of topical anaesthetic to the nares. This was based on evidence that the 
urge and ability to swallow was impaired after patients gargled a 2% lidocaine solution 
(Sider, Mintzer, Deschler, Kim, & Weinberg, 1983). In a study by Bastian and Riggs (1999) 
to determine the importance of intact sensation in swallowing, 13 participants underwent 
VES before and after application of lidocaine to the oral cavity, oropharynx, hypopharynx, 
larynx and subglottis. Ten participants in that study demonstrated a change in swallowing 
physiology. Although the authors concluded that normal swallowing could occur with 
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anaesthesia of the upper aerodigestive tract, it is clear from the results that liberal application 
of anaesthetic has the potential to alter swallowing.  
In both of these studies however, the researchers were attempting to completely block 
sensation in the pharynx; the former to reduce involuntary swallows during radiographic 
procedures and the latter to determine the role of sensation in swallowing. The liberal use of 
topical anaesthetic in these studies is quite different to judicious and focused use during VES 
and the results are of limited application in the VES context. Indeed, during VES a small 
amount of anaesthetic is applied to the nares only. Johnson, Belafsky and Postma (2003) 
investigated the effect of bilateral nasal application of 4% cocaine solution on laryngeal 
sensation. The dose they selected reflected typical use for nasendoscopy. There was no 
significant difference in laryngeal responsiveness before or after topical anaesthetic and the 
authors reported that a small amount of anaesthetic to the nares does not appear to affect 
laryngeal sensation (Johnson et al., 2003).  
Researchers from Wake Forest Baptist Medical Centre and Boston University 
Medical Centre collaborated in a series of three research studies to specifically investigate the 
effect of different doses of anaesthetic on swallowing during VES, both in healthy 
individuals and individuals with dysphagia. In the first study by Lester and colleagues (2013), 
healthy individuals underwent two VESs, 10 days apart. Participants were randomised to 
receive either the anaesthetised condition, with 1ml of lidocaine, or non-anaesthetised 
condition first, followed by the alternate condition. Each VES was reviewed by an SLT 
blinded to the condition under which it was performed. The authors reported a 1ml dose of 
4% lidocaine did result in a statistically significant increase in penetration and aspiration 
events in the anaesthetised condition (PAS ≥ 1 in 11% vs 3%). However, the clinical 
significance of this is negligible as the average PAS score with anaesthetic was only 0.16 
higher (1.05 vs. 1.21), indicating a very mild impairment of swallowing. In the second study 
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by Fife and colleagues (2014), participants with dysphagia underwent two VESs, the first 
without anaesthesia and the second with 0.5ml of lidocaine, within a single clinic visit. VES 
recordings were again reviewed by SLTs blinded to the use of anaesthesia. The authors 
reported a non-significant trend towards increased PAS scores in the anaesthetised condition. 
And finally, O’Dea and colleagues (2015) completed a similar study examining the effect of 
0.2ml lidocaine on swallowing during VES. Participants again underwent a VES without 
anaesthesia, but with decongestant, immediately followed by a VES with anaesthesia. The 
authors reported no significant difference in PAS score or residue between conditions.  A 
limitation of these studies is the use of PAS score. It is commonly used in dysphagia 
literature, but it is not an interval scale. When reporting change in PAS scores it is important 
to consider that a change from 2, penetration that is cleared to 3, penetration that is not 
cleared is arguably less significant than a change from a 7, aspiration that triggers an attempt 
to clear, to 8, aspiration that does not trigger a response. Comparing mean PAS scores or 
changes in PAS scores can be problematic. 
Lamvik (2016) investigated the impact of topical nasal anaesthesia on pharyngeal 
pressure by performing pharyngeal manometry on participants who were randomised to an 
experimental group receiving nasal anaesthesia and lubricant and a control group receiving 
only lubricant. Both the participant and researcher were blinded to the condition. Lamvik 
reported a lower mean pharyngeal during dry swallowing with anaesthesia when compared to 
the placebo group (p=.020), but a higher maximum pressure in the same condition. These 
differences did not translate to liquid swallows (Lamvik, 2016). Although in a clinical setting 
this difference may be unimportant, in a research setting even small changes in swallowing 
may influence sensitive measures, resulting in false conclusions. 
There is mixed evidence regarding the impact of anaesthesia on patient comfort. All 
three of studies by the Wake Forest and Boston University Group reported significantly less 
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pain and improved tolerance for the participants with anaesthesia. It is important to note that 
the participants in the studies by Lester and colleagues (2013) and Fife and colleagues (2014) 
were not blinded to the use of anaesthesia. This may have biased their response questions 
regarding subjective ratings of pain. Leder, Ross, Briskin and Sasaki (1997) compared patient 
comfort during nasendoscopy with a topical anaesthetic, a vasoconstrictor and placebo in a 
randomised and double-blinded study. The authors reported there was no difference in patient 
comfort between the three groups with the majority of participants reporting no or mild 
discomfort. Their results are supported by those of Lamvik (2016), who reported no 
significant difference in procedure tolerance between participants receiving nasal anaesthesia 
prior to manometry and participants receiving a placebo.  Considered alongside evidence that 
larger doses of topical anaesthetic can alter swallowing (>.5ml lidocaine), but small doses 
have no impact, it is advised that small doses of lidocaine may be safely used, but may not 
effect patient comfort and are not necessary for completion of VES.  
1.5.3.2.2 Penetration-Aspiration Scale 
The Penetration-Aspiration Scale (PAS) (Figure 6) was designed by Rosenbek and 
colleagues as a tool for researchers and clinicians to describe penetration and aspiration 
events observed on VFSS (Rosenbek et al., 1996). It is an 8-point ordinal scale, which 
classifies the depth of penetration or aspiration, the response to penetrated and aspirated 
material and the effectiveness of that response. The PAS was originally designed for VFSS 
interpretation, although reliability has also been established with VES (Colodny, 2002). A 
score of two through 5 is classified as airway penetration and a score of 6 or greater is 





Figure 6. The 8-point Penetration - Aspiration Scale. 
From “A penetration – aspiration scale”, by J. C. Rosenbek, J.A. Robbins, E. B. Roecker, J. 
L. Coyle, & J. L. Wood, 1996, Dysphagia, 11(2), p. 93-98. Copyright 1996 by Springer. 
Reprinted with permission. 
 
The PAS is often used by researchers, but does have limitations. It is purported to be 
an ordinal scale, with a score of one indicating a normal swallow and a score of eight 
assigned to the most severely impaired swallow, with material passing below the vocal cords 
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without stimulating a cough. When material enters the airway, contacts the vocal cords and is 
not ejected, this is a score of 5. This situation is arguably more severe than when material 
passes below the cords and is ejected out the airway by a strong and prompt cough, which is 
scored as 6. It is not an interval scale and the degree of severity between each step is not 
equal.  
1.5.4 Summary 
The multidisciplinary team employs a range of screening and assessment tools to 
identify and diagnose dysphagia in the ICU patient depending on local protocol and practice. 
Given the high prevalence of silent aspiration in this population, screening and assessments 
would ideally be designed to identify those patients who are at risk of silent aspiration. 
Because of the limitations of clinical assessment, instrumental assessment is essential to 
accurately diagnose dysphagia. In the ICU setting, VES offers several benefits, including 
portability and the ability to view secretions and laryngeal pathology. VES is well tolerated 
and is the preferred instrumental assessment tool for the critically ill patient.  
1.6 Cough Reflex Testing  
Given the prevalence of silent aspiration in the ICU post-extubation population, the 
ability to assess airway protection offers clear advantages. The cough reflex is one of the key 
airway protection reflexes. Assessment of the cough reflex after extubation may offer useful 
insight into an individual’s risk of silent aspiration and a close look at CRT research is 
warranted. 
1.6.1 History of Cough Reflex Testing 
Testing of the cough reflex was developed in the 1950s to aid development of cough 
medicines (Bickerman & Barach, 1954; Bickerman, German, Cohen, & Itkin, 1957). 
Participants were given various experimental cough medicines and then given tussigens, 
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substances known to stimulate cough. The effectiveness of the trial medicine was determined 
by its ability to attenuate the cough response. In the last 20 years, CRT has been further 
developed to test integrity of cough in patients with disease with the goal of developing a 
screening tool to identify individuals with dysphagia (Addington, Stephens, Gilliland, & 
Rodriguez, 1999; Addington, Stephens, Ockey, Kann, & Rodriguez, 1995; Addington, 
Stephens, Widdicombe, & Rekab, 2005; Davies, 2016; Miles, Zeng, McLauchlan, & 
Huckabee, 2013; Nakajoh et al., 2000; Nakazawa, Sekizawa, Ujiie, Sasaki, & Takishima, 
1993; Sekizawa, Ujiie, Itabashi, Sasaki, & Takishima, 1990; Wakasugi et al., 2008; Yamanda 
et al., 2008).  
1.6.2 Methods of Cough Reflex Testing 
Over the last few decades, a range of methods has been used to test cough (Davies, 
2016; Irwin et al., 2006; A. C. Miles, 2013; Morice et al., 2007; Morice, J. A. Kastelik, & R. 
Thompson, 2001; Pecova, Javorkova, Kudlicka, & Tatar, 2007; Redington, Morice, & 
Kastelik, 2005). Varying tools, including nebulisers and delivery sets, tussigens, methods and 
outcome measures, mean it is often impossible to compare studies or reproduce results and 
incorrect conclusions may be drawn. Published reviews of cough testing literature have 
strongly recommended standardisation of methods in future research (Irwin et al., 2006; 
Morice et al., 2007; Morice et al., 2001; Pecova et al., 2007; Redington et al., 2005).  
In 2007, Morice and colleagues published a set of guidelines on the assessment of 
cough to address the variability of definitions and methodology in the literature. Two of the 
authors’ primary goals were to establish “safe, standardised methods of inhalation cough 
challenge” and to promote “reliable, reproducible and relevant clinical cough recording and 
analysis” (p. 1257). The authors recommended that cough be defined in basic scientific 
articles as a “three phase motor act”, consisting of an inspiratory phase, compressive phase 
and expulsive phase (Morice et al., 2007). Morices’s recommendations and additional 
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assessment guidelines provide a standardised baseline for cough researches to use in study 
design and reporting. 
1.6.2.1 Tussigens 
The cough reflex can be stimulated mechanically or chemically and both methods are 
used to test the cough reflex. Mechanical stimulation can be performed during VES by 
ejecting a burst of air or water at the vocal folds or laryngeal mucosa and observing for a 
response (Aviv et al., 1998; Tanaka et al., 2005). Tanaka and colleagues (2005) used this 
method to test cough sensitivity in patients who had undergone simple surgery when 
comparing the impact of LMA in comparison to traditional endotracheal tubes. Sensory 
testing during videoendoscopy allows the clinician to listen for a cough response and observe 
the movements of the vocal cords during cough and other reflexes, including the glottic 
closure and the expiration reflex (Aviv et al., 1998). Together, these observations give the 
clinician an indication of an individual’s sensory integrity. However, the equipment required 
to perform this type of testing is expensive and requires a high level of skill. Therefore, while 
VES with sensory testing is useful for instrumental assessment, it is not ideal as a screening 
tool for cough sensitivity. 
Capsaicin is a non-acid chemical tussigen derived from red pepper that is frequently 
used in cough research and known to stimulate urge-related coughing through activation of 
C-fibers (Fujimura et al., 1995; Pecova et al., 2007). It has little to no effect on 
mechanoreceptors (Canning, 2006; Mazzone et al., 2005; J. Widdicombe, 2001). Cough is 
reliably stimulated by inhaled nebulised capsaicin with a good reproducibility. However, 
tachyphlylaxis occurs with repeated trials and recovery to baseline sensitivity can take more 
than three hours (Morice, Higgins, & Yeo, 1992; Pecova et al., 2007). Also, capsaicin 
stimulation, through its activation of chemoreceptors, may have little effect on elicitation of 
the “true” cough reflex (Canning, 2006).  
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Tartaric acid and citric acid are the most commonly used acid tussigens (Bickerman & 
Barach, 1954; Morice et al., 2001). Addington, and colleagues (Addington et al., 1998; 
Addington & Stephens, 1999; Addington, Stephens, Gilliland & Rodriguez, 1999; 
Addington, Stephens & Gilliland, 1999; Addington, Stephens & Goulding, 1999; Addington 
et al., 2005) have used tartaric acid in a series of studies looking at cough reflex and 
pneumonia after stroke, but did not provide a justification for the choice of tussigen. There is 
little normative data for tartaric acid and studies suggest cough reflex testing with tartaric 
acid is not as reproducible as with citric acid ( Morice et al., 2001). 
Citric acid is the most commonly used acid tussigen in cough physiology studies 
(Morice et al., 2001). Unlike capsaicin, citric acid stimulates the mechanoreceptors as well as 
chemoreceptors (Wong, Matai, & Morice, 1999), provoking both a reflexive cough as well as 
an urge-to-cough. Although citric acid stimulates receptors throughout the larynx, trachea and 
lungs (Wong et al., 1999), citric-acid sensitive receptors appear to be more dominant in the 
larynx. This is in contrast to the capsaicin receptors, which are more common in the 
peripheral airways (Hansson, Wollmer, Dahlback, & Karlsson, 1992; Morice, 1996). This is 
important as the receptors of the larynx are crucial in triggering cough to protect the airway 
from the aspiration of food and fluids (Morice et al., 2007).  
Cough testing with citric acid is reproducible and, although tachyphylaxis does occur, 
recovery to baseline sensitivity following repeated testing occurs more quickly with citric 
acid than capsaicin (Morice et al., 1992). This makes it the preferred tussigen for repeated 
cough measures, such as the dose response method, when increasing doses of the tussigen are 
delivered until a threshold is established (Morice et al., 2007). A one-minute break is 
recommended between trials to reduce the influence of tachyphlaxis (Morice et al., 2007). An 
added benefit of citric acid is its safety and record of subject tolerance; in more than 60 years 
of use there have been no recorded serious adverse reactions in response to citric acid.  
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1.6.2.1.1 Preparation of citric acid 
There is very little published research to offer guidance on the preparation of citric 
acid. In the ERS Guidelines on the Assessment of Cough, Morice and colleagues (2007) 
recommend storing a stock solution of 3.0 mol citric acid in sterile 0.9% saline solution and 
creating dilutions to the desired test concentrations daily. This is to ensure a consistent 
concentration of citric acid is delivered each time, as stability of the solution is essential for 
valid CRT results. In addition, The United States Food and Drug Administration (2002) 
recommends that all inhalation solutions be sterile due to the risk of infection caused by 
inhaling nebulised solutions contaminated with bacteria (Hovig, 1981; Reinarz, Pierce, Mays, 
& Sanford, 1965). However, daily preparation of citric acid in a sterile environment is 
expensive, time consuming and prohibitive to use in a clinical setting.  
Falconer and colleagues (2014) established a guideline for best practice in the 
preparation and use of citric acid to address these issues. Sterility testing revealed that citric 
acid was inhospitable to common bacteria with experimentally introduced staphylococcus 
aureus surviving for a maximum of 40 minutes. However, introduced candida albicans 
survives in citric acid. Therefore, there is a risk of cross-contamination when using a single 
bulk solution of citric acid solution between multiple patients. Stability testing determined 
that citric acid solution is stable for a minimum of 28 days. The authors suggested that citric 
acid be prepared aseptically every 28 days and stored in single use syringes to eliminate the 
risks of cross-contamination and degradation of the solution. These guidelines allow citric 
acid to be prepared in the hospital setting safely and at minimal cost. 
1.6.2.2 Delivery methods  
There are two primary methods of citric acid delivery during dose response cough 
reflex testing: single vital-capacity breaths and tidal breath inhalation (Morice et al., 2007). In 
the single vital-capacity breath approach, the participant’s nose is occluded and they are 
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instructed to take a single, quick breath through a mouthpiece (Addington, Stephens, & 
Gilliland, 1999). The amount of tussigen may be controlled by a dosimeter to ensure that a 
predetermined amount is administered with each trial (Morice et al., 2007).  
In the tidal breath inhalation method, participants inhale the nebulised tussigen 
through a facemask or mouthpiece for a period of time, usually 15 to 60 seconds, and the 
number of coughs is counted (Dicpinigaitis, 2007; Morice et al., 2007; Nejla, Fujimura, & 
Kamio, 2000; Redington et al., 2005; Wakasugi et al., 2008). Although some researchers 
have recommended the single-dose response method for accuracy and reproducibility 
(Dicpinigaitis, 2007; Morice et al., 2007), a comparison of the two methods produced good 
agreement (Nejla et al., 2000). Pecova and colleagues (2007) reported that fewer healthy 
participants coughed on citric acid trials compared to capsaicin trials when the patient was 
instructed to take a single, full breath. The authors warned that citric acid may not be as well 
suited for measuring decreased cough reflex sensitivity using the single vital capacity breath 
method. Therefore, tidal breath method may be more suitable to CRT with nebulised citric 
acid. 
Addington and colleagues (1995) were the first to propose CRT as a tool for assessing 
risk of silent aspiration during swallowing. They utilised a mouthpiece for delivering the 
tussive agent, a method was has been replicated by many others (Lee, Kim, Seo, & Kang, 
2014; Leow, Beckert, Anderson, & Huckabee, 2012; Wakasugi et al., 2014). However, the 
mouthpiece method has obvious drawbacks for any participant who has facial weakness or 
difficulty following commands, both of which are common among ICU patients. For these 
populations, delivering the tussigen via facemask may be more appropriate as it allows the 
participant to breath passively. This method has been employed in a number of research 
studies for this reason (Monroe, Manco, Bennett, & Huckabee, 2014; Wakasugi et al., 2008). 





Figure 7. Different Methodology Used in CRT. 
From “Cough challenge in the assessment of cough reflex,” by A. H. Morice, J. A. Kastelik, 
& R. Thompson, 2001, British Journal of Clinical Pharmacology, 52(4), p. 365-375. 
Copyright 2001 by John Wiley and Sons. Reprinted with permission. 
 
1.6.2.3 Nebulisers 
During CRT, tussigens are delivered by a nebuliser, which is a device that uses 
compressed air to convert a liquid solution into an aerosol. Jet nebulisers are usually used for 
CRT (Morice et al., 2007). They are small, easy to transport to the patient’s bedside and are 
ideal for use in ICU. The specifications of the nebuliser should be standardised across CRT 
trials as both the flow rate of the nebuliser and the droplet size produced can impact CRT 
results (Morice et al., 2007; Morice et al., 2001). When citric acid aerosol is inhaled, smaller 
particles are able to travel more distally in the airways. As a result, particles of 10m or 
greater are deposited in the mouth and throat, 5 to 10m between the throat and lungs and 
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particles less than 5mare deposited most distally in the lungs (Morice, J. A. Kastelik, & R. 
Thompson, 2001). Because citric acid is thought to stimulate cough receptors that 
predominate in the larynx (Morice, 1996), particles between 5m and 10m may be ideal 
(Redington et al., 2005).  
The flow rate varies widely across nebulisers (Terzano, Petroianni, Parola, & Ricci, 
2007) and even within nebulisers (Morice et al., 2007). Nebulisers with a lower flow rate 
produce a greater cough response, possibly due to an association between lower flow rate and 
increased deposition in the larynx (Barros, Zammattio, & Rees, 1990). To strictly control the 
inspiratory flow rate, some experts suggest integrating a dosimeter into the nebuliser 
(Dicpinigaitis, 2007; Morice et al., 2007; Redington et al., 2005). Used with the single vital 
capacity breath method, the dosimeter releases a fixed amount of tussigen over a set period 
on inhalation (Redington et al., 2005).  
1.6.2.4 Placebo 
Humans can consciously supress the urge to cough (Hegland, Bolser, & Davenport, 
2012; Hutchings, Eccles, Smith, & Jawad, 1993; Lee, Cotterill-Jones, & Eccles, 2002) and 
coughing can occur in the absence of stimulus. Guinea pigs have been conditioned to cough 
to an odour by presenting the odour with a tussigen for several days and then withdrawing the 
tussigen, suggesting that the cough response can be learned (Pinto, Yanai, Sekizawa, Aikawa, 
& Sasaki, 1995). For this reason, the authors of the ERS Guidelines on the Assessment of 
Cough recommend that placebo trials with normal saline should be randomly interspersed 
between repeated trials of citric acid, as occurs in the dose-response method of testing 
(Morice et al., 2007). 
1.6.2.5 Suppressed versus natural cough  
Cough testing can employ either a natural or supressed cough method. The ERS 
Guidelines on the Assessment of Cough recommend that subjects be clearly instructed not to 
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suppress cough, suggesting the instructions, “Allow yourself to cough if you need to and as 
much as you need to” (Morice et al., 2007). However, others suggest that the point at which 
cough can no longer be supressed may represent the truer cough threshold as this is 
presumably the point at which the person has lost the ability to cortically override the 
brainstem cough response (Hegland et al., 2012; Monroe et al., 2014). Monroe and 
colleagues (2014) performed CRT with citric acid with 160 healthy volunteers who were split 
evenly between younger and older cohorts. Cough thresholds were established in both natural 
and supressed cough conditions. The instructions to the participants performing suppressed 
cough were to, “Try to suppress the cough as much as you can” (Monroe et al., 2014). The 
researchers reported that supressed cough thresholds were significantly higher than natural 
cough thresholds, supporting the argument that the supressed cough threshold is a more 
accurate representation of the true cough reflex threshold.  
1.6.3 Interpretation of CRT results 
1.6.3.1 Norms 
A benefit of citric acid use in cough testing is that normative values and intra- and 
inter-rater reliability have been established (Miles & Huckbee, 2013; Monroe et al., 2014). 
Monroe and colleagues performed cough threshold testing on 160 individuals equally split 
across age groups (younger ≤ 60 years, older ≥ 60 years) and gender. A DeVilbiss nebuliser 
with an unrestricted flow rate of 8 l/m was used to deliver citric acid aerosol via facemask 
using the tidal breath method. Both natural and suppressed cough methods were tested. 
Placebo trials were randomly interspersed with citric acid trials. The initial cohort of 80 
patients underwent cough threshold testing with citric acid doses ranging from 0.8 to 2.6mol/l 
in increments of 0.2mol/L. However, at 0.8 mol/L, 92.5% of participants produced a natural 
and 70% produced a supressed cough, indicating a flooring effect. Eighty more participants 
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were recruited and underwent testing with doses ranging from 0.1 to 1.2 mol/l (Monroe et al., 
2014).  
Eight (5%) participants did not produce a natural cough response at any concentration 
of citric acid. However, seven of these participants were in the second cohort, where the 
highest test concentration was 1.2mol/l. Presumably some participants would have triggered a 
cough at the higher concentrations tested in the first cohort. One (<1%) participant of the 80 
tested did not produce a natural cough response at even the highest concentration of 2.6mol/l. 
Forty (22%) of the participants did not trigger a suppressed cough, but only 15 (19%) of them 
were tested at the higher concentrations. Certainly, this suggests that there is a very wide 
range of normal cough responses. Monroe and colleagues (2014) suggest considering the 
normal variation in cough sensitivity when evaluating the sensitivity and specificity of CRT. 
Of those participants who produced a cough, 97.3% had produced a natural cough by 
1.6mol/l and 95.5% produced a supressed cough by 1.2mol/l. The norms for both natural and 
supressed cough appear in Figure 8. There is a significant peak at 0.8 mol/l, but some of these 
participants would have been from the first cohort and were not tested below 0.8mol/l, which 
is a clear limitation of the study (Monroe et al., 2014).  
Miles and Huckabee (2013) reported fair to moderate inter- and intra-rater reliability 
amongst both experienced and inexperienced clinicians interpreting CRT result.  Clinicians 
viewed videos of patients receiving a single dose of nebulised citric acid over 15 seconds, 
utilising a tidal breathing method via facemask. Clinicians were better at judging the presence 
or absence of cough than judging whether a cough response was strong or weak.  It is 
interesting to note that the experienced clinicians overall inter- and intra-rater reliability was 
not significantly better than the inexperienced clinicians, despite eight hours of focused 





Figure 8. Natural and Supressed Cough Thresholds in Healthy Volunteers. 
From “Citric acid cough reflex test: establishing normative data,” by M. D. Monroe, K. 
Manco, R. Bennett, & M.-L. Huckabee, 2014, Speech, Language & Hearing, 17(4), p. 216-
224. Copyright 2014 by Taylor & Francis Group. Reprinted with permission. 
 
1.6.3.2 Factors Affecting Cough Sensitivity  
Several factors can affect the cough reflex by either increasing or decreasing 
sensitivity (Redington et al., 2005). Many of these factors may be relevant to the ICU 
population and should be considered with interpretation of cough sensitivity in this 
population. Women have demonstrated increased sensitivity to tussigens (Becklake & 
Kauffmann, 1999; Dicpinigaitis & Rauf, 1998; Fujimura et al., 1996; Monroe et al., 2014; A. 
Morice, Kastelik, & Thompson, 2000). Smokers have reduced sensitivity to cough stimuli 
(Dicpinigaitis, 2003), although sensitivity improves almost immediately after quitting 
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smoking, then quickly returns to baseline when smoking is resumed (Sitkauskiene & 
Dicpinigaitis, 2010). Recent research by Dicpinigaitis, Chang, Dicpinigaitis and Negassa 
(2016) demonstrated reduced cough sensitivity in participants immediately after they smoked 
an e-cigarette containing nicotine, which was not seen after smoking a non-nicotine e-
cigarette. The authors suggest the nicotine was responsible for blunting the cough response. 
This may indicate that the sensitivity of cough receptors is dynamic and subject to change in 
response to environmental conditions (Sitkauskiene, Stravinskaite, Sakalauskas, & 
Dicpinigaitis, 2007). Although adults have a less sensitive cough than children, natural cough 
thresholds appear to be stable throughout the adult years (Chang & Widdicombe, 2007). 
However, suppressed cough thresholds have been shown to be lower in elderly individuals 
(Leow et al., 2012). Gender, age and smoking status may be relevant to the cough sensitivity 
of individual patients in the ICU and, ideally, any study assessing the cough reflex in this 
population would capture these variables and consider their influence on CRT results. 
Smoking may be less relevant in the ICU post-extubation population as these patients have 
usually not been smoking recently due to illness, injury or smoking cessation prior to surgery, 
and the blunting effect of smoking on cough reflex appears to be short-lived. 
Watando and colleagues (2004) randomised 60 hospital-level care patients into a 
control group or experimental group in a rigorously controlled study. At the outset of the 
study there were no significant differences in cough reflex threshold between the two groups. 
The experimental group received five minutes of teeth brushing after each meal in addition to 
weekly dental care. Cough reflex testing was repeated after 30 days of the oral care protocol 
and the experimental group demonstrated significantly lower cough reflex thresholds than the 
control group. These results suggest that cough reflex sensitivity may improve following 
intensive oral care. The authors did not provide an explanation for the mechanisms behind 
this effect and it is unclear if it was the reduction in oral bacteria or the stimulation to the oral 
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cavity that led to the change in cough reflex sensitivity. Davies (2016) quantified the oral 
bacteria of 102 acute stroke patients with dysphagia at admission to hospital, discharge from 
the acute stroke ward and one month following stroke and compared bacteria counts to 
results of CRT performed at the same time points. The author reported no significant 
relationship between bacteria counts and cough sensitivity, but suggested this may be due to 
an underpowered study. Orotracheally-intubated patients are not generally able to perform 
their own oral cares and the presence of the endotracheal tube can restrict access to the 
mouth. As a result, the oral cavities of these patients are likely to have high bacteria counts. 
The endotracheal tube can become covered in a bacterial film and provides a conduit from 
the mouth to the lungs (Scannapieco, 2006). Considering the volume of oral bacteria in the 
ICU population and its potential effect on cough reflex sensitivity, it should be considered as 
a factor in future studies evaluating dysphagia, aspiration and cough reflex in the ICU 
population. 
Finally, cough reflex sensitivity has been reported to change over the course of a day, 
with stronger concentrations of citric acid required to stimulate cough in healthy volunteers in 
the afternoon (Pounsford & Saunders, 1985). Therefore, it has been recommended that 
repeated cough testing within an individual be repeated at similar times of the day (Pounsford 
& Saunders, 1985). However, in a study by Davies (2016), healthy volunteers underwent 
CRT using the tidal breathing method in the morning and afternoon and the author reported 
no significant difference in the cough sensitivity. Participants in the study by Davies (2016) 
brushed their teeth prior to CRT to reduce the potential impact of oral bacteria on cough 
sensitivity. These results indicate that time of testing may not be an important factor when 




Because opioids are used so frequently in the ICU population, particularly in the 
period immediately following extubation (Elliott et al., 2013; Shehabi et al., 2013), the effect 
of opioids on the cough reflex deserves special attention. In 2013, researchers from 41 ICUs 
reviewed 569 admitted patients over a four-hour period (Elliott et al., 2013). Sixty percent of 
the participants were receiving either an analgesic or sedative on the day of the study; 61% of 
participants were receiving bolus dose of morphine or fentanyl and 46% of participants were 
receiving one or the other intravenously. The link between opioid use and cough has been 
well established for more than a century (Chung & Chang, 2002; Fantus, 1912) and opioids 
are reported to reduce cough sensitivity to citric acid (Kelly, Shaw, Brett, Greenwood, & 
Huckabee, 2016). 
In a study by Morice and colleagues (2007), 27 participants with chronic cough were 
enrolled in a double blind, placebo-controlled crossover study evaluating the treatment effect 
of the opioid morphine. Participants in the experimental group received a 5mg dose of oral 
slow-release morphine twice per day and reported a rapid and significant improvement in 
quality of life ratings. The authors reported that treatment with morphine did not respond to a 
change in sensitivity to CRT with citric acid. It is possible that this is because the morphine 
reduced the cortically modulated urge-to-cough, but did not effect the reflexive cough 
triggered by citric acid. However, it is likely that the dose the authors used was below that 
needed to attenuate cough. Typical opioid doses in ICU are much higher than those Morice 
and colleagues (2007) studied. For example, ICU patients are routinely able to administer 
their own pain relief post-operatively via a syringe driver that delivers limited doses, most 
commonly one milligram of morphine every 5 minutes (McNicol, Ferguson, & Hudcova, 
2015), compared to the 10mg over 24 hours used by Morice and colleagues (2007).  
Kelly and colleagues (2016) examined the effect of more powerful doses of fentanyl 
on supressed cough thresholds to citric acid. Thirteen healthy volunteers each received four 
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consecutive doses of 0.5μg/kg intravenous fentanyl, each five minutes apart. The mean of the 
participants’ weights was 71.5kg, making the mean dose of fentanyl 35.8μg per dose for a 
mean total of 143μg. This is equivalent to 3.6mg of morphine per dose and a total dose of 
14.3mg morphine (10μg fentanyl = 1mg morphine). The authors selected this dose to be 
representative of what a patient would receive perioperatively. Participants’ cough reflex 
thresholds consistently rose over the course of the administration, from a mean of 0.51mol/l 
to 1.26mol/l after the final dose. Thresholds subsequently fell in the period after fentanyl 
administration, returning to a baseline in a mean of 44.6 (SD=18.8) minutes. These results 
clearly demonstrate that the use of opioids is a factor in cough testing and, as such, should be 
carefully considered in the interpretation of results. Neither Morice and colleagues (2007) nor 
Kelly and colleagues (2016) mention if gender made a difference in cough sensitivity to 
opioids, but others have reported that opioids have a significantly greater dampening effect 
on women’s coughing when emerging from surgery when compared to male counterparts 
(Soh, Park, Kang, Lee, & Lee, 2014). This is likely due to women’s increased sensitivity to 
opioids (Lee & Ho, 2013) and may further complicate the understanding of opioid effect on 
the cough reflex.  
1.6.4.1 Measuring cough presence  
When evaluating presence of the cough reflex, the most common method is to 
measure the concentration of tussive that is required to stimulate at least two coughs within 
15 seconds (Dicpinigaitis, 2007; Miles, Zeng, et al., 2013; Monroe, Huckabee, & Robb, 
2010; Wakasugi et al., 2008). The ERS recommends that researchers use either a C2 (the 
concentration of citric acid causing 2 coughs in 15 seconds) or C5 (the concentration of citric 
acid causing 5 coughs in 15 seconds) (Morice et al., 2007). The normative data of cough 
response to citric acid by Monroe and colleagues (2014) utilised the C2 method and, 
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therefore, selecting this method of recording CRT response offers the substantial benefit of 
being able to compare results to established norms.  
Miles, Zeng and colleagues (2013) added a subjective assessment of cough strength to 
their cough reflex testing protocol. If C2 was present it was classified as either strong or 
weak, a judgement that the authors report has moderate reliability in untrained clinicians 
(Miles & Huckbee, 2013). They define weak cough as, “a cough that does not appear strong 
enough to clear aspiration and is substantially weaker than their own reflexive cough” (Miles, 
Moore, et al., 2013). The authors hypothesized that individuals with weak cough may be at 
increased risk of pneumonia because, despite having a cough response, they may still be 
unable to adequately clear aspirated material (Miles, Zeng, et al., 2013). Many patients in the 
ICU have a weak cough due to, but not limited to, supine positioning (Badr, Elkins, & Ellis, 
2002), pain following surgery (Weissman, 1999) or weakness (De Jonghe et al., 2007), and 
judging cough strength may be beneficial in this group.  
1.6.5 Cough Reflex Testing Application in Dysphagia 
Addington and colleagues first proposed the application of CRT to the field of 
dysphagia in 1995. The authors initially suggested a two-part swallowing exam assessing the 
oral and pharyngeal phases of the swallow. The authors evaluated the oral phase of a 
participant’s swallowing by assessing their ability to perform an oral hold task. Participants 
also underwent CRT using nebulised tartaric acid to determine the motor and sensory 
function of the internal branch of the SLN; performance on this task was used to assess the 
pharyngeal phase of swallowing. Participants with a strong cough and ability to hold 30ml of 
water in their mouth for 15 seconds were significantly less likely to aspirate or penetrate on 
VFSS (p<.0001). It is worth noting that the assessment proposed by the authors did not 
evaluate physiology of the oral transit or pharyngeal phases of swallowing and focused 
purely on airway sensation. Intact function of the SLN is vital in swallowing, but represents 
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only a portion of the sensory input and motor output that occurs during the pharyngeal phase 
of swallowing. This study marked the beginning of a series of research studies on CRT and 
swallowing by Addington and colleagues. 
The subsequent study further developed CRT (Addington, Stephens, & Gilliland, 
1999). One hundred and sixty-one stroke patients in a rehabilitation hospital underwent CRT 
and their cough responses were judged to be normal (strong) or abnormal (weak or absent). 
The primary outcome measure of interest was development of pneumonia. Only 78 
participants underwent VFSS. One hundred and thirty-one (81%) participants had a normal 
cough response and none of these participants developed pneumonia, while of the 30 (19%) 
participants with abnormal cough, 5 (17%) developed pneumonia. Interestingly, this is a 
pneumonia rate of only 3%, which is well below reported pneumonia rates in the 
rehabilitation setting (Martino et al., 2005).  
There are a number of other issues with the methods the authors employed. 
Participants who could not follow verbal commands or who had supplemental oxygen were 
excluded from the study. In addition, results were not considered valid if the participant could 
not form a sufficient seal around the mouthpiece. These criteria likely excluded patients with 
more severe strokes from participating, thus reducing the pneumonia rate amongst 
participants. There is also no indication of the time periods over which development of 
pneumonia was assessed or what criteria were used to determine a diagnosis of pneumonia. If 
pneumonia was only recorded in the acute stage it would result in a much lower rate than if 
patients were followed up for a period of time following their stroke. It is worth noting that 
the researchers did not consider cough effectiveness in the development of pneumonia by 
analysing differences between participants with strong or weak coughs, but just presence or 
absence of response. However, the correlation between abnormal cough reflex and 
development of pneumonia deserves further exploration. 
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Following this study, Addington, Stephens and Gilliland (1999) proposed a rigid 
assessment framework for clinical application of CRT (Figure 9), which they applied in a 
prospective study of 400 consecutive acute stroke patients. Participants in the experimental 
group who had an abnormal cough were managed conservatively, with no oral intake 
allowed. Participants with normal cough and ability to follow commands were progressed 
onto oral diets on the basis of a bedside exam. VFSS was only used to assess structural 
issues, such as fistula, but not to assess physiology of swallowing. The premise of this 
method was that CRT was able to rule out silent aspiration and patients with an intact 
reflexive cough could be correctly assessed through a clinical exam only. This approach does 
not, however, take into account the benefit of VFSS for identifying abnormal swallowing 
physiology and planning rehabilitation.  
The primary outcome of the study was the development of pneumonia. Pneumonia 
rates in the experimental group, who received the CRT protocol, were compared to 
pneumonia rates in a control group at a sister hospital. Five (1%) of the 400 participants in 
the experimental group developed pneumonia compared to 27 (13%) of the 204 participants 
in the control group (Addington, Stephens, & Gilliland, 1999). When Addington, Stephens, 
Widdicombe & Rekab (2005) applied the same strict protocol to 818 consecutive acute stroke 
patients in a follow-up study, there was a significant difference in pneumonia rates for 
participants with normal versus abnormal CRT response (p<.005). The incidence of 
pneumonia was higher in participants with absent cough (15%) than weak cough (10%).  
While these results are intriguing, there are significant limitations to these studies that 
should be considered when interpreting the results. The authors again excluded an 
unidentified number of participants who could not form a lip seal around the mouthpiece and 
who could not follow commands. As discussed previously, this would likely result in the 
more severe stroke patients being excluded, while no such exclusion occurred in the control 
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group. The choice by the authors to use patients at another hospital as the control introduced 
a number of potentially confounding variables. The differences in pneumonia rates between 
the two groups may be due to differences in the patient population or patient management 
rather than use of CRT. In addition, Addington, Stephens & Gilliland (1999) do not justify 
their decision to use tartaric acid and do not refer to normative data or explain the choice of 
concentration. Because cough sensitivity varies widely within individuals it is beneficial to 
have normative data to determine concentration selection and to compare results.  
 
 
Figure 9. Algorithm of Addington and Colleagues' Reflex Cough Test. 
From “Assessing the laryngeal cough reflex and the risk of developing pneumonia after 
stroke,” by W. R. Addington, R. E. Stephens, K. Gilliland, & M. Rodriguez, 1999, Archives 
of Physical Medicine and Rehabilitation, 80(2), p. 150-154. Copyright 1999 by Elsevier.  
 
Wakasugi and colleagues (Wakasugi et al., 2008) were the first to validate CRT with 
citric acid. Two hundred and four participants who had been referred for VFSS or VES for 
suspected dysphagia underwent CRT 1% weight/volume nebulised citric acid presented via 
facemask (with a nose clip) for one minute. A response of five or more coughs during the 
minute was considered a normal response while a response of four or fewer coughs was 
considered abnormal. CRT outcome was compared to VFSS or VES. When participants who 
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silently aspirated a trace amount were grouped with participants who did not silently aspirate, 
CRT had a sensitivity of 0.87 and a specificity of 0.89 for predicting silent aspiration. In 
2014, the authors repeated the study but used a handheld nebuliser to deliver the citric acid. 
Sensitivity and specificity of CRT to predict silent aspiration was 0.86 and specificity 0.71. 
The authors did not clearly justify their choice of concentration, but all participants 
underwent instrumental assessment and their inclusion criteria and methodology were more 
likely to capture participants with severe dysphagia than those of the studies by Addington, 
Stephens, Gilliland & Rodriguez (1999) and Addington, Stephens & Gilliland (1999). 
Miles and colleagues furthered understanding of CRT as a tool for detecting silent 
aspiration risk in two important studies. The first looked at the effect of CRT use on 
pneumonia rates, specifically in the stroke population (Miles, Zeng, et al., 2013). Three 
hundred and eleven consecutive stroke patients who had been referred to SLT were enrolled 
and randomised to a control group, who received a standard clinical examination, or an 
experimental group who received a standard clinical examination plus CRT. Standard clinical 
examination included a case history, cognitive/communication screen, cranial nerve 
assessment and observation of ingestion of food and fluids. Citric acid in concentrations of 
0.8mol/L and 1.2 mol/L were delivered via tidal breathing with a facemask. Concentrations 
were selected based on the normative data from Monroe and colleagues (2014); normative 
data for concentrations below 0.8mol/L were not available at the time Miles, Zeng and 
colleagues (2013) completed their study. Natural and supressed cough were assessed at 
0.8mol/l, with two coughs on two out of three trials considered a positive response. If 
supressed cough was absent it was retested at 1.2mol/L. Clinicians were advised to consider 
CRT results when making management decisions, but there was no prescribed protocol as in 
the studies by Addington Stephens, Gilliland & Rodriguez (1999) and Addington, Stephens 
& Gilliland (1999). Patients with an abnormal response to CRT were referred for VFSS more 
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often than their counterparts with an intact cough, suggesting there was some change in 
clinician behaviour. However, referral rates for VFSS were still low. Participants who failed 
CRT, developed pneumonia and underwent instrumental assessment were all referred for 
instrumental assessment before the development of pneumonia. Participants who passed CRT 
or who didn’t undergo CRT were only referred for instrumental assessment after they 
developed pneumonia. This suggests an over-reliance by clinicians on a failed CRT result to 
refer for instrumental assessment.  
Addition of CRT to usual clinical practice was not enough to influence patient 
outcomes and the authors reported no significant differences in pneumonia rates between the 
control and experimental groups (21% and 26% respectively), mortality rates or length of 
stay. The authors suggest that a more rigid management protocol, similar to the one used by 
Addington Stephens, Gilliland & Rodriguez (1999) and Addington, Stephens & Gilliland 
(1999), may be necessary to reduce pneumonia rates. Strengths of this study include 
randomisation to experimental and control groups, adherence to the ERS Guidelines on the 
Assessment of Cough (Morice et al., 2007), clear documentation of methodology and use of 
normative values for CRT response.  
In response to the suggestion of Miles, Zeng and colleagues (2013) that a more rigid 
management protocol may have influenced patient outcomes, Davies (2016) compared 
outcomes of participants who were managed under such a protocol to the outcomes of Miles, 
Zeng and colleagues’ (2013) experimental group, who were managed with CRT, but no strict 
protocol dictating management. Two hundred and eighty four acute stroke patients underwent 
CRT prior to initiating oral intake.  Participants who produced a strong cough response to 0.8 
mol/L nebulised citric acid and could not suppress cough at 0.8 or 1.2 mol/L were considered 
to have passed CRT. Decisions regarding intake for these participants were based on clinical 
assessment by an SLT, which included oral trials of food and liquid. Participants who failed 
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CRT were kept nil by mouth until VFSS and then progressed to oral intake only if they did 
not aspirate on VFSS or aspirated with a cough response. The author reported a significantly 
lower rate of aspiration pneumonia in the protocol group, with a pneumonia rate of 10% in 
this group compared to a rate of 28% in the historical group. The odds of developing 
aspiration pneumonia were 3.24 times greater if no protocol were used.  There are some 
limitations to this study, most notably the use of an unmatched historical control group, but 
the results suggest that the implementation of a strict management protocol incorporating 
CRT can have a powerful effect on patient outcomes. 
Miles, Moore and colleagues (2013) also conducted a validity study comparing CRT 
results to instrumental assessment. A total of 181 patients referred for assessment underwent 
CRT and either VFSS or VES within one hour. Threshold testing was performed with citric 
acid doses of 0.4mol/L, 0.6mol/L and 0.8mol/L. Placebo doses were interspersed between 
each concentration change. Presentation methods were the same as the previous study (Miles, 
Zeng, et al., 2013), but only natural cough was assessed. Cough was judged to be present 
(two or more coughs on at least two of three trials) or absent (fewer than two coughs on two 
or more trials), then strong or weak, as defined previously. VFSS and VES were performed 
according to standard protocols. There was almost perfect inter-rater agreement on PAS 
scores at 98% for VES and 96% for VFSS. There was also almost perfect inter-rater 
agreement for judging aspiration response at 97%. There was a significant association 
between CRT response and cough response to aspiration when weak cough responses to CRT 
were grouped with strong responses, with the odds of silent aspiration increasing as cough 
thresholds increased. Sensitivity and specificity were calculated for each concentration and 
were optimised at 0.6mol/L for VFSS (71% and 60% respectively) and 0.4mol/L for VES 
(69% and 71% respectively). This study by Miles, Moore and colleagues (2013) was the first 
to compare CRT threshold testing to instrumental assessment. Again, the authors followed 
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the ERS Guidelines on the Assessment of Cough (Morice et al., 2007) and carefully outlined 
and justified their methodology. These steps make it possible to compare results between 
studies.  
Both sensitivity and specificity were lower than that reported by Wakasugi and 
colleagues (2008). The lower specificity is likely because of the lower concentrations of citric 
acid used by Miles, Moore and colleagues (2013). The authors reported increasing sensitivity 
and decreasing specificity as the concentration of citric acid increased. Participants with an 
intact cough reflex are less likely to fail as the strength of the tussive increases, resulting in 
greater sensitivity. However, higher concentrations of citric acid may be more likely to 
trigger cough in patients with an abnormal cough reflex, and a drop is seen in specificity with 
higher doses (Miles, Moore, et al., 2013). Grouping weak responses with absent responses 
improved sensitivity but caused a large drop in specificity. A limitation of the study is the 
slight differences in methodology between the VES and VFSS groups, which prevented the 
data being pooled. This study makes a solid attempt at validating CRT in a general 
population and the data suggest that CRT is a useful addition to a standard clinical 
evaluation.  
1.6.6 Summary 
CRT has shown promise in a number of clinical studies as a useful tool for identifying 
patients who are at risk of silent aspiration, particularly in the elderly or neurologically 
impaired populations. Given the prevalence of silent aspiration in the ICU post-extubation 
population and lack of standard screening and assessment tools, CRT could be a useful 
addition to this setting. To date, researchers evaluating the usefulness of CRT have employed 
a wide range of methodologies, making it difficult to compare or replicate results. Cough 
reflex testing with citric acid offers a number of benefits: it is safe, reproducible, results in 
less tachyphlaxis than other tussive agents and has established preparation guidelines and 
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normative data available. In line with the ERS Guidelines on the Assessment of Cough, 
which advise that standardised research methods should be developed (Morice et al., 2007), it 
would be advisable to use the same methods as the studies that established the normative 
data, which the authors developed to be in line with the ERS recommendations. Therefore, 
further CRT research with citric acid should use the dose-response method with tidal 
breathing via facemask and cough should be measured by the C2 standard. In addition, 
placebos should be randomly interspersed with citric acid trials. There are a couple of 
considerations unique to the ICU population. The effect of opioids on cough could be a 
confounding factor when assessing cough reflex in this population and should be carefully 
considered. Opioids do impact cough sensitivity and make it difficult to determine the cause 
of cough impairment, but this is less important when assessing the impact of absent cough 
reflex on swallowing. Absent cough reflex may place an individual at risk of silent aspiration 
regardless of the cause. Also, many ICU patients are likely to have a weak cough, and this 
should be taken into account with performing CRT.  
1.7 Problem and Hypothesis 
1.7.1 Statement of Problem 
Aspiration, often silent, is a frequent occurrence in intensive care patients after 
orotracheal extubation, although little is known about the effect of short-term intubation on 
swallowing and airway protection. Currently there is no standardly accepted screening tool or 
assessment protocol for the post-extubation population. The cough reflex is an important 
mechanism for protecting the airway against aspiration. There is some evidence that 
orotracheal intubation adversely affects cough reflex, but there are no clear data on the 
prevalence or duration of absent cough reflex post-extubation. CRT has shown promising 
results in other patient populations and may be a valid screening tool for identifying those 




 To determine the prevalence of absent cough reflex in ICU patients after 
extubation  
 To determine the time from extubation to return of the cough reflex 
 To determine the prevalence of aspiration - silent and overt - following extubation 
in patients with short-term (<48 hours) and prolonged (>48 hours) intubation 
 To determine the validity of CRT for identifying which patients are most likely to 
silently aspirate post-extubation 
1.7.3 Significance of Research 
The following studies will, for the first time, directly investigate the effect of 
orotracheal intubation on the cough reflex. The results of these studies will provide necessary 
data on the effect of short-term and prolonged intubation on the cough reflex and swallowing. 
These studies will provide guidance to the multidisciplinary team caring for ICU patients 
who have been orotracheally intubated. 
1.7.4 Question 1: Does Orotracheal Intubation Affect Cough Response? 
1.7.4.1 Hypotheses:   
 There is a significant decrease in sensitivity to CRT immediately following 
extubation in neurologically intact adults undergoing elective cardiac surgery.  
 In participants with an impaired cough reflex, cough response returns to baseline 
sensitivity by discharge from hospital.  
1.7.4.2 Rationale:  
Dysphagia and aspiration after orotracheal intubation in the ICU population are 
frequently reported in the literature across a variety of populations (Ajemian et al., 2001; El 
Solh et al., 2003; Hafner et al., 2008; Macht et al., 2011; Noordally et al., 2011; Scheel et al., 
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2016). Studies measuring frequency of aspiration in a general ICU population post-
extubation indicate that it occurs in up to 58% of patients (Scheel et al., 2016). Intensive care 
patients who aspirate are at increased risk of developing nosocomial pneumonia (Safdar et 
al., 2005), which is the most common infection in ICU and can result in increased length of 
stay, mortality and cost of care (Safdar et al., 2005).  
Recently extubated intensive care patients are particularly at risk of silent aspiration, 
which cannot be reliably identified by bedside clinical assessment (Barquist et al., 2001; 
Davis & Thompson Stanton, 2004; El Solh et al., 2003; Hogue et al., 1995; Leder et al., 
1998). Studies utilising instrumental assessment in this population have reported prevalence 
of silent aspiration ranging from 8% to 25% (Barquist et al., 2001; Davis & Thompson 
Stanton, 2004; El Solh et al., 2003; Hogue et al., 1995; Leder et al., 1998). Often these 
patients are allowed to eat and drink soon after extubation, potentially putting them at 
increased risk of aspiration and subsequent pneumonia. 
Sensory testing of patients after orotracheal intubation suggests that airway reflexes 
are impaired in these patients in the short and medium term (Colice et al., 1989; Tanaka et al., 
2005). Airway sensation in the recently extubated population has been tested by injection of 
water into the glottis (Tanaka et al., 2005), presence of a gag on laryngoscopy (Colice et al., 
1989), and light touch to the aeryepiglottic folds using a laryngoscope (Scheel et al., 2016).  
CRT is emerging as a useful tool for testing subjects’ ability to protect their airway 
through reflexive cough (Addington et al., 2005; Wakasugi et al., 2008). Sensory testing with 
CRT is preferable to the methods above because there are established norms (Monroe et al., 
2014) and guidelines for CRT use (Morice et al., 2007). Currently, there is no evidence in the 
literature describing the use of CRT to test sensation after extubation. Most research relating 
cough reflex to safety during swallowing has been in the stroke population. Absent cough to 
CRT with acidic tussives (i.e. citric acid and tartaric acid) has been reported to have a high 
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specificity as a predictor of aspiration pneumonia (Addington et al., 2005; Wakasugi et al., 
2008). Research by Miles, Zeng and colleagues (2013) demonstrated a non-significant trend 
for increased in mortality in patients with absent cough reflex. In addition, Miles and 
colleagues (Miles, Moore, et al., 2013) reported a significant association between absent 
response to CRT and silent aspiration on instrumental assessment in patients referred for 
instrumental assessment with a range of diagnoses.  
Given that aspiration places ICU patients at risk of pneumonia, silent aspiration is 
common in patients after extubation and CRT testing is a useful tool for determining risk of 
silent aspiration, it follows that it may be useful to use CRT with patients after orotracheal 
extubation to screen for risk of silent aspiration. However, it is not currently known if the 
cough reflex is routinely impaired after orotracheal extubation. This research study will test 
the hypothesis that orotracheal intubation inhibits cough response to nebulised citric acid in 
neurologically intact adults undergoing intubation for elective cardiac surgery. It will also 
aim to determine when, in 12-hour intervals, most subjects’ cough response returns to pre-
intubation baseline.  
1.7.5 Question 2. Is CRT result an accurate predictor of silent aspiration on VES and, if so, 
which concentration of citric acid provides the best predictive measure?  
1.7.5.1 Hypotheses:  
 There is a significant decrease in sensitivity to CRT within 24 hours following 
extubation.  
 There is a significant correlation between CRT results and the presence or absence 
of silent aspiration on videoendoscopy. 
1.7.5.2 Rationale:  
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Dysphagia and aspiration after orotracheal intubation in the ICU population are 
frequently reported in the literature across a variety of populations (Ajemian et al., 2001; El 
Solh et al., 2003; Hafner et al., 2008; Macht et al., 2011; Noordally et al., 2011; Scheel et al., 
2016). Studies measuring frequency of aspiration in a general ICU population post-
extubation indicate that it occurs in up to 58% of patients (Scheel et al., 2016). Intensive care 
patients who aspirate are at increased risk of developing nosocomial pneumonia (Safdar et 
al., 2005), which is the most common infection in ICU and can result in increased length of 
stay, mortality and cost of care (Safdar et al., 2005).  
Recently extubated intensive care patients are particularly at risk of silent aspiration, 
which cannot be reliably identified by bedside clinical assessment (Barquist et al., 2001; 
Davis & Thompson Stanton, 2004; El Solh et al., 2003; Hogue et al., 1995; Leder et al., 
1998). Studies utilising instrumental assessment in this population have reported prevalence 
of silent aspiration ranging from 8% to 25% (Barquist et al., 2001; Davis & Thompson 
Stanton, 2004; El Solh et al., 2003; Hogue et al., 1995; Leder et al., 1998). Often these 
patients are allowed to eat and drink soon after extubation, potentially putting them at 
increased risk of aspiration and consequent chest infection. 
Sensory testing of patients after orotracheal intubation suggests that airway reflexes 
are impaired in these patients in the short- and medium-term (Colice et al., 1989; Tanaka et 
al., 2005). Airway sensation in the recently extubated population has been tested by injection 
of water into the glottis (Tanaka et al., 2005), presence of a gag on laryngoscopy (Colice et 
al., 1989), and light touch to the aeryepiglottic folds using a laryngoscope (Scheel et al., 
2016).  
CRT is emerging as a useful tool for testing subjects’ ability to protect their airway 
through reflexive cough (Addington et al., 2005; Wakasugi et al., 2008). Sensory testing with 
CRT is preferable to the methods above because there are established norms (Monroe et al., 
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2014) and guidelines for CRT use (Morice et al., 2007). Currently, there is no evidence in the 
literature describing the use of CRT to test sensation after extubation. Most research relating 
cough reflex to safety during swallowing has been in the stroke population. Absent cough to 
CRT with acidic tussives (i.e. citric acid and tartaric acid) has been reported to have a high 
specificity as a predictor of aspiration pneumonia (Addington et al., 2005; Wakasugi et al., 
2008). Research by Miles, Zeng and colleagues (2013) demonstrated a non-significant trend 
for increased in mortality in patients with absent cough reflex. In addition, Miles, Moore and 
colleagues (2013) reported a significant association between absent response to CRT and 
silent aspiration on instrumental assessment in patients referred for instrumental assessment 
with a range of diagnoses.  
Given that aspiration places ICU patients at risk of pneumonia, silent aspiration is 
common in patients after orotracheal extubation and CRT testing is a useful tool for 
determining risk of silent aspiration, it follows that it may be useful to use CRT with patients 
after orotracheal extubation to screen for risk of silent aspiration. However, it is not currently 
know if absent cough to CRT is a valid predictor of silent aspiration in this population. 
Cough impairment in this population may occur as a result of laryngeal trauma or damage to 
the recurrent laryngeal nerve, which makes this group unique to other populations with 
dysphagia. It is important to validate CRT in this unique population. This study aims to do 
this as well as to determine the prevalence of cough reflex impairment in ICU patients 




































2 Study I: Recovery of Cough Following Extubation after Coronary Artery Bypass 
Grafting: A Prospective Study 
2.1 Study Objectives 
2.1.1 Primary Objective 
To test the hypothesis that there is a significant decrease in sensitivity to CRT 
immediately following extubation in neurologically intact adults undergoing elective cardiac 
surgery 
2.1.2 Secondary Objective  
To determine when, in 12-hour intervals, cough response returns to pre-intubation 
baseline. 
2.2 Material and Methods 
2.2.1 Participants 
Patients greater than 18 years of age and scheduled for elective CABG at the study 
hospital were eligible for inclusion in the study. Patients having valve surgery alone or valve 
surgery with CABG, or those with a history of dysphagia, head and neck cancer or 
neurological disease were excluded. The study size was chosen to give 90% power with a 
measurement error of +/- 10% to estimate the proportion of patients whose cough reflex had 
diminished (Stata/IC 11.2, StataCorp LP, Texas, USA). All participants were placed on 
cardiopulmonary bypass for their surgery and received opioids as part of their initial 




Each participant was enrolled prior to surgery. At the time of enrolment, CRT, as 
described below, was performed to establish each participant’s baseline threshold for 
reflexive cough (CRT1). When each participant was extubated following surgery, the ICU 
nurse notified the researcher who then performed the first follow-up assessment (CRT2) 
within two hours of extubation. Each participant that failed CRT2 was further evaluated each 
morning between 0700 and 0900 and each evening between 1900 and 2100. Testing was 
continued until each participant’s cough was judged to be at their CRT1 level, they were 
discharged from hospital, they withdrew or they died. Follow-up testing was performed in 
ICU and on the cardiothoracic unit. In addition to CRT results and demographic information, 
anaesthetic and surgical details (endotracheal tube size, airway intubation grade, time on 
bypass) and information regarding on-going treatment (length of intubation, ICU discharge 
date, discharge destination, Acute Physiology & Chronic Health Evaluation III [APACHEIII] 
scores and opioid type and dose) were gathered from the medical record. 
2.2.2.1 Cough Reflex Testing 
Five millilitre syringes of sterile citric acid diluted in 0.9% sodium chloride were 
prepared in three concentrations: 0.4, 0.8 and 1.2 mol/L. These concentrations were chosen 
based on normative data which indicates that 95.5% of normal participants triggered 
suppressed cough at or below 1.2 mol/L while the mean for triggered supressed cough for 
elders was 1.03 mol/L (Monroe et al., 2014). Citric acid solution was presented using a 
PulmoMate Compressor/Nebuliser (Model 4650I, DeVilbiss Healthcare LLC, Pennsylvania, 
USA) with a predetermined free-flow output of 8 L/min and a restricted flow output of 6.6 
L/min. 
The participant was seated upright to at least 60°. The lowest concentration of citric 
acid (0.4 mol/L) was presented first, followed by 0.8 and 1.2 mol/L as needed. Citric acid 
was delivered for 15 seconds and patients were instructed to “breathe normally and try not to 
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cough”. A suppressed cough method was chosen to guard against placebo cough and because 
it may represent a more accurate reflection of the true reflexive cough (Hegland et al., 2012). 
In addition, patients were reluctant to cough after cardiothoracic surgery and instinctively 
suppressed cough, so use of a suppressed cough method ensured consistency in pre- and post-
intubation testing. Each concentration was presented up to three times with a minimum of 1 
minute between each presentation to prevent tachyphylaxis (Morice et al., 2007). In this 
study, we define cough as a “forced expulsive manoeuvre or manoeuvres against a closed 
glottis that are associated with a characteristic sound or sounds”, which is consistent with 
ERS recommendations (Morice et al., 2007, p.1256). The cough reflex was considered 
present if the participant produced two or more audible successive coughs (C2) on two 
presentations of a single concentration. Saline trials were randomly interspersed with citric 
acid trials. If a participant coughed in response to a saline trial, a second saline trial was 
administered. If the participant coughed on two trials of saline, the cough response was 
considered abnormal and the participant excluded. Increasing concentrations were presented 
until the cough reflex threshold was identified or judged absent. During follow-up testing, the 
participant’s baseline threshold was the lowest concentration of citric acid that produced a C2 
suppressed response. 
2.2.2.2 Opioids 
Opioids are known to supress cough (Kamei, 1996). All patients were sedated peri- 
and post-operatively with propofol and only extubated once sedation had been ceased and 
they woke. All received opioids as part of their anaesthesia and for post-operative analgesia. 
The only opioids administered were morphine and fentanyl; morphine was avoided in 
patients with pre-existing or post-operative renal impairment. No other agents with known 
anti-tussive properties (e.g., lidocaine) were used with patients in the post-extubation period. 
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The morphine equivalent dose was calculated for each participant using ten 
micrograms fentanyl equals one milligram morphine. The total morphine equivalent dose 
administered from time of induction to final CRT was divided first by patient weight in 
kilograms then by the number of hours in this period to determine the administered mean 
morphine dose in milligrams per kilogram per hour (mg/kg/hr). Further analysis of opioid 
dose was completed on data from CRT2. Morphine equivalent dose in mg/kg/hr was again 
calculated for each participant, capturing only opioids administered intra-operatively and 
post-operatively up to completion of CRT2. 
2.3 Statistical Analysis 
The average time post-extubation of each follow-up and the percentage of participants 
with cough response present at baseline level at each follow-up were calculated. For the 
predictor variables, continuous variables were grouped into quartiles for analysis. Time to 
return of baseline cough response for each participant was plotted using the Kaplan-Meier 
survival curve. Log rank tests were performed to evaluate for significance between groups 
with an a priori significance level set at 0.05. A Mann-Whitney U test was performed to 
analyse the relationship between morphine equivalent dose and performance at CRT2 with an 
a priori significance level set at p<0.05.  
2.4 Results 
Recruitment began in March 2013 and was completed in August 2013. During that 
period, a total of 104 patients met eligibility criteria of which 84 (68 male) consented to 
participation. Two participants were excluded because they did not cough at any 
concentration, therefore post-extubation reduction in cough could not be assessed. One 
participant was excluded from analysis because he did not regain consciousness following 
surgery and later died. Demographics of the participants who completed the study are 
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displayed in Table 2. The mean age of participants was 65 years (SD=8.45). Endotracheal 
tube size ranged form 7 to 9 and intubation grade was 1 in over half of the participants (n=48, 
59%). Eighty percent  (n=65) of participants were discharged directly home from hospital. 
One participant died after completing the study due to a new stroke. Time on bypass, length 
of intubation, morphine equivalent dose, APACHE III score and length of ICU stay are all 




Table 2. Participants' Baseline Characteristics 
Total participants  n=81 
Gender Male 68 (84%) 
 Female 13 (16%) 
Age  Mdn=66, IQR=60,70 
Tube size 7 3 (4%) 
 8 61 (75%) 
 9 17 (21%) 
Intubation grade 1 48 (59%) 
 2 27 (33%) 
 3 3 (4%) 
 Missing 3 (4%) 
Discharge destination Home 65 (80%) 
 Other hospital 15 (19%) 
 Died 1 (1%) 
Time on Bypass  Mdn=93mins, IQR=74,111) 
Length of intubation  Mdn=10.2hrs, IQR=8.75,13.3 
Morphine dose (mg/kg/hr)  Mdn=0.175, IQR=0.088,1.14 
APACHEIII score  Mdn=39, IQR=34,45 
Length of ICU stay  Mdn=26hrs, IQR=23,46 
 
At pre-surgery baseline test, CRT1, 73% (n=59) of participants had a positive cough 
response at 0.4 mol/L citric acid, 16% (n=13) at 0.8 mol/L and 11% (n=9) at 1.2 mol/L. All 
participants had absent cough to normal saline (100%). Two participants withdrew following 
surgery and did not undergo follow-up CRT. These participants were excluded from analysis. 
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A further 11 participants withdrew at various points across the study because they did not 
want to repeat CRT. The numbers of participants tested at each study point are outlined in 
Figure 10 below with numbers passing and failing CRT at their baseline level each follow-up.  
Results of follow-up CRTs are displayed in Table 3 and a bar chart displaying the 
proportion of present and absent cough responses at baseline level at first follow-up, CRT2, 
through CRT6 is displayed in Figure 11. At CRT2, 60% of participants had an abnormal 
cough while 40% had a cough response present at baseline level. By CRT3, these numbers 
had reversed with 35% of participants with abnormal cough and 65% with present cough. 
The percentage of participants with a cough present at baseline level gradually increased over 
subsequent tests. At CRT6, 86% of the participants had recovered a reflexive cough to 
baseline level.  
Summaries of the predictor variables are displayed in Tables 4 and 5. Analysis of data 
revealed that neither age, gender, length of intubation, endotracheal tube size, length of stay 
in ICU, discharge destination, cardiopulmonary bypass time, airway intubation grade, or 
Acute Physiology & Chronic Health Evaluation (APACHE) III score correlated with cough 
recovery.  
The total morphine equivalent dose (mg/kg/hr) from initial morphine dose to 
completion of the study correlated significantly with time to return to baseline reflexive 
cough (x
2
(df)=17.0(3), p=0.001). Participants administered higher doses of opioids had a 
significantly shorter time to cough recovery. Analysis of morphine equivalent (mg/kg/hr) 
dose at CRT2 was completed to control for the confounding effect of time and tapering of 
dosing. A Mann-Whitney U test indicated that the distribution of opioid doses (mg/kg/hr) 
was the same in patients who had a cough present at CRT2 (Mdn=1.80) as in patients whose 





Figure 10. Flowchart outlining number of participants with a cough response present at 






Table 3. Results of Each Follow-up CRT. 
 Time post-extubation 
in hours 








CRT2 M=1.16, SD=0.908 39.5% (n=32) 60.5% (n=49) 
CRT3 M=12.0, SD=3.80 64.2% (n=53) 34.6% (n=28) 
CRT4 M=24.5, SD=5.16 75.3% (n=61) 19.8% (n=16) 
CRT5 M=38.1, SD=6.15 81.5% (n=66) 11.1% (n=9) 
CRT6 M=48.4, SD=4.74 86.4% (n=70) 3.70% (n-3) 
CRT7
c 
69.4  98.8% (n=80) 1.23% (n=1) 
CRT8 82.2 98.8% (n=80) 1.23% (n=1) 
CRT9 93.7 98.8% (n=80) 1.23% (n=1) 
CRT10 107 98.8% (n=80) 1.23% (n=1) 
CRT11 117 98.8% (n=80) 1.23% (n=1) 
CRT12 131 98.8% (n=80) 1.23% (n=1) 
a
 The number (n) of the total participants who had exhibited a baseline cough response by the 
follow-up. 
b 
The number (n) of the total participants who exhibited an abnormal cough response at the 
follow-up. 
c 
From CRT7, only one participant continued to be tested as all others had passed or 







Figure 11. Results of CRT at each Follow-up CRT2 through CRT6. 
 
 
Table 4. Summary of Continous Variables. 
 
Quartiles  
Continuous variables 25th 50th 75th x
2(df)
 p value 
Age in years  60 66 70 0.93(3) p=.818 
Length of intubation in hours  8.75 10.2 13.3 3.73(3) p=.293 
Length of stay in ICU in hours  23 26 46 2.68(3) p=.443 
Length of bypass in minutes  74 93 111 1.95(3) p=.584 
APACHE III Score  34 38 45 0.955(3) p=.812 






Table 5. Summary of Categorical Variables. 
Categorical Variables  n x
2(df)
 p value 
Gender Male 68 1.49(1) p=.222 
 Female 13   
Endotracheal tube size 7 3 3.91(5) p=.562 
8 61   
 9 17   
Intubation Grade
a
  1 48 0.375(2) p=.821 
2 27   
 3 3   
 Not 
recorded 
3   
Discharge destination
b 
Home 65 2.35(2) p=.309 
Other 
hospital 
15   
 Died 1
c
   
a
 Cormack-Lehane Classification 
b
 Home, other hospital or died 
c


















3 Study II: Comparison of CRT with VES in Recently Extubated ICU Patients 
3.1 Study Objectives 
3.1.1 Primary Objective 
The primary objective is to determine the sensitivity and specificity of nebulized citric 
acid for detecting the presence of cough reflex on aspiration by analysing the relationship 
between response to CRT and presentation of airway compromise on endoscopy. 
3.1.2 Secondary Objective 
The secondary objective is to determine the prevalence of aspiration in this 
population, both overt and silent. 
3.2 Material and Methods 
3.2.1 Participants 
Patients greater than 18 years of age who were admitted to ICU and required invasive 
ventilation were eligible for participation in this study. Patients who were receiving palliative 
care only were excluded. Because completion of the VES required ingestion of fluid, those 
who were strictly nil by mouth for surgical or gastrointestinal reasons or who were 
considered unsafe for oral intake due to a reduced Glasgow Coma Scale (GCS) score 
(patients scoring 12 or less) were also excluded. The study size was calculated to give 80% 
power to detect a reduction of sensitivity from 90% to 60% at the 0.05 level of significance 
(Li & Fine, 2004). Enrolment occurred between May and December 2014.  
3.2.2 Procedures 
Participants were enrolled after extubation. If a participant’s GCS was less than 15, 
both the participant’s assent and agreement of the next of kin was required for enrolment. 
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CRT and VES were performed within 24 hours of extubation by a single researcher. VES 
always followed CRT within one hour and was interpreted by a SLT blinded to CRT results. 
This ensured that the VES result could not influence CRT interpretation. In addition to 
performing CRT and VES, the researcher gathered demographic and treatment details, 
including admitting diagnosis, reason for intubation, length of intubation, APACHE III score, 
and morphine equivalent dose (mg/kg) in the 12 and 24 hours preceding testing. Where 
fentanyl was administered, the morphine equivalent dose was calculated assuming ten 
micrograms fentanyl was equivalent to one milligram morphine. The total morphine 
equivalent dose administered from time of induction to CRT was divided first by participant 
weight in kilograms then by the number of hours in this period to determine the administered 
mean morphine dose in milligrams per kilogram per hour (mg/kg/hr). 
3.2.2.1 Cough Reflex Testing 
Citric acid concentrations were selected based on previous research by Miles, Moore 
and colleagues (2013) that found 0.4 mol/L had optimal sensitivity and specificity for 
identifying silent aspiration when using a natural cough method. For this study, a suppressed 
cough method was used to guard against placebo cough and because it may represent a more 
accurate reflection of the true reflexive cough (Hegland et al., 2012). Also, the majority of 
patients admitted to the study ICU are intubated for cardiothoracic surgery and, as observed 
in Study I, these patients tend to supress cough to avoid pain associated with coughing. 
Instructing all participants to supress cough improved consistence of methods across 
participants. Normative data indicate that individuals’ suppressed cough threshold is 
significantly higher than their natural cough threshold (Monroe et al., 2014), so 
concentrations of 0.4, 0.6 and 0.8 mol/L of 0.9% sodium chloride were selected. The citric 
acid solutions were prepared as per the recommendations of Falconer and colleagues (2014) 
in 5ml syringes by Optimus Healthcare Ltd. and were presented using a PulmoMate 
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Compressor/Nebulizer (Model 4650I, DeVilbiss Healthcare LLC, Pennsylvania, USA) with a 
predetermined free-flow output of 8 L/min and a restricted flow output of 6.6 L/min via a 
face mask. 
Participants were seated upright to at least 60°. Supplemental oxygen was removed 
during delivery of aerosol, but returned between tests to avoid hypoxemia. The lowest 
concentration of citric acid, 0.4 mol/L, was presented first, followed by 0.6 and 0.8 mol/L 
until participants coughed. Citric acid was delivered for 15 seconds and participants were 
instructed to “breathe normally and try not to cough”. Each concentration was presented up to 
three times with a minimum of 1 minute between each presentation to prevent tachyphylaxis 
(Morice et al., 2007). In this study, cough is defined as a “forced expulsive maneuver or 
maneuvers against a closed glottis that are associated with a characteristic sound or sounds” 
as recommended in the ERS guidelines (Morice et al., 2007, p.1256). Nebulized 0.9% saline 
was randomly interspersed between citric acid doses (Morice et al., 2007). If a participant 
coughed on a trial of saline a second saline trial was administered. If the participant coughed 
on two trials of saline their cough was considered abnormal and they were excluded from the 
study. The cough reflex was considered present if the participant produced two or more 
audible successive coughs (C2) on two presentations of a single concentration. Cough reflex 
was classified as strong if the researcher judged the cough to be sufficient to clear aspirated 
material or weak if judged insufficient. If the participant produced a strong cough response at 
0.4 or 0.6 mol/L the cough was assumed to be strong at higher concentrations. Increasing 
concentrations were presented until the cough reflex threshold was identified or judged 
absent.  
3.2.2.2 VES 
VES was performed at the participant’s bedside using an Olympus ENf-V2 Ultra Slim 
Rhino-larnygo-videoscope (Olympus Corporation, Shinjuku, Tokyo, Japan). Images were 
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recorded onto an Olympus IMH-10 image capture device. Participants did not receive topical 
anaesthesia. The scope was passed transnasally and the tip was positioned in the pharynx, 
allowing for a clear view of pharyngeal and laryngeal structures. Participants were asked to 
swallow five single sips of blue-dyed milk (or juice if unable to drink milk) via straw 
followed by approximately 150 millilitres via consecutive swallows. If they demonstrated 
aspiration on single sips they were not asked to take consecutive sips. The videos obtained 
from all studies were recorded on an external computer hard drive and later evaluated using 
the PAS (Rosenbek et al., 1996). Presence or absence of reflexive cough was also recorded. 
3.3 Statistical Analysis 
Statistical analyses were completed using SPSSv22 software (SPPS, Chicago, IL, 
USA). Generalized linear mixed effects analysis was completed to examine the data for 
relationships between the independent variables and both the presence and absence of cough 
reflex to CRT and the presence or absence of aspiration on VES. Descriptive statistics are 
presented as means with standard deviation or medians with interquartile range depending on 
the data distribution. Categorical data are presented as raw numbers and percentage. In cases 
where data were missing, no assumptions were made about missing data. A Mann-Whitney U 
test was performed to compare the distributions of time from extubation to CRT result data 
across different conditions. Sensitivity and specificity tables were created using Chi-squared 
tests. Analyses were completed with weak responses grouped with strong, and again with 
weak grouped with absent. When calculating sensitivity and specificity, Pearson’s 
Coefficient was not appropriate because all tests had at least one group with an expected 
count of less than 10. Therefore, Fishers Exact Test was performed to determine significance. 




Recruitment began in May 2014 and was completed in December 2014. During that 
period, a total of 501 patients met eligibility criteria of which 112 (78 male) consented to 
participation. Five participants were excluded because they could not participate due to 
agitation or reduced GCS and one participant declined VES. Therefore, 106 participants 
underwent both CRT and VES. Participant characteristics are displayed in Table 6 and 7. 
Testing was initiated at a median of 17.7 hours post-extubation (IQR=9,22). Median 
intubation time was 12.4 hours (IQR=8.83,25.0). Thirteen of the 106 participants were 





Table 6. Participants Baseline Characteristics. 
Total Participants  n=106 
Age  Mdn=64 years, IQR=54,74 
Gender Male 78 (74%) 
 Female 28 (26%) 
Ethnicity European 81 (76%) 
 Māori 16 (15%) 
 Other 9 (8%) 
Reason for Admission Surgical 77 (73%) 
 Non-surgical 29 (27%) 
Diagnosis Cardiothoracic 69 (65%) 
 Neurological 15 (14%) 
 Cardiac 5 (5%) 
 Pneumonia 3 (3%) 
 Other 14 (13%) 
GCS >15 85 (80%) 
 
Table 7. Summary of Continuous Predictor Variables. 
 Median IQR 
Length of Intubation (in hours) 12.4 8.83, 25.0 
APACHE III 40.0 33.3,47.8 
Opioids in previous 12 hours
a
 6.0 3.00,16.0 
Opioids in previous 24 hours
a
 20.0 10.0,33.0 
a




3.4.1 CRT results 
Fifty-four percent of participants (n=57) had an absent cough reflex to CRT at 0.4 
mol/L, 46% (n=49) at 0.6 mol/L and 37% (n=39) at 0.8 mol/L nebulized citric acid. The 
presence or absence of a cough reflex did not significantly correlate with age, gender, length 
of intubation, ethnicity, diagnosis, reason for intubation, APACHE III score or morphine 
equivalent dose (mg/kg/hr) at any concentration as shown in Table 8. There was no 
significant difference in the distributions of time from extubation to CRT data between those 
with a cough reflex response and those without a response when analysed by concentration, 
with weak cough responses grouped with strong cough responses and weak cough responses 





Table 8. Results of Generalised Linear Mixed Effect Model Testing for Relationships Between 
Fixed Effects and CRT Result. 
 F (df1, df2) p value 
Age 1.59 (1,618) .212 
Length of Intubation 0.000 (1,618) .961 
Ethnicity 0.270 (5,618) .929 
Gender 0.928 (1,618) .336 
Reason for Admission 0.182 (1,618) .670 
Diagnosis 0.744 (4,618) .562 
APACHE III 0.228 (1,618) .633 
Opioids in previous 12 hours
a 0.217 (1,618) .641 
Opioid in previous 24 hours
a 0.218 (1,618) .370 
a
 Morphine equivalent dose (mg/kg/hr) 
 
Table 9. Results of Mann-Whitney U Test Comparing Distribution Between Time from 
Extubation to CRT and Results of CRT. 
  U value p value 
0.4 mol/L Weak responses grouped with strong (n=49) 1392 .854 
 Weak responses group with absent (n=64) 1286 .614 
0.6mol/L Weak responses grouped with strong (n=57) 1366 .713 
 Weak responses group with absent (n=58) 1292 .435 
0.8 mol/L Weak responses grouped with strong (n=68) 1251 .625 




3.4.2 VES Results 
Forty-five (42%) participants penetrated (PAS 2-5) and 13 (12%) aspirated (PAS 6-8) 
on VES. Of the participants who aspirated on VES, 9 (69%) did not cough in response to 
aspiration (PAS 8). Neither age, gender, ethnicity, diagnosis, reason for intubation, APACHE 
III score nor morphine equivalent done (mg/kg/hr) were significant predictors of aspiration as 
displayed in Table 10. Intubation time was a significant predictor of aspiration (β=-0.017, 
p<.01). Figure 12 displays a boxplot of the intubation times for participants who did not 
aspirate (PAS 1-5) compared to participants who did aspirate (PAS 6-8). A Mann-Whitney U 
test determined that there was not a significant difference between the distributions of length 
of intubation between participants who silently aspirated (n=3) and participants who overtly 





Table 10. Results of Generalised Linear Mixed Effects Model Testing for Relationships 
Between Fixed Effects and Presence of Aspiration on VES. 
 Aspiration 
 F (df1,df2) p value 
Age 0.006 (1,192) .938 
Length of Intubation 6.36 (1,192) .013 
Ethnicity 0.479 (5,192) .791 
Gender 0.115 (1,192) .735 
Reason for Admission 1.78 (1,192) .184 
Diagnosis 1.08 (4,192) .366 
APACHE III 0.711 (1,192) .400 
Opioids in previous 12 hours
a 3.40 (1,192) .238 
Opioids in previous 24 hours
a 0.218 (1,618) .067 
a 






Figure 12. Boxplot of Intubation Duration by Absence (PAS 1-5) or Presence (PAS 6-8) of 
Aspiration on VES. 
 
3.4.3 Sensitivity and Specificity 
Sensitivity and specificity of CRT to predict silent aspiration on VES are displayed in 
Table 12. There was a significant relationship between CRT responses and the presence or 
absence of silent aspiration at all concentrations when weak responses were grouped with 
absent responses. Sensitivity of CRT to identify silent aspiration reached 100% in two 
conditions, at the concentrations of 0.4 and 0.6 mol/L, with weak cough responses grouped 
with absent responses. However, in both conditions, specificity was less than 50%.  
Sensitivity and specificity of CRT to detect silent aspiration were optimized at 88% and 58% 
respectively at 0.8 mol/L citric acid with weak cough responses grouped with absent 
responses. The highest specificity for the whole cohort was achieved at 0.8 mol/L citric acid 
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when weak cough responses were grouped with strong (66%), but sensitivity in this condition 
was only 63%.  
Table 13 displays the sensitivity and specificity values of CRT to detect aspiration on 
VES, which was optimized at optimized at 85% and 50% respectively at 0.6 mol/L citric acid 
with weak responses grouped with absent responses. There was a significant relationship 
between CRT responses and the presence or absence of aspiration at 0.4 and 0.6 mol/L when 
weak responses were grouped with absent responses. Table 14 displays the CRT results of 




Table 11. Sensitivity, Specificity and Odds Ratio of CRT at Three Concentrations for Predicting Silent Aspiration on VES. 
 Weak grouped with strong Weak grouped with absent  









0.4 75% 47% .285 2.71 0.520,14.1 100% 42% .021 N/A N/A 
0.6 75% 56% .142 3.77 0.724, 19.6 100% 49% .008 N/A N/A 
0.8 63% 66% .135 323 0.727,14.4 88%
b 
58% .022 9.56 1.13,80.8 
 
a
 Significance calculated using Fishers Exact Test 
b




Table 12. Sensitivity, Specificity and Odds Ratio of CRT at Three Concentrations for Predicting Aspiraiton on VES. 
 Weak grouped with strong Weak grouped with absent  









0.4 77% 50% .084 3.26 0.843,12.6 92% 44% .014 9.46 1.18,75.8 
0.6 69% 57% .135 2.98 0.856,10.4 85%
b 
50% .034 5.38 1.32,25.6 
0.8 46% 57% .538 1.63 0.506,5.27 62% 57% .244 2.12 0.645,6.97 
 
a
 Significance calculated using Fishers Exact Test 
b




Table 13. Breakdown of CRT Response by PAS Score. Data are Presented as Raw Number and (Percentage). 
VES Result PAS 1 (n=48) PAS 2-5 (n=45) PAS 6-8 (n=13) 







































































3.4.4 Prolonged intubation 
Thirteen participants were intubated for 48 hour or more. Five of the 13 (38%) 
participants aspirated (PAS 6-8) on VES, 3 (60%) without cough (PAS 8). Of the 79 (75%) 
participants who were intubated for less than 24 hours, 8 (8%) aspirated (PAS 6-8), 3 (38%) 
without a cough response (PAS 8). The sample size of participants with prolonged intubation 
was too small to calculate sensitivity and specificity in this cohort, but those participants’ 





Table 14. Outcomes of Participants (n=13) who were Intubated for more than 48 Hours. 
Participant Length of 
Intubation 




1 53.3 Yes 1  
2 75.3 Yes 1  
3 68.2 Yes 2 
Penetration
b 
4 69.8 Yes 3 
5 121 No 3 
6 48.4 Yes 3 
7 265 No 4 
8 228 No 5 
9 79.0 Yes 7 
Aspiration
b 
10 95.2 No 7 
11 91.3 No 7 
12 72.3 Yes 8 Silent 
Aspiration
b 
13 145 Yes 8 
a
 Did the patient cough to any concentration of citric acid? 
b 




3.4.5 Neurological Patients 
The characteristics of the 14 participants with a neurological diagnosis are listed in 
Table 15. Participants with a neurological diagnosis had a lower median age (Mdn = 59.0, 
IQR = 46.0, 72.0) than participants with other diagnoses (Mdn = 65.0, IQR = 55.0, 74.0). 
Participants with a neurological diagnosis also had a longer median intubation time (Mdn = 
20.4, IQR = 8.64, 53.4) than their non-neurological participants (Mdn = 11.8, IQR = 8.75, 
21.8). Twenty-five percent of participants with a neurological diagnosis had an absent cough 
reflex at all concentrations of citric acid compared to 64.3% of participants with a non-
neurological diagnosis. Two of the 14 participants aspirated on VES, one of these without a 
cough response. The participant who silently aspirated had a weak cough response on 0.4, 0.6 
and 0.8 mol/L citric acid. The sample size of participants with a primary neurological 
diagnosis was too small to calculate sensitivity and specificity in this cohort, but those 
participants’ length of intubation, response to CRT and PAS score are provided in Table 
15.Only two of the participants with a neurological diagnosis had an absent cough and both 





Table 15. Characteristics of Participants Admitted with a Primary Neurological Diagnosis 







PAS Score  
72 21.5 37 Yes 1  
49 19.7 38 Yes 1  
75 21.0 50 Yes 1  
47 17.6 31 Yes 1  
31 2.58 29 Yes 1  
62 68.2 32 Yes 2 
Penetration
c 
72 9.83 52 No 3 
54 2.50 42 Yes 3 
63 48.4 35 Yes 3 
19 121 26 Yes 3 
56 5.08 35 Yes 3 
43 37.7 24 No 3 
62 19.5 37 Yes 6 Aspiration
c 




Total length of intubation in hours 
b
 Did the patient cough to any concentration of citric acid? 
c 
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4 Discussion, Limitations and Future Research  
This thesis describes the first research programme to systematically evaluate the 
cough reflex in post-extubated ICU patients and validate CRT for identifying silent aspiration 
in this population. In summary, in Study I, cough reflex was frequently impaired following 
extubation. In addition, impaired cough reflex often persisted for up to 48 hours following 
extubation in patients undergoing CABG. More than a quarter of participants in Study II 
aspirated on VES within 24 hours of extubation. However, diagnostic specificity of CRT was 
poor, despite significant relationships between response to CRT and aspiration. 
There is significant clinical value in improving the assessment of swallowing in ICU 
and, particularly, in identifying patients at risk of silent aspiration. There is evidence that ICU 
patients with impaired airway reflexes are more likely to develop pneumonia (Chevret et al., 
1993). Patients who develop pneumonia stay in hospital longer, cost more to treat and are 
more likely to die (Safdar et al., 2005). The results of Studies I and II indicate that ICU 
patients are at high risk of impaired cough reflex following extubation, especially within the 
first few hours. Given the reported links between absent cough reflex and pneumonia 
(Addington, Stephens, & Gilliland, 1999; Davies, 2016), it seems likely that patients with 
impaired cough reflex after extubation would be at a greater risk of developing pneumonia 
than their counterparts with intact cough reflex.  
Any pneumonia that occurs within 24 hours of extubation is labelled as VAP. 
Although the precise contribution of impaired cough reflex to VAP has not been investigated, 
impaired airway reflexes at the time of intubation has been identified as a predictor of VAP 
(Chevret et al., 1993). In addition, aspiration of oral or gastric contents is considered to be a 
major contributor to VAP (Bouza et al., 2003; Bouza et al., 2008; Safdar et al., 2005). 
Participant age, APACHE score, and length of intubation have previously been linked to the 
development of VAP in ICU (Apostolopoulou, Bakakos, Katostaras, & Gregorakos, 2003; 
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Lewis, Li, Murphy, & Klompas, 2014; Weinstein, Bonten, Kollef, & Hall, 2004). 
Interestingly, none of these variables correlated with the presence or absence of cough reflex 
in the current research programme. However, because patient outcomes were not gathered in 
this study, including the development of pneumonia, limited conclusions can be drawn about 
the relationship between CRT and VAP in the ICU population. 
4.1 Impact of Intubation on Cough Reflex 
Intubation appears to have a statistically and clinically significant impact on the 
cough reflex, which is most marked in the few hours immediately following extubation, but 
can persist for two days or longer. Interestingly, impaired cough appears to occur as 
frequently after short periods of intubation as after prolonged intubation. This is consistent 
with the findings of Tanaka and colleagues (2005) who reported that the cough reflex was 
impaired in 100% of study participants following brief intubation for minor surgery. There is 
ample evidence in the research that orotracheal intubation causes trauma to the larynx after 
even short periods of intubation (Heffner, 2010) and this seems the most plausible cause for 
impaired cough. Although not systematically evaluated, anecdotally many participants in 
Study II had evidence of laryngeal trauma on VES. Colton House and colleagues (2011) 
suggested that dysphagia could occur as a result of injury to the laryngeal tissues causing 
oedema, ulceration and granulation of the tissue or damage to the RLN as a result cuff 
pressure (Colton House et al., 2011). It seems plausible that these factors could also 
contribute to impaired cough reflex. True cough receptors are concentrated in the larynx and 
trachea and damage to these tissues may affect the sensitivity of these receptors. In addition, 
the RLN is essential for swallowing (Canning et al., 2004) and damage to the nerve from cuff 
pressure would likely impact cough.  
Other proposed causes of post-extubation dysphagia, including weakness from muscle 
atrophy (Brown et al., 2011; DeVita & Spierer-Rundback, 1990; Tolep et al., 1996) and 
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disruption in respiration (de Camargo, Ono, Park, Caruso & Carvalho, 2010), seem less likely 
to contribute to cough reflex impairment. Although muscle weakness would likely lead to 
weak cough, it would not explain absent cough. Similarly, disruption in respiration may 
contribute to abnormal or weak cough, but not absent cough. The designs of Studies I and II 
were not sufficient to determine the cause of cough impairment, but this remains an important 
area of research. Further research evaluating the relationship between presence, location and 
severity of laryngeal injury and cough reflex impairment would be particularly beneficial. 
4.2 Aspiration Following Extubation 
Aspiration prevalence has been reported to range from 22% to 56% in studies where 
all patients underwent instrumental assessment regardless of the presence or absence of signs 
or symptoms of dysphagia (Ajemian et al., 2001; El Solh et al., 2003; Leder et al., 1998; 
Scheel et al., 2016). This range reflects varied patient groups in different ICU settings and 
varied enrolment criteria. The prevalence of aspiration amongst our cohort was below this 
range at 12%. The most likely explanation for this variance is that previous studies all 
enrolled participants following 48 hours or more of intubation, while Study II included 
participants following intubation periods of any length. In fact, the median length of 
intubation in Study II was just 12 hours. There were only 13 participants in Study II who 
were intubated for 48 hours or longer and five (38%) of these participants aspirated (PAS ≥ 
6). An aspiration rate of 38% in participants who have been intubated for 48 hours or more is 
consistent with previous studies. Similarly, although only 9 of 112 (8%) participants silently 
aspirated on VES, 2 out of 13 (15%) of the participants who were intubated more than 48 
hours aspirated silently. Others have reported a prevalence of silent aspiration of 8% (Scheel 
et al., 2016) to 25% (Ajemian et al., 2001) amongst ICU patients who have been 
orotracheally intubated for more than 48 hours. Although the number of participants in Study 
II with prolonged intubation was too small for detailed analysis, the percentage of 
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participants who aspirated and silently aspirated in the current study appears to be in line with 
other studies.  
Length of intubation was the only factor that correlated significantly with the 
presence of aspiration in Study II. This is in agreement with several other studies that 
reported a link between prolonged intubation and development of dysphagia (Barker et al., 
2009; Bordon et al., 2011; Brown et al., 2011; Hogue et al., 1995; Kwok et al., 2013; Macht 
et al., 2011; Malandraki et al., 2016; Rousou et al., 2000). However, it is important to note 
that Study II measured aspiration specifically and not dysphagia, which may be present 
without aspiration. Previous studies evaluating post-extubation aspiration on instrumental 
assessment have not found a relationship between length of intubation and prevalence of 
aspiration (Ajemian et al., 2001; Barquist et al., 2001; El Solh et al., 2003; Leder et al., 1998; 
Scheel et al., 2016). This may be because these studies all excluded patients who had been 
intubated for less than 48 hours and, as reported in Study II, participants with shorter periods 
of intubation are less likely to aspirate. Therefore, Study II offers unique information about 
the relationship between intubation length and risk of aspiration. 
Although patients with longer periods of intubation were more likely to aspirate, 
Study II is the first research to demonstrate that aspiration and silent aspiration occurred in 
participants who were intubated for only a short period. There are no previous studies in a 
general ICU setting in which all participants underwent instrumental assessment, regardless 
of presence or absence of overt symptoms of dysphagia or length of intubation. Studies that 
only include patients who have been intubated for more than 48 hours overlook the real and 
clinically significant problem of dysphagia after short periods of intubation.  
There are a number of reasons that ICU patients would have dysphagia, and 
specifically aspiration, following extubation. As a group these patients display a number of 
risk factors. Seventy-three percent of participants in Study II were admitted to ICU following 
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a surgery. As identified in the literature review, patients undergoing surgery have an 
increased risk of dysphagia due to perioperative stroke (Selim, 2007), cranial nerve damage 
(DiLisio et al., 2013), supine positioning (Aderinto‐Adike & Quigley, 2014) and altered 
sensorium (Schenning & Deiner, 2015).  
Fourteen percent of patients in Study II had a primary neurological diagnosis. Given 
the high prevalence of dysphagia in patients with neurological disorders (Mackay et al., 1999; 
Mann et al., 2000), it may be presumed that some participants in Study II may have had 
dysphagia resulting from primary neurological impairment as well as a secondary impact of 
intubation. Interestingly, the prevalence of absent cough reflex was actually lower in the 
neurological group (14%) than the entire cohort (37%). Prevalence of aspiration was very 
similar between the two groups, at 14% in the neurological group compared to 12% in the 
total cohort, as was prevalence of aspiration, at 7% in the neurological group compared to 8% 
in the total cohort. However, with only two participants in the neurological group having 
absent cough to CRT and two aspirating on VES, one overtly and one silently, the numbers 
are simply to small to support or refute the theory of neurological injury impairing both 
swallowing and cough in this cohort. 
Another potential cause of dysphagia and aspiration in the ICU population is the use 
of opioids. Many of the participants in both studies were prescribed opioids in the 24 hours 
preceding CRT assessment. Although the opioid dose did not correlate with aspiration in 
Study II, opioids are known to result in an impaired level of consciousness in patients 
(Devlin, 2009), which may put them at increased risk of dysphagia. The above risk factors 
combine in any individual patient to create a complex picture of risk and for this reason, it is 
impossible to determine the specific cause of dysphagia after extubation. 
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4.3 Impact of Opioids 
The issue of opioids requires additional discussion. Patients routinely receive opioids 
during mechanical ventilation and in the hours following extubation for sedation and 
analgesia (Elliott et al., 2013). Kelly and colleagues (2016) examined the effect of fentanyl 
on cough and reported that clinically relevant doses of fentanyl diminish the cough reflex. 
They reported an average time of 45 minutes from cessation of fentanyl administration to a 
participant’s return to baseline cough sensitivity. In addition to the carefully controlled doses 
of opioids delivered in theatre and during unconscious sedation, all patients in Study I and 
many in Study II were able to self-administer opioids via a patient-controlled analgesia 
system. In addition, opioids can affect men differently than women (Lee & Ho, 2013). As a 
result, the total effective opioid dose varied widely from patient to patient. These factors 
make it very difficult to control precisely for opioid dose when performing research in the 
ICU setting.  
In Study I, there was a highly significant relationship between morphine equivalent 
dose and time to return of a participant’s baseline cough sensitivity, with those patients who 
received larger doses of opioids returning more quickly to their baseline cough reflex 
threshold. This is counterintuitive given the anti-tussive properties of opioids and is most 
likely a result of dosing patterns rather than a cause and effect relationship between 
increasing opioid dose and greater cough reflex sensitivity. The pattern of opioid 
administration was peak dosing in the intra-operative period with gradual tapering of dosing 
over the hours and days following extubation as a participant’s pain subsided. Therefore, 
participants who recovered their cough reflex sooner were more likely to have a higher per 
hour mean opioid dose.  
In Study II, when CRT was performed only once within 24 hours of extubation, there 
was no relationship between opioid dose and the presence or absence of cough as might have 
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been expected. Any effect that opioids had on cough reflex may have been masked by the 
more substantial effect of intubation. Although no firm conclusions can be drawn from these 
studies regarding the effects of opioids on the cough reflex and swallowing, the presence of 
cough in many participants immediately following extubation, shortly after the period of peak 
dosing, suggests that opioid use was not the primary factor in impairment of cough reflex in 
these participants. 
4.4 Validity of CRT after Extubation 
CRT achieved high sensitivity for identifying patients who silently aspirate post-
extubation in Study II, but specificity was consistently poor. CRT correctly identified most 
or, in the case of 100% sensitivity, all participants who silently aspirated on VES. However, 
it also identified many participants as silent aspirators when they did not silently aspirate on 
VES. Use of CRT in this population would grossly over-identify silent aspiration risk. For 
example, based on these data, only 13 of every 100 patients with an absent or weak cough to 
CRT at 0.4 mol/L would silently aspirate, 14 at 0.6 mol/L and 15 at 0.8 mol/L. A strict CRT 
protocol as has been proposed for stroke patients (Davies, 2016), in which patients with an 
absent cough would be kept nil by mouth until instrumental assessment, would create 
unnecessary discomfort to patients, risk of malnutrition and missed medications and 
increased costs to the health system for limited clinical gain. 
These results contrast with the findings of previous studies in different patient 
populations, which report specificity figures as high as 0.89 (Miles, Moore, et al., 2013; 
Wakasugi et al., 2008). One explanation for the difference may be that both Miles, Moore 
and colleagues (2013) and Wakasugi and colleagues (2008) recruited only participants who 
presented with symptoms of dysphagia while Study II included all patients regardless of the 
presence or absence of overt signs of dysphagia. The wider inclusion criterion is a strength of 
this study and increases its external validity.  
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CRT is a test of cough sensitivity. Specifically, it measures the body’s ability to detect 
and respond to irritant stimuli. The cough reflex is an important component of airway 
protection during swallowing, but individuals can have an absent cough reflex and not be 
dysphagic. This would especially be the case if the mechanism causing dysphagia were 
different than the mechanism causing impairment of the cough reflex. If the causes were the 
same, one could expect validity of CRT to predict silent aspiration. However, if swallowing 
impairment were independent of cough impairment, which these results suggest, individuals 
with an absent cough reflex may not be dysphagic. This would result in low specificity as 
reported in Study II.  
The higher specificity figures reported by Wakasugi and colleagues (2008) and Miles, 
Moore and colleagues (2013) when compared to Study II support the argument that the 
causes of post-extubation dysphagia and impaired cough reflex are different. Fourteen 
percent of participants in Study II had a primary neurological diagnosis compared to 59% 
(Miles, Moore, et al., 2013) and 56% (Wakasugi et al., 2008). Given altered neurology can 
affect both swallowing and the cough reflex, specificity of CRT may be higher in patient 
groups with a high prevalence of neurological disorders. In patients without a neurological 
impairment, the mechanism of cough impairment may be more likely to be independent of 
swallowing impairment. In Study II, only two of the 14 participants with a neurological 
diagnosis aspirated on VES, on silently, and both of these participants had a cough response 
to CRT. Two different participants had an absent cough to CRT and both penetrated to a level 
above the vocal cords and did not eject the material. The sample size of Study II is too small 
to draw specific conclusions on the link between aspiration and CRT in this cohort.  
It is interesting to note that sensitivity of CRT to predict aspiration and silent 
aspiration was consistently higher when weak cough responses were grouped with absent 
responses, indicating that participants with a weak cough were more likely to aspirate. This is 
147 
 
consistent with the findings of Miles, Moore and colleagues (2013). Patients who are weak as 
a symptom of their illness or a sequelae of their treatment may be more likely to experience 
concurrent dysphagia, contributing to greater sensitivity.  
4.5 Clinical Implications 
Currently there are no standardised assessment protocols for the ICU post-extubation 
population and no standardly accepted criteria for resuming oral intake following extubation. 
In the hospital where these studies were conducted, patients are routinely allowed water as 
soon as 30 minutes after extubation. If patients have an obvious neurological deficit or cough 
persistently with oral intake they may be referred at the discretion of the patient’s nurse or 
doctor to the SLT for swallowing assessment. However, a patient with an absent cough reflex 
may aspirate without overt signs, making it unlikely to detect at bedside by even the most 
observant nurse and consequent referral to SLT unlikely.  
This research supports several other studies in finding that post-extubation dysphagia 
can occur and patients are at increased risk of aspiration, both overt and silent, in the 24 hours 
following extubation. In addition, both studies identify that many participants had an 
impaired cough reflex following intubation. The cough reflex is one of the key airway 
defence mechanisms (Pitts et al., 2013). Clinical assessment is based on the observation of 
overt signs of aspiration, including coughing, and does not identify silent aspiration. 
Although CRT had poor specificity as a screening tool for silent aspiration, it may still have a 
place as one of the clinician’s tools for assessment. When used with patients who are at the 
highest risk of dysphagia, including those with primary neurological diagnoses and those who 
have been intubated for extended periods of time, CRT may still provide useful information 
about integrity of sensation and the need for instrumental assessment. On-going research that 
contributes to the development of validated and standardised assessment of dysphagia in the 
post-extubation would be welcome. 
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4.6 Limitations of the Studies 
There are several limitations to this research programme. Eleven participants 
withdrew from Study I, citing discomfort caused by coughing. Encouraging coughing 
following CABG is routine practice, despite the discomfort it causes, and patients all had 
access to analgesia to decrease pain associated with coughing. The researcher noted that 
participants were more likely to withdraw as the study progressed. It is impossible to know at 
what point these participants would have returned to baseline CRT sensitivity, but the 
withdrawal of participants likely biased the results. This bias cannot be overcome in any 
study in which participants have the freedom to withdraw.  
Another limitation is the length of time between testing points. In Study I, there was 
an average of 12 hours between each follow-up point. A participant may have had an absent 
cough reflex at 12 hours following extubation. His cough reflex may have returned at 13 
hours, but not have been measured and recorded as present until the next follow-up at 24 
hours following extubation. Because of this, average time to baseline cough recovery could 
not be reported. Ideally, CRT would have been repeated more frequently, perhaps every three 
hours. However, this is unrealistic as there likely would have been a much higher rate of 
participant withdrawal.  
In study two, the range of citric acid concentrations was a limitation of this study and 
if we had included a wider range, including citric acid concentrations below 0.6 mol/L, 
specificity may have improved. Indeed, Miles, Moore and colleagues (2013) reported 
improved specificity with decreasing concentrations of citric acid. However, many patients in 
ICU fatigue easily and have a limited ability to attend to a task and the CRT and VES needed 
to be performed within one hour. Thus, it was not practical to perform a lengthy assessment 
and CRT trials were kept to a minimum. 
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Analysis of opioid effect on cough recovery was limited and confounded by the effect 
of tapering doses. Patient variability in opioid clearance and sensitivity along with differing 
opioid types and doses administered meant that measuring a true opioid effect in this 
population was difficult and beyond the scope of this study. 
Finally, participant outcomes were not included as part of this study. Although many 
patients had an impaired cough reflex or aspiration following extubation, we do not know if 
those participants had poorer outcomes than their peers without impairment of cough or 
swallowing. Previous research indicates that patients with dysphagia have poorer outcomes 
(Safdar et al., 2005), but there has been no research on the impact of an impaired cough 
reflex in the absence of dysphagia. 
4.7 Future Research 
These studies provide valuable insights into the effect of intubation on the cough 
reflex, aspiration and the link between the two, but there is much we don’t know. Researchers 
have previously reported that CRT has reasonable sensitivity and specificity for predicting 
which patients are at the greatest risk of silent aspiration (Miles, Moore, et al., 2013; 
Wakasugi et al., 2008). The poor specificity reported in Study II suggests that validity of 
CRT for predicting silent aspiration varies in different patient populations. Clearly, more 
research is needed to clarify in which patient populations CRT is most useful. Future research 
with larger sample sizes of ICU participants that include a wider range of pathologies would 
allow for analysis of subgroups to determine if post-extubation CRT validity differs by 
diagnosis. Ideally, studies should include participants both with and without clinical signs of 
dysphagia.  
Considering the specificity of CRT to predict silent aspiration was poor, the 
mechanism of impairment of cough reflex and silent aspiration is presumably different in at 
least some cases. In other patient groups, including those who have had a stroke, a single 
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event may impair both swallowing and the cough reflex. It seems likely that cough can be 
impaired by neurological insult, such as damage to the brainstem or cortical pathways of 
cough, as well as by localized laryngeal trauma. Further research could tease out these 
different types of cough impairment and their relevance to swallowing assessment. 
This study does indicate that aspiration, both overt and silent, and impaired cough 
reflex occur after short periods of intubation. The median length of intubation in study II was 
twelve hours and many participants with relatively short periods of intubation had impaired 
cough. The majority of research studies to date have included only participants who were 
intubated for greater than 48 hours (Ajemian et al., 2001; Barker et al., 2009; Barquist et al., 
2001; Bordon et al., 2011; Daly et al., 2016; El Solh et al., 2003; Leder et al., 1998; 
Noordally et al., 2011; Padovani et al., 2008; Scheel et al., 2016), although it is not clear 
where this delineation originated. Future studies should include participants with widely 
varying durations of intubation. In addition to the ICU population, it would be worthwhile 
assessing the cough reflex with CRT in patients with even shorter periods of intubation who 
are not admitted to ICU. Research by Tanaka and colleagues (2005) suggests that patients do 
not cough to water injected into the glottis following brief intubation. There is still much to 
be learned about the effect of intubation on cough.  
Another point that requires further exploration is the mechanism of post-extubation 
cough impairment. There is a range of theories for how intubation affects swallowing, 
including laryngotracheal trauma, muscle atrophy (Brown et al., 2011) and disruption of 
respiration (de Camargo et al., 2010). There is less written about the possible causes of the 
attenuation of the cough reflex post-extubation, but possibilities include neurological 
adaptation (Hasegawa & Nishino, 1999; Tanaka et al., 2005) and the administration of 
opioids (Chung & Chang, 2002) and laryngeal injury. Laryngeal injury is common following 
extubation (Colton House et al., 2011; Scheel et al., 2016; Tadie et al., 2010), although the 
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relationship between laryngeal injury and cough reflex has not been studied. Future research 
into the cough reflex following intubation should include observation, classification and 
grading of laryngeal injury. 
Opioids are known to impair the cough reflex, although there was not a significant 
relationship between opioid does and cough reflex sensitivity in Study II. To examine the role 
of opioids, it would be ideal to study patients who were intubated but did not receive opioids. 
Unfortunately, this isn’t practical in a clinical setting as sedation for intubation usually 
includes opioids. At a minimum, studies looking at cough recovery should record opioid dose 
and attempt to control for the effect of opioids when analysing results of CRT. 
Finally, the significance of impaired cough reflex in the absence of aspiration 
warrants further research. There is evidence that absent cough in the stroke population is 
associated with a greater risk of pneumonia (Addington, Stephens, & Gilliland, 1999; Davies, 
2016), but this has not been investigated in the ICU population. The results of Studies I and II 
indicate that many patients have an absent cough in the 48 hours following intubation, but the 
clinical significance of this is unknown. 
4.8 Conclusions 
This is the first systematic programme of study to evaluate the cough reflex following 
extubation in the ICU population and to look at the recovery of cough reflex. It is also the 
first attempt to determine the validity of CRT in this population. The results confirm that the 
cough reflex is impaired following orotracheal extubation, but usually returns to baseline 
within 48 hours of extubation. In addition, aspiration, both overt and silent, often occurs in 
the 24 hours following extubation. Both can occur after even short periods of intubation, 
though patients who are intubated for longer periods are more likely to aspirate. Because 
cough is often impaired following extubation, clinical assessment may not be reliable. 
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PRÉCIS  
Study Title  
A Prospective Study of Cough Response to Nebulised Citric Acid following 
Intubation for Elective Cardiac Surgery 
Objectives  
The primary objective is to determine the relationship between orotracheal intubation 
and cough response to nebulized citric acid in patients who have undergone elective 
cardiothoracic surgery. 
The secondary objective is to determine when, in 12-hour intervals, cough returns to 
pre-intubation baseline. 
Participants 




Consecutive subjects admitted for elective cardiovascular surgery will be enrolled in 
the study.  The Coordinating Investigator (CI) will gather medical history from the medical 
record and patient interview.  Any patient with a history of neurological disorder, medical 
condition or trauma involving the head or neck region or dysphagia will be excluded. 
Participants will receive written and verbal explanation of the project, including screening 
and enrollment process and criteria, and given the opportunity to consent.   
Once enrolled, each subject will undergo a Cough Reflex Test (CRT) performed by 
the CI.  The initial CRT will be performed before anaesthesia is administered for surgery. 
Cough testing is described in detail in section 5.1.  Any subject with an absent cough in the 
pre-intubation testing will be excluded from the study. 
The CRT will be repeated within two hours of extubation.  All patients will have the 
CRT repeated twice daily, once between 0700 and 0900 and again between 1900 and 2100 
until resolution of cough, discharge from hospital or death.  Resolution of cough will be 
judged as a return to pre-intubation cough baseline performance.  Patients will be excluded 
from analysis if they suffer a new neurological event, such as intra- or post-operative stroke.  
If a patient requires reintubation, this will be noted and the cough tests will resume after 
extubation.  Patients that receive tracheostomies will be excluded from the study. 
Outcome measures.  
Dependent variable: 
 Response to cough reflex test, classified as present or absent 
Independent variable: 
 Time from extubation 
Covariates: 
 Complication noted on intubation 






 Type and amount of anaesthesia used 
 Surgery bypass time 
 Length of intubation 
 Length of stay in ICU 
Statistical plan 
Analyses will include binomial distribution and Kaplan-Meier Life Table as well as 
McNemar’s test, Wilcoxon Sign Rank test, T-Test and the Cox Proportional Hazard Model. 
 
1. STUDY OBJECTIVES 
1.1 Primary Objective 
To test the hypothesis that orotracheal intubation inhibits cough response to nebulised 
citric acid in neurologically intact adults undergoing intubation for elective cardiac surgery. 
1.2 Secondary Objectives 
To determine when, in 12-hour intervals, cough response returns to pre-intubation 
baseline.  This data will be used to design a swallow screening protocol to be used with 
patients after extubation. 
2. BACKGROUND AND RATIONALE 
2.1 Background on Condition, Disease, or Other Primary Study Focus 
Each year in Capital & Coast Intensive Care Unit approximately 1200 patients are 
intubated.  Dysphagia, or disordered swallowing, is common post-intubation with studies in 
the general ICU population indicating that over 50% of patients have some level of dysphagia 
soon after extubation.  Up to one half of these patients aspirate “silently” or without overt 
evidence of aspiration, such as coughing.  Patients who aspirate silently are particularly 
difficult to detect as ICU staff use the presence of coughing with food and drink to determine 
if patients have dysphagia.  Currently, patients are only referred to speech-language therapy 
for a swallowing assessment if they demonstrate overt signs of aspiration and it is likely that 
many patients are allowed to eat and drink while silently aspirating.  Aspiration can be a 
causal factor in the development of pneumonia, which is the most common nosocomial 
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infection in ICU.  Development of pneumonia significantly increases length of stay, risk of 
death and cost of treatment (Safdar et al., 2005). 
    2.2 Study Rationale 
Dysphagia and aspiration after orotracheal intubation in the Intensive Care Unit (ICU) 
population is common (Ajemian et al., 2001; de Larminat et al., 1995; El Solh et al., 2003; 
Macht et al., 2011; Noordally et al., 2011).  Studies measuring frequency of aspiration in a 
general ICU population post-extubation indicate that it occurs in 27% to 56% of patients 
(Ajeman, El Solh, Noordally).  Intensive care patients who aspirate are at increased risk of 
developing pneumonia.  Pneumonia results in increased length of stay, mortality and cost of 
care (Safdar et al., 2005).   
Recently extubated intensive care patients are particularly at risk for silent aspiration, 
which cannot be identified by bedside clinical assessment (Barquist et al., 2001; Davis & 
Thompson Stanton, 2004; El Solh et al., 2003; Hogue et al., 1995; Leder et al., 1998).  Most 
studies that have looked specifically at silent aspiration report silent aspirators as a 
percentage of total aspirators, with rates ranging from 22% to 44% (Barquist et al., 2001; 
Davis & Thompson Stanton, 2004; El Solh et al., 2003; Hogue et al., 1995; Leder et al., 
1998).  Often these patients are allowed to eat and drink soon after extubation, potentially 
putting them at increased risk of aspirating. 
Sensory testing of patients after orotracheal intubation suggests that airway reflexes 
are impaired in these patients in the short and medium term (Colice et al., 1989; Tanaka et al., 
2005).  Airway sensation in the recently extubated population has been tested by injection of 
water into the glottis (Tanaka), presence of a gag on laryngoscopy (Colice), and light touch to 
the aeryepiglottic folds using a laryngoscope (Scheel).   
The Cough Reflex Test (CRT) is emerging as a useful tool for testing subjects’ ability 
to protect their airway through reflexive cough (Addington et al., 2005; Wakasugi et al., 
2008).  Currently, there is no evidence in the literature describing the use of CRT to test 
sensation after extubation.  Most research relating cough reflex to safety during swallowing 
has been in the stroke population.  Absent cough to CRT with acidic tussives (i.e. citric acid 
and tartaric acid) has high specificity as a predictor of aspiration pneumonia (Addington et 
al., 2005; Wakasugi et al., 2008).  In 2005, Addington and colleagues reported on 818 
consecutive stroke patients who all underwent CRT with tartaric acid before starting oral 
intake after acute stroke.  Patients who failed the CRT were kept nil by mouth.  Three and 
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one half percent of subjects with a normal response to CRT developed pneumonia during 
their hospital stay compared to 10% of subjects with a weak response to CRT and 16% of 
patients with an absent cough response (Addington et al., 2005).  Research recently 
conducted in New Zealand by the supervisor of this project, Dr. Maggie-Lee Huckabee and 
Anna Miles (under review) showed a non-significant trend for an increase in mortality in 
patients with absent cough reflex. CRT with nebulized citric acid is gaining traction as a tool 
for dysphagia assessment in New Zealand, particularly with stroke patients. 
Given that aspiration places ICU patients at risk of pneumonia, silent aspiration is 
common in patients after orotracheal intubation and CRT testing is a useful tool for 
determining risk of silent aspiration, it follows that it may be useful to use CRT with patients 
after orotracheal intubation to help determine safety of oral intake.  However, we do not 
currently know if the cough reflex is often impaired after orotracheal intubation.  This 
research study will test the hypothesis that that orotracheal intubation inhibits cough response 
to nebulised citric acid in neurologically intact adults undergoing intubation for elective 
cardiac surgery.  It will also aim to determine when, in 12-hour intervals, most subjects’ 
cough response returns to pre-intubation baseline.  If the hypothesis is proven and patients do 
indeed have impaired cough reflex after extubation, the data will be used to design a swallow 
screening protocol to be used with patients after orotracheal intubation.   
3. STUDY DESIGN 
This is a prospective cohort observational study. 
4. SELECTION AND ENROLLMENT OF PARTICIPANTS  
4.1 Inclusion Criteria 
Participants must meet all of the inclusion criteria below to participate in this study.  
 18 years of age or older 
 Undergoing intubation for elective (non-urgent) coronary artery bypass 
grafting (CABG) without valve replacement 
4.2 Exclusion Criteria 




 Presence or history of neurological disorder (e.g. stroke, Parkinson’s, MS) 
documented as per medical records 
 Presence or history of cancer of the head or neck documented in medical 
records 
 Presence or history of oropharyngeal dysphagia documented in medical 
records or obtained in patient interview 
 History of trauma to the neck documented in medical records 
 Inability or unwillingness of individual to give written informed consent.  
4.3 Study Enrollment Procedures  
 The Cardiac Liaison Nurse will ensure all patients scheduled for elective CABG 
without valve replacement receive a one-page Introductory Letter (Appendix A) 
and Patient Information Sheet (Appendix B) by post with their pre-admission 
paperwork.  
 During the admission process the ward clerk will ask each patient if they would 
be willing to speak to the CI about the study 
 The CI will visit each patient who agrees and provide each candidate with 
written and verbal information about the study.  
 Consenting participants will sign the Consent Form (Appendix C) and be 
recorded in the Participants Log (Appendix D). 
 The CI will review the medical record and collect history from each participant 
to identify exclusion criteria. 
 Patients who do not consent and those who are excluded from the study will be 
recorded in the Screening Log (Appendix E). 
5. SCHEDULE OF EVALUATIONS  
5.1 Baseline Assessment (CRT1) 
Once a subject is enrolled a Cough Reflex Test (CRT) will occur immediately or no 
later that 30 minutes before delivery of anaesthesia.  The procedure for CRT will be the same 
each time and is described below. 
 The patient must be sitting up in a bed or chair for assessment with head raised 
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at least 60 degrees. 
 In CRT1, up to three concentrations will be trialed.  These are 0.4, 0.8 and 1.2 
mol (diluted in .9% sodium chloride). 
 In CRT1, the CI will first test with the lowest concentration of citric acid. 
 Three to four milliliters of sterile citric acid solution will be placed in a 
nebulizer cup, which is attached by tubing to a DeVilbiss Pulmomate nebulizer 
with a free-flow rate of eight liters per minute.   
 A facemask will be attached by connecting tubing to the nebulizer.  The CI will 
place the facemask over the subject’s nose and mouth and ask them to quietly 
breath for 15 seconds.  The subject will be told that they should try not to 
cough. 
 If the subject does cough at least twice on two of three trials the cough will be 
judged present.  The CI will judge the cough to be present or absent and record 
the result on the Case Report Form E). 
 The citric acid test will be followed by one trial with normal saline water.  If the 
patient coughs with normal saline, the cough will be considered abnormal and 
the patient will be excluded from the study.  The results will be recorded on the 
case report sheet and saved with the study records. 
 If the subject’s cough is present on the first concentration of citric acid and 
absent on the saline solution the test is complete. 
 If the subject’s cough is absent, the test will be repeated with the next 
concentration (0.8 mol).  Testing will continue with a third concentration (1.2 
mol) if needed.   
 The CRT will always end with a trial of saline.  Their results will be recorded 
on the case report sheet and saved with the study records.  
 Subjects who do not cough on any concentration will be considered abnormal 
and their data will not be included in the study.  Their results will be recorded 
on the case report sheet and saved with the study records. 
5.2 Follow-up Assessments 
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The CI will repeat the CRT within two hours of extubation (CRT2).  Extubation may 
occur the day of surgery or up to several days later.  ICU nursing staff will phone the CI 
when planning extubation.  CRT2 will follow the procedure exactly as described above, 
except will start with the concentration that successfully prompted a cough at baseline 
(CRT1) and then increase in concentration as needed.  The same concentrations of citric acid 
will be used.  These are 0.4, 0.8 and 1.2 mol.  The CI will again rate each cough as present or 
absent and record the results on the Case Report Form. 
Subjects with a cough present at their baseline threshold or lower will have completed 
the study.  Subjects with an absent cough or a higher threshold will have a repeat CRT twice 
daily until they achieve a pass at their baseline threshold.  The CI will perform repeat CRT 
tests twice daily, the first between 0730 and 0930 and the second between 1930 and 2130.  
Testing will continue for each patient according to this schedule until they pass with a strong 
cough, are discharged from hospital or die.  If a patient dies before CRT2, their data will not 
be included in analysis.  If they die after CRT2 their data will be included in analysis. 
Subjects who receive a tracheostomy will be excluded from the study at the time the 
tracheostomy is inserted.  Subjects who suffer a new neurological event, such as intra-
operative stroke, will continue in the study, but their data will be analysed separately.  A 
suspected or confirmed neurological event documented in the medical record by the Intensive 
Care physician or cardiothoracic surgeon will constitute a new neurological event.   
6. SAFETY ASSESSMENTS/ADVERSE EVENTS 
An adverse event is defined as any unfavorable and unintended diagnosis, symptom, 
sign syndrome or disease that is not related to the subject’s medical condition.  The CI does 
not anticipate adverse events.  Subjects may experience a choking sensation or momentary 
chest tightness during the test (Dicpinigaitis, 2007).  If an adverse event is suspected the CI 
will request a review by the patient’s doctor and the doctor will determine if it’s safe to 
continue the study.  The CI will complete a Reportable Event on the hospital system.  
7. STATISTICAL CONSIDERATIONS  
7.1 General Design Issues  
The primary hypothesis is that orotracheal intubation inhibits cough response to 




The CI chose patients undergoing elective cardiothoracic surgery for this study 
because it provides the opportunity to assess cough reflex before and after intubation.  The 
study will only include patients undergoing coronary artery bypass grafting without valve 
replacement to obtain some homogeneity in the group.  All subjects will be intubated for a 
minimum of several hours and it is likely that some will be intubated for a number of days.  
This means data can be collected on subjects with a wide range of intubation times.  CRT 
will be performed before intubation and soon after extubation to measure the effect of 
intubation on cough reflex.   
Repeating the CRT twice per day is practical and will allow the researchers to identify 
in what 12-hour window most patients recover their cough.  This relates to the secondary 
objective of the study, to determine when, in 12-hour intervals, cough response returns to pre-
intubation baseline.  Because these data will be used to determine when nurses should screen 
swallowing, a 12-hour window is sufficient.  It is not necessary to know at which hour nurses 
should screen swallowing, as this is not practical in the ward environment.   
The dependent variable for both studies is the response to the cough test.  The 
independent variable is time.  Covariates include: 
 Complication noted on intubation 




 Type and amount of anaesthesia used 
 Bypass time 
 Length of intubation 
 Length of stay in ICU 
 Time post intubation that CRT1 is tested 
7.2 Sample Size and Randomization 
The study population is patients undergoing elective cardiothoracic surgery at 
Wellington Hospital.  This is a single cohort observational study.  With 100 participants the 
study will have 90% power to estimate the proportion of patients whose cough reflex has 
diminished with a measurement error of +/- 10% (Stata/IC 11.2, StataCorp LP, Texas, USA).  
7.3 Data Analyses  
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The CI will use binomial distribution to estimate the proportion of subjects who do 
not have a normal cough after intubation. 
To meet the secondary aim, time to recovery of cough will be plotted using data 
points spread across a timeline.  These data will be analysed using a Kaplan-Meier Life Table 
with intervals of twelve hours.  Other measures will be analysed using a combination of the 
McNemar’s test, Wilcoxon Sign Rank test, T-Test and the Cox Proportional Hazard Model. 
Further analyses will be undertaken on time to recovery of baseline cough, effect of 
intubation on presence and threshold of cough, correlation between length of intubation and 
recovery of cough and relationship between other variables and outcome.  Specifically the 
time at which > 50% of patients recover cough response and the time at which > 80% of 
patients recover cough will be calculated.  If a detrimental effect is identified, the CI will also 
calculate the minimum amount of intubation time that has a significant detrimental effect on 
cough. Patients who suffered new neurological event will be analysed as a sub-group. 
8. DATA COLLECTION AND QUALITY ASSURANCE 
All data from screening to CRT results will be recorded on the Case Report Form 
(Appendix F).  All data will be collected by the CI and viewed only by her, the supervisor 
and co-supervisor.  All records will be stored in clearly labeled binder in a locked-filing 
cabinet and scanned and saved electronically on a password-protected computer/network.  
Any information taken off site will be identified only by Patient Identification Number and 
patient initials. 
9. PARTICIPANT RIGHTS AND CONFIDENTIALITY  
9.1 Ethics Approval  
This protocol, the Patient Information Sheet (Appendix B), Consent Form (Appendix 
C) and any subsequent modifications will be reviewed and approved by the New Zealand 
Health and Disability Ethics Committee (HDEC) and Canterbury University Human Ethics 
Committee. 
9.2 Informed Consent Forms 
Information about the screening process, enrollment and study procedures will be 
provided verbally and in writing.  An interpreter will be made available through Language 
Line if requested.  A signed consent form will be obtained from each participant.  A copy will 
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be given to each participant and this will be documented in the participant’s record.  
9.3 Participant Confidentiality  
All paperwork will be kept in a locked filing cabinet when not in use.  Records will 
also be scanned and saved electronically in a password-protected file.  Subjects’ names will 
only appear on the Consent Form (Appendix C) and Record of Participants (Appendix D), 
which will not leave the site.  Other documentation will be identified with the Participant 
Identification Number (PIN) and participant’s initials to maintain confidentiality.  All 
analysis will be completed using the PIN only.  Only PIN and initials will identify any 
information shared with the Co-Investigators.  Information will not be released without 
written permission of the participant, except as necessary for monitoring by the HDEC. 
9.4 Study Discontinuation  
The HDEC the Canterbury University Ethics Committee, or other government agency 
may discontinue the study at any time as part of their duties to ensure that research 
participants are protected  
10. PUBLICATION OF RESEARCH FINDINGS  
Any presentation, abstract, or manuscript will be available for review by the sponsor 
and the HDEC prior to submission.  
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APPENDIX A – INTRODUCTORY LETTER 
                                                                              
Dear Sir or Madam: 
 
You are having heart surgery soon at Wellington Hospital.  When you come into 
hospital, staff will ask if you would like to take part in a research study.  This study is 
looking at the effect of breathing tubes on people’s ability to cough.  Information from 
this study will help us provide the best treatment for patients in the future. 
Please look at the information provided with this letter to learn more about the study.  
The information will tell you more about why we are doing the study and what you 
would be asked to do.  When you are admitted staff will ask if you would be willing to 
meet with the researcher to talk about the study.  If you agree, the researcher will 
visit you to answer any questions you have and see if you fit the criteria for the study. 
It is up to you if you would like to participate or not. You will receive the same care 
and medical treatment during your hospital stay whether or not you take part in the 
study.  There will be no direct benefits to you. 




Dr. Alex Psirides 
ICU Consultant 
Capital & Coast District Health Board 
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APPENDIX B - INFORMATION SHEET 
                                         
INFORMATION 
Research Title: A Prospective Study of Cough Response to Nebulised Citric 




Department of Speech-Language Therapy  
Capital & Coast District Health Board 
Department of Communication Disorders, University of Canterbury 
(04) 806 2345 
 
Co-Investigators: 
Maggie-Lee Huckabee PhD 
Senior Lecturer, Department of Communication Disorders, University of 
Canterbury 
Senior Researcher, New Zealand Brain Research Institute   
(03) 378 6070 
 
Dr. Alex Psirides 
Intensivist 
Wellington Intensive Care Unit 
Capital & Coast District Health Board 
(04) 806 0432 
 
Introduction and aims of the project: 
We invite you to take part in a research study.  This study is part of a PhD 
research project with the University of Canterbury.  It will measure the effect of a 
breathing tube on your cough.  You have the right to not participate in the study or 
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stop participating in this study at any time.  If you do not participate this will not affect 
your treatment in any way.   
 
Cough is your body’s way of clearing saliva, food or fluid from your airway.  
Material may get into the lungs and cause an infection if the cough reflex is absent or 
weak.  This could slow recovery after surgery.  Sometimes people have trouble 
swallowing when the breathing tube is removed after surgery.  Swallowing problems 
put people at extra risk of food or fluid entering the lungs, especially if their cough 
reflex isn’t working.  
 
The aim of this project is to measure how the breathing tube affects the cough 
reflex.  We also want to know how long it takes the cough to return to normal after 
the breathing tube is removed.  This information will help the hospital team know 
who is at the highest risk for getting an infection in the lungs.  We can then provide 
the best and safest treatment.  
 
To test the cough reflex we do something called a Cough Reflex Test (CRT).  
The CRT involves breathing a mist though a mask.  This mist contains citric acid.  
Citric acid occurs naturally in many things we eat, like oranges, and is used in many 
packaged foods.  When people inhale enough citric acid it makes them cough.  Citric 
acid has been used to cause coughing since the 1950s with no harmful effects.  
Each cough test takes about ten minutes. 
 
Participant selection: 
You are being asked to take part in this study because you are having cardiac 
surgery.  If you agree, we will look at your medical record.  We want to know if you 
have had a neurological disorder, head or neck cancer, swallowing problems or 
damage to your throat.  If not, you will be enrolled in the study and have the cough 
test.  The study will include a total of 100 people who are having cardiac surgery.  
Remember, you can withdraw from the study at any time.  
 
The research procedure: 




1. Once you have agreed to take part in the study, the researcher will look at 
your medical records and ask you a few questions to make sure you can participate.  
 
2. Then the researcher will place a small amount of liquid into a nebuliser.  The 
nebuliser is a device that turns the liquid into mist so you can inhale it.  You will be 
asked to breathe the mist in for 15 seconds.    
 
3. The mist you inhale may make you feel like coughing. You will be asked to try 
not to cough.   
 
4. After 15 seconds the mask will be taken off and you can relax.  The test will 
be repeated up to four more times.   
 
5. If you do not cough on at least two of these tests they will be repeated with a 
different solution. 
 
6. If you do not cough on any of the tests you will be finished with the study. 
 
7. If you do cough on two of the three tests you will continue with the study (Step 
8 and 9). 
 
8. After your surgery, the test will be repeated in the same way within two hours 
of the breathing tube being removed.  This usually happens within about twelve 
hours of your surgery, but it may be later. 
 
9. The test will be repeated each morning and evening until your cough returns 
to normal.  This may happen immediately or take several days. 
 
Outcome Measurements: 
We will measure if your cough is present or absent after the removal of the 
breathing tube.  If your cough reflex is absent, we will determine how long it takes for 
it to return to normal by repeating the test.  We will also record things about your 




Risks and Benefits: 
There will be no direct benefit to you if you take part in this study.  There have 
been no harmful effects from the cough test in other research.  You may feel slightly 
tight in your chest when inhaling the mist.  Coughing may feel uncomfortable after 
surgery, but coughing is important to your recovery and the doctors and nurses will 
encourage you to cough.  A trained person will monitor you carefully during the 
cough test.  We hope that the results of this study will help us to make better 
decisions about how we treat people after they have been intubated.  
 
Participation: 
If you do agree to take part in this study you are free to stop at any time.  You 
do not need to give a reason for stopping.  Your family or whānau can also withdraw 
on your behalf.  Stopping will not change the care you receive.  Your participation in 
the study will be stopped should any harmful effects appear.  
 
Confidentiality: 
The results of this study may be presented at meetings in New Zealand and in 
other countries.  They may also be printed in medical journals.  No information that 
could identify you will be used in any reports.  This form and other paperwork will be 
locked in a filing cabinet in the Speech-Language Therapy department at the hospital 
or will be stored on password-protected computers. All records will be stored for a 
period of ten years then sent to the national archive.   Results from this study may be 
used in future studies that have ethical approval from the New Zealand Health and 
Disability Ethics Committee. 
 
Results: 
You can have copies of the publications that arise from this research.  You 
can also choose to have someone discuss the results of the study with you.  It will be 
several months after the study is completed before any information is available.  






You may have a friend, family, or whanau support person to help you 
understand the risks and benefits of this study.  They are welcome to speak to the 
Primary Researcher with your permission. 
 
Please contact the Primary Researcher listed on the front page of this 
information sheet if you have any questions.  
 
An interpreter can be provided if you need one. 
 
This project has been reviewed and approved by the University of Canterbury 
Human Ethics Committee (Private Bag 4800, Christchurch, email human-
ethics@canterbury.ac.nz). 
 
You can contact a Health and Disability Advocate if you have any questions or 
concerns about your rights: 
  
Wellington Office: (04) 389 2502 
National Free Phone: 0800 555 050 




APPENDIX C – CONSENT FORM 
                                                                                               
 




I wish to have an interpreter. Yes No 
Maori 
 





Oute mana’o ia iai se fa’amatala upu. Ioe Leai 
Tongan 
 




Ka inangaro au i  tetai tangata uri reo. Ae Kare 
Niuean 
 




I, ____________________________________, have read and I understand the 
Information Sheet Version 2.0 for volunteers taking part in the study designed to 
collect information about the usefulness of cough reflex testing. I have had the 
opportunity to discuss this study. I am satisfied with the answers I have been given. 
 
I have had this project explained to me by Molly Kallesen, the main researcher. 
 
I understand that taking part in this study is voluntary (my choice) and that I may 
withdraw from the study at any time and this will in no way affect my current, 
continuing or future health care. My family or whānau can also withdraw on my 
behalf.  I understand that if I choose to withdraw from the study, I may also withdraw 




I understand that the information obtained from this research may be published. 
However, I understand that my participation in this study is confidential and that no 
material that could identify me will be used in any reports on this study.  
 
  Cough Reflex Testing 
 
I understand that the investigation will be stopped if it should appear harmful to me 
and I know who to contact if I have any side effects to the study or have any questions 
about the study. 
 
I understand the potential risks of participation in the study as explained to me by the 
researcher. 
 
I understand that I do not receive payment for this study.  
 
I have had time to consider whether to take part. 
 
I wish to receive a copy of the results.       
YES  /  NO 
 
I, _________________________________ hereby consent to take part in this study.   
Date_________________________________________ 
 Signature _______________________________ 
 
Signature of researcher___________________ Name of researcher: Molly Kallesen 
Name of primary researcher and contact phone numbers:  
Name:  Molly Kallesen at Capital & Coast District Health Board 
  04 806 2345 or molly.kallesen@ccdhb.org.nz 
 
   
(Note: A copy of the consent form to be retained by participant and (in the case of patients) a copy to be 
placed in the medical file.) 
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APPENDIX D – RECORD OF PARTICIPANTS 
 
# NHI Patient Name Date 
Enrolled 
PIN Initials Excluded 
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       





APPENDIX E – SCREENING LOG 
 
NHI Patient Name 
Date 
Screened 
Reason for Exclusion 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    










Patient Identification Number : 
 
Date of screening and enrolment: 
 
Date of completion of study:  
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Patient Initials:  
Patient Identification Number:  




Patient Questions:  




- “Please describe the difficulty.” 
- “Have you had any tests done for it?” 
- “When did it start?” 










Baseline Characteristics:  
History of Dysphagia Yes No 
History of Head & Neck Cancer Yes No 
History of neurological disorder 
(e.g., stroke, Parkinson’s, MS, TBI) 
Yes No 
Able to provide consent  Yes No 
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Comments on above: 
 
 




Patient Initials:  
Patient Identification Number:  
Any medications started in hospital 
 
 
Any medications withheld prior to 








COUGH REFLEX TEST 1 (BASELINE): 
Record for each trial A = absent, P = present, X = not administered 
Date of CRT  
Time of CRT  
Concentration  Presentation 1 Presentation 2 Presentation 3 
____ mol / saline    
____ mol / saline    
____ mol / saline    
____ mol / saline    
Subject Threshold = _____________        OR   Absent Cough (Discontinue) 







Patient Initials:  
Patient Identification Number:  
OPERATIVE DATA:  
Operation performed 
(APACHE III Subcode for Cardiac Surgery) 
 




Time of knife to skin  
Time onto bypass  
Time of cross clamp removal  
Total bypass time  
Cross clamp time  
IABP (balloon pump) used Yes No 
Intervention successfully applied Yes No 
Type and size of endotracheal tube   
Complications noted during intubation Yes No 







Patient Initials:  
Patient Identification Number:  
Induction  
Midazolam dose (mg)  
Fentanyl dose (mcg)  
Analgesia  
Total supplemental fentanyl (mcg)  
Morphine dose (mg)  
Euroscore   
Other drugs  
Were any non-protocol drugs 
administered during cardiac anaesthesia? 
Yes No 
If yes, give drug(s), dose(s) and reason 





Length of stay  
ICU admission date and time  
ICU discharge time  





Patient Initials:  
Patient Identification Number:  
COUGH REFLEX TEST 2 (POST EXTUBATION): 
Record for each trial A = absent, P = present, X = not administered 
Date of extubation   
Time of extubation  
Date of CRT  
Time of CRT  
Begin at subject’s baseline threshold =  
Concentration  Presentation 1 Presentation 2 Presentation 3 
____ mol / saline    
____ mol / saline    
____ mol / saline    
____ mol / saline    
Subject Threshold = _____________        OR   Absent Cough  
Adverse events:  NO  YES (See adverse event record) 









Patient Initials:  
Patient Identification Number:  
COUGH REFLEX TEST # ___ 
Record for each trial A = absent, P = present, X = not administered 
Date of CRT  Time of CRT  
Begin at subject’s baseline threshold =  
Concentration  Presentation 1 Presentation 2 Presentation 3 
x.x mol    
x.x mol    
x.x mol    
Subject Threshold = _____________        OR   Absent Cough  
Adverse events:  NO  YES (See adverse event record) 
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Study Title  
Testing Cough Reflex after Extubation on the Intensive Care Unit: A validation study. 
Objectives  
The primary objective is to determine the sensitivity and specificity of nebulized citric 
acid for detecting the presence of cough reflex on aspiration by analyzing the correlation 
between response to cough reflex testing (CRT) and presentation of airway compromise on 
endoscopy. 
The secondary objective is to determine the sensitivity and specificity of detecting 
silent aspiration when aspiration is observed on videoendoscopy (VES). 
Participants 
108 Intensive Care Unit (ICU) patients who meet the inclusion criteria.  Enrollment 
will be capped at a maximum of 54 participants with a primary surgical diagnosis and 54 
with a non-surgical primary diagnosis.  Participants will be enrolled consecutively, seven 
days a week, two weeks on and one week off. 
Method 
The CI will consider all ICU patients who meet the inclusion criteria after extubation 
to enroll in the study.  The CI will visit ICU each morning and evening as described in the 
Study Enrollment Procedures section below and liaise with the Associate Charge Nurse 
Manager to identify potential participants who have been extubated in the previous 24 hours.  
Participants who consent and who are not excluded will undergo a CRT followed within one 
hour by a VES, both performed by the CI.  The CI will judge the cough to be present or 
absent and if present, as weak or strong.  The VES will be recorded by the CI and rated later 
by a SLT blinded to results of CRT.  The blinded SLT will rate aspiration as absent, present 
or trace and for those with present or trace aspiration, rate cough as present or absent. 




 Cough to aspiration, rated as present or absent 
Independent variable: 
 Response to cough reflex test, classified as present or absent and if present 
Covariates: 
 Time from extubation 




 Diagnosis Group (Surgical or Non-surgical) 
 APACHE III score 
 Opiate dose in the previous 24 hours 
 Secretion rating score (Murray et al., 1996) 
Analysis will primarily address the sensitivity and specificity of CRT to predict cough 
to aspiration on VES. 
1. STUDY OBJECTIVES 
1.1 Primary Objective 
The primary objective is to determine the sensitivity and specificity of nebulized citric 
acid for detecting the presence of cough reflex on aspiration by analyzing the correlation 
between response to cough reflex testing (CRT) and presentation of airway compromise on 
endoscopy. 
1.2 Secondary Objectives 




2. BACKGROUND AND RATIONALE 
2.1 Background on Condition, Disease, or Other Primary Study Focus 
Each year in Capital & Coast ICU approximately 1200 patients are intubated.  
Dysphagia, or disordered swallowing, is common post-intubation with studies in the general 
ICU population indicating that over 50% of patients have some level of dysphagia soon after 
extubation.  Up to one half of these patients aspirate “silently” or without overt evidence of 
aspiration, such as coughing.  Patients who aspirate silently are particularly difficult to detect 
as ICU staff use the presence of coughing with food and drink to determine if patients have 
dysphagia.  Currently, patients are only referred to speech-language therapy for a swallowing 
assessment if they demonstrate overt signs of aspiration and it is likely that many patients are 
allowed to eat and drink while silently aspirating.  Aspiration can be a causal factor in the 
development of pneumonia, which is the most common nosocomial infection in ICU.  
Development of pneumonia significantly increases length of stay, risk of death and cost of 
treatment (Safdar et al., 2005). 
    2.2 Study Rationale 
Dysphagia and aspiration after orotracheal intubation in the Intensive Care Unit (ICU) 
population is common (Ajemian et al., 2001; de Larminat et al., 1995; El Solh et al., 2003; 
Macht et al., 2011; Noordally et al., 2011).  Studies measuring frequency of aspiration in a 
general ICU population post-extubation indicate that it occurs in 27% to 56% of patients 
(Ajeman, El Solh, Noordally).  Intensive care patients who aspirate are at increased risk of 
developing pneumonia.  Pneumonia results in increased length of stay, mortality and cost of 
care (Safdar et al., 2005).   
Recently extubated ICU patients are particularly at risk for silent aspiration, or 
aspiration without spontaneous cough. Most studies that have looked specifically at silent 
aspiration as diagnosed on instrumental assessment report silent aspirators as a percentage of 
total aspirators, with rates ranging from 22% to 44% (Barquist et al., 2001; Davis & 
Thompson Stanton, 2004; El Solh et al., 2003; Hogue et al., 1995; Leder et al., 1998). 
However silent aspiration cannot be reliably identified by bedside clinical assessment 
(Barquist et al., 2001; Davis & Thompson Stanton, 2004; El Solh et al., 2003; Hogue et al., 
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1995; Leder et al., 1998). Often these patients are allowed to eat and drink soon after 
extubation, potentially putting them at increased risk of aspirating. 
Sensory testing of patients after orotracheal intubation suggests that airway reflexes 
are impaired in these patients in the short and medium term (Colice et al., 1989; Tanaka et al., 
2005).  Airway sensation in the recently extubated population has been tested by injection of 
water into the glottis (Tanaka et al., 2005), presence of a gag on laryngoscopy (Colice et al., 
1989), and light touch to the aeryepiglottic folds using a laryngoscope (Scheel et al., 2009).   
The Cough Reflex Test (CRT) is emerging as a useful tool for testing subjects’ ability 
to protect their airway through reflexive cough (Addington et al., 2005; Wakasugi et al., 
2008).  Currently, there is no evidence in the literature describing the use of CRT to test 
sensation after extubation.  Most research relating cough reflex to safety during swallowing 
has been in the stroke population.  Absent cough to CRT with acidic tussives (i.e. citric acid 
and tartaric acid) has high specificity as a predictor of aspiration pneumonia (Addington et 
al., 2005; Wakasugi et al., 2008).  In 2005, Addington and colleagues reported on 818 
consecutive stroke patients who all underwent CRT with tartaric acid before starting oral 
intake after acute stroke.  Patients who failed the CRT were kept nil by mouth.  Three and 
one half percent of subjects with a normal response to CRT developed pneumonia during 
their hospital stay compared to 10% of subjects with a weak response to CRT and 16% of 
patients with an absent cough response (Addington et al., 2005).  Research recently 
conducted in New Zealand by the supervisor of this project, Dr. Maggie-Lee Huckabee, Anna 
Miles and their colleagues (Miles, Moore, et al., 2013) showed a significant relationship 
between CRT result and response to aspiration on instrumental assessment. CRT with 
nebulized citric acid is gaining traction as a tool for dysphagia assessment in New Zealand, 
particularly with stroke patients. 
To determine sensitivity and specificity, CRT is compared to a “gold standard” 
assessment.  The two methods of instrumental assessment of dysphagia used by speech-
language therapists are Videofluoroscopic Swallowing Studies (VFSS) and VES.  For this 
study we are using VES because it offers many advantages in the ICU environment.  It can be 
performed at bedside, requires fewer resources than VFSS and is good for assessing response 
to aspiration (Ref).  Miles et.al. has already looked at validity of CRT in a general ward 
environment with primarily stroke patients (Miles, Moore, et al., 2013).  However, in recently 
extubated ICU patients the etiology of dysphagia is different and it will be worth ensuring 
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that the CRT is valid with this population, rather than assuming that the results of general 
ward patients applies. 
Given that aspiration places ICU patients at risk of pneumonia, silent aspiration is 
common in patients after orotracheal intubation and CRT testing is a useful tool for 
determining risk of silent aspiration, it follows that it may be useful to use CRT with patients 
after orotracheal intubation to help determine safety of oral intake.  However, we do not 
currently know if CRT is a sensitive and specific indicator of silent aspiration in the intubated 
population.  This research study will test the hypothesis that recently intubated ICU patients 
with an absent cough to CRT will demonstrate greater incidence of silent aspiration during 
VES and people with a strong cough will demonstrate lower incidence of silent aspiration 
during VES. 
3. STUDY DESIGN 
This is a prospective cohort observational study. 
4. SELECTION AND ENROLLMENT OF PARTICIPANTS  
4.1 Inclusion Criteria 
Participants must meet all of the inclusion criteria below to participate in this study.  
 Extubated within the 24 hours preceding enrollment 
 Have been an inpatient on the Intensive Care Unit at the time of extubation 
 18 years of age or older 
 Be a candidate for oral intake (e.g., not nil by mouth for recent gastric surgery) 
 Enrollment will be capped at 54 participants with a primary surgical requirement for 
intubation (e.g., post cardiothoracic surgery) and 54 with a non-surgical reason for intubation 
(e.g., pneumonia, stroke) 
4.2 Exclusion Criteria 




 Inability or unwillingness of individual or relative/whanau/friend to give consent.  
 Glasgow Coma Scale score less that 13 
 Recent cannulation (tracheostomy) 
 Have a history of severe (life threatening) nosebleeds 
 Have recent (less than four weeks) facial or base of skull fractures 
 Be for palliative treatment 
4.3 Study Enrollment Procedures  
 Patients will be enrolled Monday through Sunday, 14 days on and seven days off.  This is 
to ensure the study is practical to complete for a single researcher.  Enrollment is expected to 
take three months.   
 The ICU nurse will provide the relative/whanau member/friend of the patient with an 
Information Sheet for Relative/Whanau Member/Friend (Appendix A) during the period of 
intubation.  The patient will also receive a Participant Information Sheet (Appendix B) at the 
time of extubation.   
 When a patient is extubated, nursing staff will ask the patient and relative/whanau 
member/friend (if present) if they would be willing to meet with the researcher.   
 Each morning and evening of the enrollment period, the CI will round the unit and as 
nurses if they have any potential participants who have agreed to meet the CI. 
 The CI will provide further verbal information and the potential participant or 
relative/whanau member/friend will have the opportunity to discuss the study. 
 If there is any question about the patient’s competence to consent, and in all cases where 
the patient’s GCS is less than fifteen, the CI will ask the treating doctor if the patient is 
competent. 
 Consenting participants will sign the Participant Consent Form (Appendix B).  
Relative/whanau/friends will sign the Consent Form for Relative/Whanau/Friend (Appendix 
A).  All participants will be recorded in the Record of Participants (Appendix C). 
 When the quota has been reached for a diagnostic group (Surgical or Non-surgical) 
enrollment for that group will stop but enrollment for the other group will continue. 
 Patients who do not consent or who are excluded from the study will be recorded in the 
Screening Log (Appendix D). 
5. SCHEDULE OF EVALUATIONS  
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5.1 Cough Reflex Test 
Once a subject is enrolled, the CI will perform a Cough Reflex Test (CRT).  The 
procedure for CRT will be the same each time and is described below. 
 The patient must be sitting up in a bed or chair for assessment with head raised at 
least 60 degrees. 
 Up to three concentrations of citric acid will be trialed.  These are 0.4, 0.6 and 0.8 mol 
(diluted in .9% sodium chloride). 
 The CI will first test with the lowest concentration of citric acid. 
 At least 2.5 milliliters of sterile citric acid solution will be placed in a nebulizer cup, 
which is attached by tubing to a DeVilbiss Pulmomate nebulizer with a free-flow rate 
of eight liters per minute.   
 A facemask will be attached by connecting tubing to the nebulizer.  The CI will place 
the facemask over the subject’s nose and mouth and ask them to quietly breath for 15 
seconds.  The subject will be told that they should try not to cough. 
 There will be a break of at least one minute between each trial. 
 If the subject does cough at least twice on two of three trials the cough will be judged 
present.  
 If the cough is absent, the CI will repeat the CRT with the next higher concentration, 
continuing until the patient achieved a present strong cough or until the CI determines 
that the participant has an absent cough on all concentrations.   
 The citric acid trials will be interspersed with placebo trials of normal saline water.  If 
the patient coughs on two trials of normal saline, the cough will be considered 
abnormal and the patient will be excluded from the study.   
 If the subject’s cough is present on the first concentration of citric acid and absent on 
at least one of the saline solution tests, the test is complete. 
 Results will be recorded on the Case Report Form (Appendix E) and saved with the 
study records.  
5.2 Videoendoscopic Evaluation of Swallowing (VES) 




 Participant is seated upright at least 45° in a bed or chair 
 CI applies lubricant to endoscope. 
 CI guides endoscope along floor of nose. 
 CI then guides endoscope into nasopharynx and positions endoscope for an optimal 
view of larynx. 
 An assisting nurse or clinician will then provide participant with 5 controlled single 
sips of thin fluid.  If the participant manages this without significant aspiration, the nurse will 
next provide 150 mls to be taken via rapid ingestion.  
 The study will be recorded for review by an SLT blinded to the results of CRT.  
Recordings will be identified by study name and PIN. 
 Any significant findings that represent a potential risk to the participant, such as 
aspiration, absence of cough, poor control of secretions or laryngeal pathology will be 
recorded in the medical record and may be discussed with treating clinicians with the 
participant’s permission (as covered in Consent Form) 
 Tasks will be recorded on the Case Report Form.   
 The FEES will be recorded electronically, identified by PIN only and sent via 
encoded zip files to the reviewer.  The reviewer will complete the VES Rating Form 
(Appendix H).  If aspiration occurs on any trial aspiration will be recorded as present. 
6. SAFETY ASSESSMENTS/ADVERSE EVENTS 
An adverse event is defined as any unfavorable and unintended diagnosis, symptom, 
sign syndrome or disease that is not related to the subject’s medical condition.  The CI does 
not anticipate adverse events.  Subjects may experience a choking sensation or momentary 
chest tightness during the CRT (Dicpinigaitis, 2007).  In a study of outpatients undergoing 
VES, most found it not uncomfortable or mildly uncomfortable (62%), while 32% found it 
moderately uncomfortable (Cohen et al., 2003).  In rare cases patients can have minor, self-
limiting nosebleeds or fainting (Warnecke et al., 2009).  If an adverse event is suspected the 
CI will request a review by the patient’s doctor and the doctor will determine if it’s safe to 
continue the study.  The CI will complete a Reportable Event on the hospital system and 
report to ethics committee.  
7. STATISTICAL CONSIDERATIONS  
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7.1 General Design Issues  
CRT as a screening test is being compared to the gold standard of VES.  Analysis will 
aim to determine the sensitivity and specificity of CRT to predict absence of cough to 
aspiration on VES. 
The CI chose a general ICU population so that sample group is representative of a 
broad spectrum of patients and so that the results can be applied to a general ICU population.  
Because there is a predominance of surgical patients admitted to ICU, the enrollment is 
capped at 54 surgical patients and 54 non-surgical patients.  This is to ensure adequate 
numbers of participants in each group for analysis. 
The CI is performing both the CRT and VFS, which introduce bias.  It is not practical 
to have different clinicians perform each test due the timing – both examinations need to be 
done within one hour and within 24 hours of extubation.  This is prohibitive because of cost 
and resourcing.  The design controls for bias by the order of the examinations and using an 
SLT blinded to the results of the CRT to interpret the VES.  The CRT will be performed first 
and the CI will not have an expectation of performance.  The results of the CI will be 
recorded prior to the VES.  The VES will be performed by the CI, recorded, and sent to a 
blinded SLT for interpretation.  The blinded SLT will be indicating if aspiration is present or 
absent and if present, if cough was present or absent. 
7.2 Sample Size 
Using Method 2 of Jialiang Li and Jason Fine’s suggested methods for sample size 
and power calculations for disease screening tests (Li & Fine, 2004), with a “no cough” 
prevalence of 0.3 (30%) or less, 108  people will give us 80% power to detect a reduction of 
sensitivity from 90% to 60% at the .05 level of significance. 
7.3 Data Analyses  
The CI will calculate the proportion of participants with aspiration and silent on VES 
post intubation.  These data will then be used to compare to the results of the cough test to 
calculate sensitivity and specificity with 95% confidence intervals of the CRT to predict 
presence or absence of cough to aspiration on VES.  This will be repeated for each 
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concentration of citric acid.  In addition, the CI will perform stratified Chi-squared test to test 
for the significance of a relationship between the covariates and presence or absence of 
aspiration post-intubation (p < .05).  The cohort will be analysed as a whole and by 
diagnostic subgroup (surgical versus non-surgical). 
8. DATA COLLECTION AND QUALITY ASSURANCE 
All data from screening to CRT results will be recorded on the Case Report Form.  
All data will be collected by the CI and viewed only by her, her supervisor and co-supervisor.  
All records will be stored in clearly labeled binder in a locked-filing cabinet and scanned and 
saved electronically on a password-protected computer/network.  Any information taken off 
site will be identified only by Patient Identification Number and patient initials. 
9. PARTICIPANT RIGHTS AND CONFIDENTIALITY  
9.1 Ethics Approval  
This protocol, the information sheets, consent forms and any subsequent 
modifications will be reviewed and approved by the New Zealand Health and Disability 
Ethics Committee (HDEC) and Canterbury University Human Ethics Committee. 
9.2 Informed Consent Forms 
Information about the screening process, enrollment and study procedures will be 
provided verbally and in writing.  A signed consent form will be obtained from each 
participant.  When a participant is not competent to consent (as determined by treating 
doctor) the CI will provide written and verbal information to an appropriate 
relative/whanau/friend of the participant and ask them to sign the Statement for 
Relative/Whanau/Friend if they agree.  A copy of the consent form/statement will be given to 
each participant and this will be documented in the participant’s record.  
If a participant is not competent at the time of the study but regains competence 
during the course of their hospital stay, the CI will visit the participant, fully explain the 
study, and seek their consent.  The CI will explain that the participant has the option of 
withdrawing their information from the study. 
225 
 
9.3 Participant Confidentiality  
All paperwork will be kept in a locked cupboard when not in use.  Records will also 
be scanned and saved electronically on a password-protected computer.  Participants’ names 
will only appear on the Consent Form, Record of Participants, and Screening Log, which will 
not leave the site.  Other documentation will be identified with the Participant Identification 
Number (PIN) and participant’s initials only to maintain confidentiality.  All analysis will be 
completed using the PIN only.  Only PIN and initials will identify any information shared 
with the Co-Investigators.  Information will not be released without written permission of the 
participant, except as necessary for monitoring by the HDEC. 
9.4 Study Discontinuation  
All data will be collected unless an unexpected complication arises and the researcher 
feels the study may be creating risks for participants.   The study may also be discontinued if 
midway analysis demonstrates that results are reached sooner than anticipated.  
10. PUBLICATION OF RESEARCH FINDINGS  
The results will be summarized and submitted to an international, peer-reviewed 
journal for publishing. 
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APPENDIX A – INFORMATION SHEET FOR RELATIVE/WHANAU/FRIEND 
 
                                         
Information Sheet for Relative, Whānau Member or 
Friend 
Study title: CRAIn II 
Locality: C&CDHB Ethics committee ref.: 14/CEN/15 
Lead 
investigator: 
Molly Kallesen Contact phone number: 04 806 2345 
 
Your relative/whānau member/friend is invited to take part in a study on how breathing tubes 
affect swallowing.  Whether or not your relative/whānau member/friend takes part is your 
choice.  If you don’t want your relative/whānau member/friend to take part, you don’t have to 
give a reason, and it won’t affect the care they receive.  If you do want them to take part 
now, but change your mind later, you can pull them out of the study at any time.   
 
This Participant Information Sheet will help you decide if you would like for your 
relative/whānau member/friend to take part.  It sets out why we are doing the study, what 
participation would involve, what the benefits and risks might be, and what would happen 
after the study ends.  We will go through this information with you and answer any questions 
you may have.    You do not have to decide today whether or not you will agree for your 
relative/ whānau member/friend to participate in this study. Before you decide you may want 
to talk about the study with other people, such as family, whānau, friends, or healthcare 
providers.  Feel free to do this.  Unfortunatley, this study does not have funding to provide an 
interpreter for you or your relative/whānau member/friend. 
 
If you agree to take part in this study, you will be asked to sign the Consent Form on the last 
page of this document.  You will be given a copy of both the Information Sheet for Relative, 
Whānau Member of Friend and the Consent Form to keep. 
 
This document is seven pages long, including the Consent Form.  Please make sure you 




WHAT IS THE PURPOSE OF THE STUDY? 
Cough is the body’s way of clearing saliva, food or fluid from your airway.  Material can get 
into the lungs and cause a serious lung infection if the cough reflex is absent or weak.  
Sometimes people have trouble coughing and swallowing after they’ve had a breathing tube.  
This can slow recovery and healing.   
 
The aim of this project is to find out if a cough screening test is a useful way to predict how 
you protect your airway when eating and drinking.  To do this we will compare a new cough 
screening test to a well established test of swallowing.  The new cough screening test is 
quicker, easier and cheaper than the traditional test and is used routinely with people who 
have had a stroke.  However, we don’t know how reliable it is for patients in ICU who have 
had breathing tubes.  We want to know if this cough screening test can be used to identify 
ICU patients who are at high risk for getting an infection in the lungs.  We can then provide 
the best and safest treatment to avoid an infection.   
 
This study is sponsored by Capital and Coast DHB (C&CDHB) and the University of 
Canterbury (UC).  The lead investigator is a Speech-Language Therapist at C&CDHB and a 
student at UC.  This project has been reviewed and approved by the Central Health and 
Disability Ethics Committee, University of Canterbury Human Ethics Committee (Private Bag 
4800, Christchurch, email human-ethics@canterbury.ac.nz) and Capital & Coast District 
Health Board Research Advisory Group – Maori. 
 
If you have any questions about this study, you can contact the lead investigator using the 
details below. 
Molly Kallesen (Lead Investigator) 
04 806 2345 
molly.kallesen@ccdhb.org.nz 
 
WHAT WILL MY PARTICIPATION IN THE STUDY INVOLVE? 
You are being asked to agree to your relative/whānau member/friend taking part in this study 
because they have had a breathing tube (intubation) as part of their treatment in ICU.  In 
order to take part, they need to have had the breathing tube remove within the previous 
twelve hours, be older than 18 and able to eat and drink at the time the lead investigator 
comes to see them.  If they have had serious life-threatening nosebleeds, recently broken 
bones in the face or skull, are not for active treatment or have had a tracheostomy they will 
not be able to take part.  They must be able to give consent or have a relative, whānau 
member or friend who can consent on their behalf.  A total of 108 participants will be 
enrolled, half with a surgical reason for admission and half with a non-surgical diagnosis. 
 
If you agree for your relative/whānau member/friend to take part in the study, the lead 
investigator will come see them within 24 hours of having their breathing tube removed.  If 
you relative/whānau member/friend is able to make decisions at this time they will be asked 
to agree to the study themselves and will have the right to say no.  If they are not able to 
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make decisions the researcher will refer to your decision.  However, if it’s obvious that your 
relative/whānau member/friend does not want to take part (e.g. they push the tube away or 
shake their head no), the researcher will stop. 
 
If your relative/whānau member/friend agrees, they will have a cough reflex test (CRT) and 
videoendoscopy of swallowing (VES).  The two tests are described below.  The VES 
immediately follows the CRT and both should be finished in at total of 30 to 45 minutes. 
 
Cough Reflex Test (CRT):    
 The researcher will place a small amount of liquid into a nebuliser.  The nebuliser 
is a small device that turns the liquid into mist so it can be inhaled.  The mist is 
delivered through a mask that the researcher holds up to your relative/whānau 
member/friend’s mouth and nose.  They will be asked to breathe the mist in for 
15 seconds.    
 The mist may make them feel like coughing. The researcher will ask them to try 
not to cough.  The researcher will record any coughs. 
 After 15 seconds the mask will be taken off and your relative/whānau 
member/friend can relax.  The test may need to be repeated several more times. 
 
Videoendoscopy (VES):   
 Your relative/whānau member/friend will 
be asked to sit still and relax. 
 The researcher will pass a thin tube 
(4.9mm) through their nose with a tiny camera 
at the tip.  This should take about 10 to 15 
seconds.  The tube is well lubricated so that it 
can pass smoothly and easily through the nose.  
You can see a picture of the tube below next to 
a normal drinking straw, which is 6mm across.  
The camera takes a video, which is recorded on 
a DVD.  If you’re present, you will also be able to 
see the video on the screen. 
 
 Once the camera is in place the 
researcher may ask your relative/whānau 
member/friend to make some sounds, swallow and cough.  On the video the 
researcher will be able to see how well the structures of the throat and voice box are 
working. 
 The researcher will then ask them to swallow a few bites and sips of food that has 
been coloured blue or green.  The researcher will be looking to see if the food and 
drink go down the way they should.  
 The camera will then be gently removed and the test is finished. 
 
After these two tests are finished, the researcher will collect some information from the 




details about the breathing tube and pain medication.  Your relative/whānau member/friend 
will not need to do anything more for the study.   
 
You may decide that you do not want your relative/whānau member/friend to participate in 
the study.  In that case, the speech-language therapist may still assess them if the nurses or 
doctors suspect they are having swallowing problems.  They may have the tests described 
above as part of routine care if the team think this would help them make decisions about 
treatment and if your relative/whānau member/friend agrees.  This is not part of the study 
and any test results will not be recorded or stored outside of their medical record. 
 
WHAT ARE THE POSSIBLE BENEFITS AND RISKS OF THIS STUDY? 
The cough test has been used for many years.   No harmful effects from cough testing have 
been reported.  Your relative/whānau member/friend may feel slighy tightness in their chest 
when inhaling the mist.  Coughing may feel uncomfortable if they’ve just had surgery.  
Coughing is important for recovery and the doctors and nurses will encourage your 
relative/whānau member/friend to cough.   
 
Videoendoscopy is used routinely by speech-language therapists and doctors and is very 
safe.  A trained person will monitor your relative/whānau member/friend closely throughout 
the testing. The first 10 to 15 seconds when the camera is being positioned can be mildy to 
moderately uncomortable, but should not be painful.  A very small number of people have 
mild nosebleeds or faint during the test.  If your relative/whānau member/friend finds the 
VES too uncomfortable they can ask to stop. 
 
The videoendoscopy may identify that your relative/whānau member/friend has swallowing 
problems.  This will be useful information for making sure they have the best recovery 
possible.  The researcher may feel that they would benefit from further testing or advice 
about their swallowing.  In this case, the researcher will ask you or your relative/whānau 
member/friend’s permission to share this information with the people treating them.  The 
researcher or another speech-language therapist may come to visit your relative/whānau 
member/friend again to help manage any swallowing problems.  This is part of usual ICU 
treatment and is not part of the study.  The researcher will be very clear if she is seeing your 
relative/whānau member/friend for a reason unrelated to the study. 
  
 
WHO PAYS FOR THE STUDY? 
All costs for this study are covered by the University of Canterbury and C&CDHB.  It will not 
cost you or your relative/whānau member/friend anything to participate.  They will not 
receive any payment for taking part. 
 
WHAT IF SOMETHING GOES WRONG? 
If your relative/whānau member/friend were injured in this study, which is unlikely, they 
would be eligible for compensation from ACC just as they would be if they were injured in an 
accident at work or at home. They will have to lodge a claim with ACC, which may take 
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some time to assess. If their claim is accepted, they will receive funding to assist in their 
recovery.   
 
If your relative/whānau member/friend has private health or life insurance, you may wish to 
check with their insurer that taking part in this study won’t affect their cover. 
 
WHAT ARE MY RIGHTS? 
Participation: If you do agree for your relative/whānau member/friend to take part in this 
study you, or your your relative/whānau member/friend,  can stop at any time.  You do not 
need to give a reason for stopping.  Stopping will not change the care they receive.  Their 
participation in the study will be stopped should any harmful effects appear.  
 
Confidentiality:  The staff involved in treating your relative/whānau member/friend will know 
whether or not your relative/whānau member/friend is participating in this study.  Any 
identifiable information that is collected about your relative/whānau member/friend in 
connection with this study will remain confidential and will be shared only with your 
permission, except as required by law.  The identity of your relative/whānau member/friend 
will remain confidential in any study reports, publications or presentations.   
 
Questions: You may have a friend, family, or whanau support person to help you understand 
the risks and benefits of this study.  They are welcome to speak to the researcher with your 
permission.  Please contact the researcher listed on the front page of this information sheet 
if you have any questions.  
 
WHAT HAPPENS AFTER THE STUDY OR IF I CHANGE MY MIND? 
This form and other paperwork will be stored in a locked cupboard on the ICU or password-
protected computer and will only be available to the researcher and supervisors of the study.  
All records will be stored for a period of ten years then sent to the national archive.   The 
same investigator may use information collected in this study in future studies that have 
ethical approval from the New Zealand Health and Disability Ethics Committee. 
 
You and your relative/whānau member/friend can have copies of any publication of from this 
research.  You can also choose to have someone discuss the results of the study with you 
and/or your relative/whānau member/friend.  It will likely be one year before any information 
is available.  Please let the researcher know if you would like her to share the results with 
you. 
 
WHO DO I CONTACT FOR MORE INFORMATION OR IF I HAVE CONCERNS? 
If you have any questions, concerns or complaints about the study at any stage, you can 
contact the study supervisor at:  
 
Dr. Maggie-Lee Huckabee (Supervisor) 





If you want to talk to someone who isn’t involved with the study, you can contact an 
independent health and disability advocate on: 
 
Phone:  0800 555 050 
Fax:   0800 2 SUPPORT (0800 2787 7678) 
Email:   advocacy@hdc.org.nz 
 
For Maori health support please contact : 
 
Whānau Care Services 
04 806 0948 
wcs@ccdhb.org.nz 
 
You can also contact the health and disability ethics committee (HDEC) that approved this 
study on: 
 Phone:  0800 4 ETHICS 





                                         
Consent Form 
Please tick to indicate you consent to the following (Add or delete as appropriate) 
 
I have read, or have had read to me, and I understand the 
Information Sheet for Relative, Whānau Member of Friend.   
Yes  No  
I have been given sufficient time to consider whether or not to 
participate in this study. 
Yes  No  
I have had the opportunity to use a legal representative, whanau/ 
family support or a friend to help me ask questions and understand 
the study. 
Yes  No  
I am satisfied with the answers I have been given regarding the 
study and I have a copy of this consent form and information sheet. 
Yes  No  
I understand that taking part in this study is voluntary (my choice) 
and that I, or my relative/whānau member/friend, may withdraw 
from the study at any time without this affecting the medical care of 
my relative/whānau member/friend. 
Yes  No  
I consent to the research staff collecting and processing my 
relative/whānau member/friend’s information, including information 
about their health. 
Yes  No  
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If I decide to withdraw my relative/whānau member/friend from the 
study, I agree that the information collected about them up to the 
point when I withdraw may continue to be processed. 
Yes  No  
I consent to the medcial team being informed about my participation 
in the study and of any significant abnormal results obtained during 
the study. 
Yes  No  
I agree to an approved auditor appointed by the New Zealand 
Health and Disability Ethic Committees, or any relevant regulatory 
authority or their approved representative reviewing my 
relative/whānau member/friend’s relevant medical records for the 
sole purpose of checking the accuracy of the information recorded 
for the study. 
Yes  No  
I understand that my relative/whānau member/friend’s participation 
in this study is confidential and that no material, which could identify 
my relative/whānau member/friend, will be used in any reports on 
this study. 
Yes  No  
I know who to contact if I have any questions about the study in 
general. 
Yes  No  








Declaration by Relative/Whānau member/Friend: 
I hereby consent for my relative/whānau member/friend to take part in this study. 
 





Declaration by member of research team: 
 
I have given a verbal explanation of the research project to the participant’s relative/whānau 
member/friend, and have answered their questions about it.   
 
I believe that the relative/whānau member/friend understands the study and has given 










APPENDIX B – PARTICIPANT INFORMATION SHEET 
                                         
Participant Information Sheet  
Study title: CRAIn II 
Locality: C&CDHB Ethics committee ref.: 14/CEN/15 
Lead 
investigator: 
Molly Kallesen Contact phone number: 04 806 2345 
 
You are invited to take part in a study on how breathing tubes affect swallowing.  Whether or 
not you take part is your choice.  If you don’t want to take part, you don’t have to give a 
reason, and it won’t affect the care you receive.  If you do want to take part now, but change 
your mind later, you can pull out of the study at any time.   
This Participant Information Sheet will help you decide if you would like to take part.  It sets 
out why we are doing the study, what participation would involve, what the benefits and risks 
might be, and what would happen after the study ends.  We will go through this information 
with you and answer any questions you may have.  Before you decide you may want to talk 
about the study with other people, such as family, whānau, friends, or healthcare providers.  
Feel free to do this.  This study does not have funding to provide an interpreter for you. 
 
If you agree to take part in this study, you will be asked to sign the Consent Form on the last 
page of this document.  You will be given a copy of both the Participant Information Sheet 
and the Consent Form to keep. 
 
This document is seven pages long, including the Consent Form.  Please make sure you 
have read and understood all the pages. 
 
WHAT IS THE PURPOSE OF THE STUDY? 
Cough is the body’s way of clearing saliva, food or fluid from your airway.  Material can get 
into the lungs and cause a serious lung infection if the cough reflex is absent or weak.  
Sometimes people have trouble coughing and swallowing after they’ve had a breathing tube.  




The aim of this project is to find out if a cough screening test is an accurate way to predict 
how you protect your airway when eating and drinking.  To do this we will compare a new 
cough screening test to a well established test of swallowing.  The new cough screening test 
is quicker, easier and cheaper than the traditional test and is used routinely with people who 
have had a stroke.  However, we don’t know how reliable it is for patients in ICU who have 
had breathing tubes.  We want to know if this cough screening test can be used to identify 
ICU patients who are at high risk for getting an infection in the lungs.  We can then provide 
the best and safest treatment to avoid an infection.   
 
This study is sponsored by Capital and Coast DHB (C&CDHB) and the University of 
Canterbury (UC).  The lead investigator is a Speech-Language Therapist at C&CDHB who is 
also a student at UC.  This project has been reviewed and approved by the Central Health 
and Disability Ethics Committee, University of Canterbury Human Ethics Committee (Private 
Bag 4800, Christchurch, email human-ethics@canterbury.ac.nz) and Capital & Coast District 
Health Board Research Advisory Group – Maori. 
If you have any questions about this study, you can contact the lead investigator using the 
details below. 
Molly Kallesen (Lead Investigator) 
04 806 2345 
molly.kallesen@ccdhb.org.nz 
 
WHAT WILL MY PARTICIPATION IN THE STUDY INVOLVE? 
You are being asked to take part in this study because you have had a breathing tube 
(intubation) as part of your treatment in ICU.  In order to take part, you need to have had the 
breathing tube remove within the previous twelve hours, be older than 18 and able to eat 
and drink at the time the lead investigator comes to see you.  If you have had serious life-
threatening nosebleeds, recently broken bones in the face or skull, are not for active 
treatment or have had a tracheostomy you will not be able to take part.  You must be able to 
give consent or have a relative, whānau member or friend who can consent on your behalf.  
A total of 108 participants will be enrolled, half with a surgical reason for admission and half 
with a non-surgical diagnosis. 
 
The lead investigator will come see you within 24 hours of having the breathing tube 
removed.  If you agree to take part in the study, you will have a cough reflex test (CRT) and 
videoendoscopy of swallowing (VES).  The two tests are described below.  The VES 
immediately follows the CRT and both should be finished in at total of 30 to 45 minutes. 
 
Cough Reflex Test (CRT):    
 The researcher will place a small amount of liquid into a nebuliser.  The nebuliser is a 
small, electronic device that turns the liquid into mist so it can be inhaled.  The mist is 
delivered through a mask that the researcher holds up to your mouth and nose.  You 
will be asked to breathe the mist in for 15 seconds.    
 The mist may make you feel like coughing. The researcher will ask you to try not to 
cough.  The researcher will record any coughs. 
264 
 
 After 15 seconds the mask will be taken off and you can relax.  The test may need to 
be repeated several more times. 
 
Videoendoscopy (VES):   
 You will be asked to sit still and relax. 
 The researcher will pass a thin tube (4.9mm) through your nose with a tiny camera at 
the tip.  This should take about 10 to 15 seconds.  The tube is well lubricated so that 
it can pass smoothly and easily through the nose.  You can see a picture of the tube 
below.  The camera takes a video, which is recorded 
on a DVD.  You may be able to see the video on the 
screen. 
 
 Once the camera is in place the researcher 
may ask you to make some sounds, swallow and 
cough.  On the video the researcher will be able to see 
how well the structures of the throat and voice box are 
working. 
 The researcher will then ask you to swallow a 
few bites and sips of food that has been coloured blue 
or green.  The researcher will be looking to see if the 
food and drink go down the way they should.  
 The camera will then be gently removed and 
the test is finished. 
 
After these two tests are finished, the researcher will collect some information from the 
medical notes about why you are in hospital and details about the breathing tube and pain 
medication.  You will not need to do anything more for the study.   
 
You may decide that you do not want to participate in the study.  In that case, a speech-
language therapist may still assess you if the nurses or doctors suspect you are having 
swallowing problems.  You may have the tests described above as part of routine care if the 
team think this would help them make decisions about your treatment and if you agree.  This 
is not part of the study and any test results will not be recorded or stored outside of your 
medical record. 
 
WHAT ARE THE POSSIBLE BENEFITS AND RISKS OF THIS STUDY? 
The cough test has been used for many years.   No harmful effects from cough testing have 
been reported.  You may feel slight tightness in your chest when inhaling the mist.  
Coughing may feel uncomfortable if you’ve just had surgery.  Coughing is important for 
recovery and the doctors and nurses will encourage you to cough.   
 
Videoendoscopy is used routinely by speech-language therapists and doctors and is very 
safe.  A trained person will monitor you closely throughout the testing. The first 10 to 15 




should not be painful.  A very small number of people have mild nosebleeds or faint during 
the test.  If you find the VES too uncomfortable you can ask to stop. 
 
The videoendoscopy may identify that you have swallowing problems.  This will be useful 
information for making sure you have the best recovery possible.  The researcher may feel 
that you would benefit from further testing or advice about your swallowing.  In this case, the 
researcher will ask your permission to share this information with the people treating you.  
The researcher or another speech-language therapist may come to visit you again to help 
manage any swallowing problems.  This is part of usual ICU treatment and is not part of the 




WHO PAYS FOR THE STUDY? 
All costs for this study are covered by the University of Canterbury and C&CDHB.  It will not 
cost you anything to participate.  You will not receive any payment for taking part. 
 
WHAT IF SOMETHING GOES WRONG? 
If you were injured in this study, which is unlikely, you would be eligible for compensation 
from ACC just as you would be if you were injured in an accident at work or at home. You 
will have to lodge a claim with ACC, which may take some time to assess. If your claim is 
accepted, you will receive funding to assist in your recovery.   
 
If you have private health or life insurance, you may wish to check with your insurer that 
taking part in this study won’t affect your cover. 
 
WHAT ARE MY RIGHTS? 
Participation: If you do agree to take part in this study you can stop at any time.  You do not 
need to give a reason for stopping.  Stopping will not change the care you receive.  Your 
participation in the study will be stopped should any harmful effects appear.  
 
Confidentiality:  The staff involved in treating you will know whether or not you are 
participating in this study.  Any identifiable information that is collected about you in 
connection with this study will remain confidential and will be shared only with your 
permission, except as required by law.  Your identity will remain confidential in any study 
reports, publications or presentations.   
 
Questions: You may have a friend, family, or whanau support person to help you understand 
the risks and benefits of this study.  They are welcome to speak to the researcher with your 
permission.  Please contact the researcher listed on the front page of this information sheet 




WHAT HAPPENS AFTER THE STUDY OR IF I CHANGE MY MIND? 
This form and other paperwork will be stored in a locked cupboard on the ICU or password-
protected computer and will only be available to the researcher and supervisors of the study.  
All records will be stored for a period of ten years then sent to the national archive.   The 
same investigator may use information collected in this study in future studies that have 
ethical approval from the New Zealand Health and Disability Ethics Committee. 
 
You can have copies of any publication of from this research.  You can also choose to have 
someone discuss the results of the study with you.  It will likely be more than one year 
before any information is available.  Please let the researcher know if you would like her to 
share the results with you. 
 
WHO DO I CONTACT FOR MORE INFORMATION OR IF I HAVE CONCERNS? 
If you have any questions, concerns or complaints about the study at any stage, you can 
contact the study supervisor at:  
 
Dr. Maggie-Lee Huckabee (Supervisor) 
03 378 6070 
maggie-lee.huckabee@canterbury.ac.nz 
 
If you want to talk to someone who isn’t involved with the study, you can contact an 
independent health and disability advocate on: 
 
Phone:  0800 555 050 
Fax:   0800 2 SUPPORT (0800 2787 7678) 
Email:   advocacy@hdc.org.nz 
 
For Maori health support please contact : 
 
Whānau Care Services 
04 806 0948 
wcs@ccdhb.org.nz 
 
You can also contact the health and disability ethics committee (HDEC) that approved this 
study on: 
Phone:  0800 4 ETHICS 
Email:  hdecs@moh.govt.nz 
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Participant Consent Form 
Please tick to indicate you consent to the following (Add or delete as appropriate) 
 
I have read, or have had read to me, and I understand the 
Participant Information Sheet. 
Yes  No  
I have been given sufficient time to consider whether or not to 
participate in this study. 
Yes  No  
I have had the opportunity to use a legal representative, whanau/ 
family support or a friend to help me ask questions and understand 
the study. 
Yes  No  
I am satisfied with the answers I have been given regarding the 
study and I have a copy of this consent form and information sheet. 
Yes  No  
I understand that taking part in this study is voluntary (my choice) 
and that I may withdraw from the study at any time without this 
affecting the my medical care. 
Yes  No  
I consent to the research staff collecting and processing my 
information, including information about my health. 
Yes  No  
If I decide to withdraw from the study, I agree that the information 
collected about me up to the point when I withdraw may continue to 




I consent to the medcial team being informed about my participation 
in the study and of any significant abnormal results obtained during 
the study. 
Yes  No  
I agree to an approved auditor appointed by the New Zealand 
Health and Disability Ethic Committees, or any relevant regulatory 
authority or their approved representative reviewing my relevant 
medical records for the sole purpose of checking the accuracy of 
the information recorded for the study. 
Yes  No  
I understand that my participation in this study is confidential and 
that no material, which could identify me, will be used in any reports 
on this study. 
Yes  No  
I know who to contact if I have any questions about the study in 
general. 
Yes  No  






Declaration by Participant: 
I hereby consent to take part in this study. 
 





Declaration by member of research team: 
 
I have given a verbal explanation of the research project to the participant and have 
answered their questions about it.   
 

















    
    
    
    
    
    
    









Reason for Exclusion 
   
   
   
   
   
   
   




APPENDIX E – CASE REPORT FORM 
 
Patient Initials:  Date of 
Enrollment: 
 









History of severe nosebleeds Yes (exclude) No 
Facial or base of skull fracture < 4 
weeks 
Yes (exclude) No 
Patient or NOK able to provide 
consent? 
Yes No (exclude) 
GCS  <13  ≥13 
Ok for oral intake? Yes No 
Patient palliative? Yes (exclude) No 
Comments on above: 
 
Covariates: 
Date & time of intubation:             /          /  
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Date & time of extubation:             /          /  
Diagnosis type:   Surgical                  Non-surgical 
Primary diagnosis: 
Apache III score:  




Patient ID:  
 
Videoendoscopic Evaluation of Swallowing (VES): 
 5 controlled sips thin fluid  
If stopped, comment why incomplete: 
 
 
 150mls thin fluid continuous drinking 
If stopped, comment why incomplete: 
 
 
COUGH REFLEX TEST: 
Record for each trial A = absent, W = weak, S = strong pass, X = not administered 
Instruct the participant to try not to cough 
Date of CRT  
Time of CRT  
Concentration  Presentation 1 Presentation 2 Presentation 3 
____ mol / saline    
____ mol / saline    
____ mol / saline    
____ mol / saline    
Subject Threshold = _____________        OR   Absent Cough 











PIN: Date reviewed: 
Date of FEES: Reviewer: 
Aspiration 
(circle one below) 
Cough 
(circle one below) 
Present         Absent         Trace        Present                     Absent 
Secretions Rating (circle)            0            1            2            3 
Comment on secretions: 
 
